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ZUSAMMENFASSUNG 
Temporallappen Epilepsie (TLE) gehört zu den häufigsten Epilepsieformen und spricht oft nicht 
auf Pharmakotherapie an, insbesondere wenn TLE mit hippocampaler Sklerose (HS) assoziiert 
ist. TLE ist charakterisiert durch spontane rezidivierende Anfälle (SRS, Englisch: spontaous 
recurrent seizures), die im medialen Temporallappen ihren Ursprung nehmen. Solche Anfälle 
treten infolge einer initialen Hirnverletzung nach einer gewissen Latenzphase auf. Eine 
unilaterale Injektion von Kainate (KA) in den dorsalen Hippocampus einer ausgewachsenen 
Maus führt zu vielen Veränderungen, vergleichbar zu jenen, die dem Krankheitsbild von TLE 
zugeschrieben werden. Die intrahippocampale Kainate (IHK) Injektion löst einen Status 
epilepticus (SE) aus, der nach einer Latenzphase zur Entstehung von SRS führt. Ferner, kommt 
es nach dem IHK-induzierten SE zu einem progressiven Verlust von spezifischen Zellgruppen 
im Hippocampus, einer axonalen Reorganisation und der Dispersion von Körnerzellen im Gyrus 
Dentatus. Obwohl dieses TLE Modell histologisch und funktionell sehr gut charakterisiert ist, 
herrscht nach wie vor Unklarheit, welcher dieser vielen Veränderungen schlussendlich zur 
Epileptogenese beiträgt. Aus diesem Grund haben wir in der vorliegenden Studie den Einfluss 
der neuronalen Entzündung und früher epileptischer Aktivität während der Latenzphase auf die 
Epileptogenese in TLE untersucht. Ferner haben wir untersucht, wie sich frühe pathologische 
Veränderungen, die mit der Alzheimer Krankheit (AD, Englisch: Alzheimer’s disease) 
einhergehen, auf die Entwicklung von Epilepsie im Kainate Model von TLE auswirken. 
In der ersten Studie haben wir verschiedene Komponenten des Immunsystems untersucht, die 
mit der Epilepsie assoziiert sind und potentiell für die Entstehung eines epileptischen Fokus 
verantwortlich sind. Als erstes haben wir evaluiert, welchen Effekt eine chronische Störung des 
angeborenen Immunsystems, durch ein sogenanntes „priming“, auf Epileptogenese und das 
Auftreten von SRS hat. Zu diesem Zweck haben wir Mäuse pränatal und/oder postnatal 
systemisch mit dem viralen Imitator PolyI:C injiziert, der das Immunsystem „primen“ soll. 
Obwohl wir keinen Effekt nach vorausgeganger, systemischer Infizierung auf die Entwicklung 
der später induzierten Epilepsie beobachten konnten, sind die Resultate nicht eindeutig, 
insbesondere im Hinblick auf die Tatsache, dass es an einem unabhängigen Beleg gefehlt hat, der 
darauf hingewiesen hätte, dass das „primen“ des Immune Systems funktioniert hat. Als nächstes 
haben wir intrazelluläre Sensoren untersucht, sogenannte Inflammasome, die in Mikroglia und 
Makrophagen die Produktion von Interleukin (IL)-1β verantwortlich ist. Wir haben evaluiert, 
welchen Auswirkungen das Fehlen von NLRP3 Inflammasome in Knockout Mäusen auf das 
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neurodegenerative Muster und die damit assoziierte Immunantwort hat während der Kainate-
induzierten Epileptogenese. Da wir keine Unterschiede feststellen konnten zu Kontrollmäusen, 
gehen wir davon aus, dass die Produktion von IL-1β und das mit der Entzündung einhergehende 
Zellsterben im Kainate Model von TLE unabhängig von NLRP3 Inflammasomen sind. 
Schliesslich haben wir basierend auf den Schlussfolgerungen einer früheren Studie genauer 
untersucht, welche Rolle infiltrierende, periphere monozytische Phagozyten für das Überleben 
von Körnerzellen haben. Das Fehlen von C-C Chemokinen Rezeptor Typ 2 (CCR2) in Knockout 
Mäusen hatte jedoch keine Auswirkung auf das Überleben der Körnerzellen während der 
Kainate-induzierten Epileptogenese. 
Bereits in einem frühen Krankheitsstadium weisen Patienten und Tiermodelle mit AD eine 
Dysfunktion des neuralen Netzwerkes und anomale epileptische Aktivität auf. Aus diesem Grund 
haben wir in der zweiten Studie untersucht, ob frühe Veränderungen, die mit AD assoziiert sind, 
das hippocampale Netzwerk empfänglich macht für die Entstehung von erworbener Epilepsie. 
Wir konnten nachweisen, dass unser AD Maus Modell noch vor dem Auftreten der für die AD 
charakteristischen amyloiden Plaque Ablagerungen eine erhöhte Anfälligkeit auf den SE und 
eine verfrühtes Auftreten von SRS zeigen. Elektrophysiologische Experimente in CA1 
hippocampalen Neuronen haben erwiesen, dass diese drei Monate alten ArcticAβ Mäuse eine 
reduzierte synaptische Erregbarkeit, eine erhöhte KA-induzierte Langzeit Potenzierung (LTP, 
Englisch: long-term potentiation) und reduzierte Frequenz von spontanen inhibitorischen 
Strömen besitzen. Das neurodegenerative Muster, die Entzündungsreaktion, die axonale 
Reorganisation oder die adulte Neurogenese hat sich nach der IHK-induzierten Epileptogenese 
zwischen ArcticAβ und Kontrollmäusen nicht unterschieden. Im Gegensatz dazu, wurde jedoch 
eine Abschwächung der SE-assoziierten Erhöhung von Neuropeptide Y (NPY) in Moosfasern 
und Körnerzellen im AD Model beobachtet. Obwohl eine Beeinträchtigung in der NPY 
Signalkaskade direkte zum verfrühten Auftreten von SRS beitragen könnte, konnte der 
übererregbare Phänotyp und die verfrüht auftretenden SRS unterbunden werden, wenn vor der 
IHK-induzierten Epileptogenese die löslichen Aβ Spezimen in ArcticAβ Mäusen mit Hilfe eines 
intrazerebral applizierten anti-Aβ spezifischen Antikörpers entfernt wurden.  
Schliesslich haben wir in der dritten Studie untersucht, welche Rolle der frühen epileptiformen 
Aktivität während der Latenzphase zukommt und wie diese den Entwicklung von SRS 
beeinflusst. Zusammen mit diesen kurzen epileptischen Entladungen treten viele andere 
Veränderungen während der Latenzphase auf, wie zum Beispiel das Zellsterben oder die 
Schaffung von zurückprojizierenden, erregenden Kreisläufen. Eine optogenetische Intervention 
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im geschlossenen Kreislauf (COI, Englisch: closed-loop optogenetic intervention) während der 
zwei Wochen langen Anfallsfreien Latenzzeit wurde verwendet, um herauszufinden ob diese 
frühe epileptische Aktivität die der Epileptogenese zugrunde liegende Netzwerk Reorganisation 
begünstigt. Wir haben erfolgreich einen Algorithmus entwickelt, der es ermöglicht schnell 
(innerhalb von weniger als 40ms) online kurze epileptische Aktivität zu detektieren. Unsere 
vorläufigen Daten zeigen eine Reduktion in der SRS Frequenz vier Monate nachdem während 
der IHK-induzierte Epileptogenese mit Hilfe von COI anomale Aktivität inhibiert wurde.  
Unsere Resultate weisen darauf hin, dass frühe epileptiforme Aktivität während der Latenzphase 
mit hoher Wahrscheinlichkeit direkt die Entstehung von SRS beeinflusst. Ferner ist während der 
Latenzphase die Entzündungsreaktion als Antwort auf die Neurodegeneration und insbesondere 
das angeborene Immunsystem involviert in die Netzwerkreorganisation und Bildung eines 
epileptischen Fokus im IHK Model von TLE. Jedoch sollte die Aktivierung des angeborenen 
Immunsystems als ein Teil einer breiteren Immunantwort verstanden werden, in welcher 
bestimmte Prozesse höchstwahrscheinlich von anderen Immunzellen kompensiert werden 
können ohne dabei den Verlauf der Epileptogenes zu beeinflussen. In einem AD Mausmodell 
konnten wir das Auftreten von SRS während der Latenzphase auf das Vorhandensein von 
löslichen Aβ Spezimen zurückführen, die sehr wahrscheinlich die synaptische Funktion 
beeinflussen. Obwohl wir zeigen konnten, dass die Anfallspathologie durch eine Intervention 
während der Latenzphase beeinflusst werden kann, deuten diese Resultate darauf hin, dass das 
Netzwerk bereits früh nach dem SE sich so verändert hat um die Entstehung von SRS zu 
ermöglichen. 
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ABSTRACT 
Temporal lobe epilepsy (TLE) is one of the most common form of adult seizure disorders, and 
when associated with hippocampal sclerosis (HS) often resistant to pharmacotherapy. 
Electrographically, TLE is defined by the occurrence of spontaneous recurrent seizures (SRS) 
originating from the medial temporal lobe after latent period following a precipitating brain 
insult. The unilateral injection of kainic acid (KA) into the dorsal hippocampus in adult mice 
mirrors many characteristics of TLE and induces a status epilepticus (SE), which is followed by 
a two-week latent period and subsequently the onset of SRS. Histologically, intrahippocampal 
kainic acid (IHK) injection causes a progressive loss of specific groups of hippocampal cells, 
axonal reorganization and dispersion of granule cells (GC) in the dentate gyrus (DG), similar to 
TLE. Although this model of TLE is well characterized histologically and functionally, it still 
remains unknown which of these multiple alterations contribute to epileptogenesis. Therefore, 
we evaluated the contribution of neuroinflammation and early epileptiform activity to 
epileptogenesis in TLE, as well as the impact of early pathophysiological alterations related to 
Alzheimer’s disease (AD) on the development of epilepsy in the IHK model of TLE.  
In the first study, we investigated the role of different components of the epileptogenesis-
associated immune reaction to the formation of an epileptic focus. First, we assessed the effect of 
chronically perturbing innate immunity, ‘priming’, on epileptogenesis and SRS occurrence by 
prenatally and/or postnatally exposing mice to the viral mimic PolyI:C. Although no effect of 
these systemic immune challenges was observed on the development of epilepsy, we lacked 
independent evidence that the immune system was primed as expected at the time of IHK-
induced SE. Therefore, these results remain inconclusive. Second, mice devoid of NLRP3 
inflammasomes were examined to determine if these intracellular sensors involved in the 
interleukin (IL)-1β production of microglia and macrophages affect the pathogenesis of a pro-
epileptic lesion. The IHK-induced neurodegenerative pattern and associated immune response 
was not altered, suggesting that the production of IL-1β and inflammation-associated 
neurodegeneration are independent of NLRP3 inflammasomes in the IHK model of TLE. 
Finally, as proposed by an earlier study, we examined whether preventing infiltration of 
peripheral monocytic phagocytes is essential for GC survival in the DG. Selectively interfering 
with their recruitment, the absence of infiltrating peripheral phagocytes in C-C chemokine 
receptor type 2 (CCR2)-KO mice had no effect on the survival of GC during IHK-induced 
epileptogenesis. 
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Already at early disease stages, neuronal network dysfunction and aberrant epileptic activity are 
detected in both patients and animal models of AD. We determined in the second study whether 
early AD-associated alterations render the hippocampal network more susceptible to 
development of acquired epilepsy. We found an increased susceptibility to IHK-induced SE and 
early onset of SRS in an AD mouse model, ArcticAβ mice, characterized by delayed amyloid 
deposition in the brain. In 3-months-old ArcticAβ mice, prior to plaque formation, 
electrophysiological recordings in CA1 hippocampal neurons revealed a decreased synaptic 
strength, increased KA-induced long-term potentiation (LTP), and reduced frequency of 
spontaneous inhibitory currents. While ArcticAβ mice and wildtype littermates did not differ in 
the IHK-induced pattern of neurodegeneration, neuroinflammation, axonal reorganization or 
adult neurogenesis, the elevated expression of neuropeptide Y (NPY) in mossy fibers and GC 
induced by IHK was attenuated in mutants. While impaired NPY signaling might directly 
contribute to the early seizure onset, the hyperexcitable phenotype and the SRS pathology early 
during epileptogenesis in ArcticAβ mice were prevented by clearing soluble Aβ species by an 
Aβ-specific antibody applied intracerebrally prior to induction of acquired epilepsy.  
Finally, the third study examined the role of early epileptiform activity occurring during the 
latent period for the development of SRS. Together with these brief epileptic discharges, 
multiple alterations, including neurodegeneration and the formation of new recurrent excitatory 
circuits, precede the first occurrence of SRS. Closed-loop optogenetic intervention (COI) was 
used for the first two weeks after IHK injection to curtail brief epileptic discharges and 
determine whether this early aberrant activity drives epileptogenesis-associated network 
reorganization. We succeeded to develop an algorithm for fast (<40ms) on line detection of brief 
discharges. Our preliminary data reveal a reduction in SRS frequency four months after 
interfering with IHK-induced epileptogenesis by COI.  
Our results suggest that early epileptiform activity during the latent period most likely affects the 
development of SRS directly, while the neurodegeneration-associated immune responses, in 
particular of the innate immune system, are involved in concomitant network reorganization and 
the formation of an epileptic focus in the IHK model of TLE. However, as part of a broader 
immune response, certain processes might be compensated by other immune cells, without 
affecting epileptogenesis per se. In the AD-mouse model, the early onset of SRS during the 
latent period is mediated primarily by soluble Aβ specimen, probably by affecting synaptic 
function. Although seizure pathology can be influenced later on, our findings suggest that 
alterations occurring early after SE render the network highly susceptible to the generation of SR
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I. GENERAL INTRODUCTION 
Epilepsy and seizure classification 
Epilepsy is a group of chronic neurological disorder with 65 million people being affected 
worldwide. The International League Against Epilepsy (ILAE) formulated two definitions for 
seizure and epilepsy. The conceptual definitions were formulated by Fisher et al. (2014): 
• “An epileptic seizure is a transient occurrence of signs and/or symptoms due to abnormal 
excessive or synchronous neuronal activity in the brain.” 
• “Epilepsy is a disorder of the brain characterized by an enduring predisposition to 
generate epileptic seizures, and by the neurobiologic, cognitive, psychological, and social 
consequences of this condition. The definition of epilepsy requires the occurrence of at least one 
epileptic seizure.” 
Practical clinical definition of epilepsy, however, demands two unprovoked or reflex seizures, 
which are more than twenty-four hours apart (Fisher et al., 2014). The classification of seizures 
is based on different categorize and summarized in the ILAE 2017 seizure classification (Fisher 
et al., 2017b; Fisher et al., 2017a). Seizures of focal, generalized and unknown onset can be 
distinguished. While focal seizures are limited to one hemisphere and are often originate in 
subcortical structures, generalized seizures rapidly spread bilaterally. Seizures of unknown onset 
still can feature certain characteristics and serves as a placeholder for future reclassification 
(Fisher et al., 2017b). The other levels of classification are optional and in some cases specific 
for one of the categorize mentioned above (Table 1).  
Table 1 The basic ILAE 2017 operational classification of seizure types (Fisher et al., 2017b; Fisher et al., 2017a) 
Focal Onset Generalized Onset Unknown Onset 
Aware/Impaired Awareness Motor  
(Tonic-clonic/other motor) 
Nonmotor (Absence) 
Motor  
(Tonic-clonic/other motor) 
Nonmotor (Absence) 
Focal to bilateral tonic-clonic  Unclassified 
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Temporal lobe epilepsy (TLE) and different animal models 
Temporal lobe epilepsy (TLE) is a group disorders that involves the generation of focal seizures 
originating from the temporal lobe of one hemisphere. Two main categories can be 
distinguished: mesial (MTLE) and lateral temporal lobe epilepsy (LTLE). While seizures in 
MTLE arise from the inner aspect of the temporal lobe, including the hippocampus, 
parahippocampal gyrus and the amygdala, LTLE seizures originate from neocortex at the outer 
surface of the temporal lobe.  
MTLE (which we from now on refer to as TLE) is often associated with hippocampal sclerosis 
(HS), delineating the epileptic focus. Typical HS features a loss of neurons in the cornu ammonis 
(CA) region 1 (CA1) and in the polymorphic layer - the so-called hilus of the dentate gyrus (DG) 
(Thom, 2004). Occasionally, a dispersion of granule cells (GC) can be found in the DG, and only 
in a few cases GC loss is observed (Houser, 1990). In TLE patients, mossy fibers, GC axons that 
project into the hilus of the DG and stratum lucidum of CA3, were shown to target GC dendrites 
in the inner molecular layer of the DG (Scheibel et al., 1974), in a process termed mossy fiber 
sprouting.  
Although it still not entirely resolved what mechanisms underlie the induction of these multiple 
alterations in humans, several animal models exist mirroring certain aspects of the histological 
and electrographic hallmarks of TLE. Experimentally, traumatic brain injury, different 
pharmacologic agents or electrical stimulation can induce a status epilepticus (SE), which is 
defined as continuous seizure activity lasting for more than 30 min (for tonic-clonic SE) or 60 
min (for focal SE) (Trinka et al., 2015). Common pharmacological models of SE are pilocarpine 
or kainic acid (KA). Pilocarpine is a cholinergic agonist and induces after systemic 
administration brain damage in hippocampal and extrahippocampal regions, including olfactory 
cortex, amygdala, thalamus, neocortex, and substantia nigra (Turski et al., 1983; Curia et al., 
2008). Since KA can be injected on different ways (intracerebroventricular, intracerebral, or 
systemically), different lesion patterns are observed. Systemic injection of KA causes damage in 
the hippocampus, entorhinal cortex, amygdala, pyriform cortex, septum and medial thalamus, 
whereas in the hippocampus, the ventral area seems particularly vulnerable (Lothman and 
Collins, 1981). Even within the brain, intrahippocampal KA (IHK) injection (described below) 
differed from the intracerebroventricular (icv) injection of KA, showing hippocampal damage 
most consistently in CA3 (Nadler et al., 1978).   
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Histopathology during TLE epileptogenesis in the IHK model 
Neurodegeneration and granule cell dispersion 
Some of the first cells that disappear after a IHK injection are calretinin (CR)-positive hilar 
mossy neurons in the ipsilateral hippocampus, as evident in Nissl-stained sections 24 hours after 
the injection (Bouilleret et al., 2000b). At the same time, pyknotic pyramidal cells are found in 
CA1 and in CA3, proximal between the blades of the DG (CA3c), while CA2 and CA3a,b cell 
are generally spared (Figure 1) (Bouilleret et al., 2000b; Bouilleret et al., 2000a). The pattern 
remains the same at about 600-800 µm both anterior and posterior from the injection side, while 
gradually diminishing posteriorly thereafter (personal observation). Although the entire CA1-3 
can be affected at the injection side, the IHK-induced lesion can presumably be conceived as a 
uniform focus. The following days, cell loss in the pyramidal layers and dispersion of GC 
becomes evident (Suzuki et al., 1995b; Bouilleret et al., 1999). The dispersion of GC was found 
to be a result of reelin deficiency (Heinrich et al., 2006) and could be locally prevented by an 
infusion of exogenous reelin (Müller et al., 2009). Duveau et al. (2011) revealed that reelin 
secretion from Cajal-Retzius, located in the hippocampal fissure, is impaired due to abnormal 
proteolytic processing and the production of truncated reelin. After 4 months, the dispersed DG 
enlarged and covered almost the entire hippocampal formation, while CA3 was reduced and CA1 
 
Figure 1 Characteristic changes in the epileptic focus in patients with TLE and the IHK model of TLE.    
A. Cresyl violet-stained (Nissl) section of a control (left) and an epilepsy (middle) specimen, showing the 
hippocampal formation. Cell loss is apparent in CA1, parts of CA3 and the hilus. The dentate gyrus shows a 
dispersion of granule cell (see also higher magnification on the right). B. Similar neuropathological alterations 
can be seen in adult mice 15 days post IHK injection (dpi) in the ipsilateral (middle), but not in the contralateral 
hippocampus (left). The dispersion of granule cells progressively increases, as seen 4 months post injection 
(right). Images are modified from Houser (1990) for A and Bouilleret et al. (1999; 2000b) for B. 
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almost completely disappeared (Bouilleret et al., 2000b). Strikingly, Bouilleret et al. (2000b) 
observed that GC dispersion at 7 or 15 days post injection (dpi) was only evident in mice 
displaying a severe degeneration of CA1. This was later confirmed by simultaneously alleviating 
cell loss in CA1 and GC dispersion after an intrahippocampal application of botulinum 
neurotoxin E (BoNT/E) 3 hours after IHK-induced SE (Antonucci et al., 2008), in a process 
shown to involve brain derived neurotrophic factor (BDNF)-tropomyosin receptor kinase B 
(TrkB) signaling (Duveau et al., 2011).  
Reelin-and CR-positive Cajal-Retzius are one of the few interneurons that survive in the 
epileptic focus. In contrast, parvalbumin (PV)-, calbindin (CB)-, somatostatin (SOM)-, 
neuropeptide Y (NPY)- and other reelin-positive interneurons disappear in CA1, DG and to some 
extent in CA3, while CR-positive interneurons were mostly spared (Bouilleret et al., 2000b; 
Bouilleret et al., 2000a; Duveau et al., 2011). The loss of interneurons happens within the first 24 
hours and was confirmed to be not just a loss of staining of a particular protein (e.g. calcium-
binding protein) by observing a simultaneous disappearance of GABAA-receptor ɑ1 subunit-
immunoreactivity (IR) (Bouilleret et al., 2000b; Bouilleret et al., 2000a), which is expressed by 
all hippocampal PV-positive interneurons (Gao and Fritschy, 1994).  
Synaptic reorganization 
Different forms of sprouting were reported, however mainly involving the DG. For example, 
mossy fibers and axons of GC projecting to CA3 were found to sprout and innervate GC 
dendrites in the inner molecular layer after epileptic activity. As also noticeable after chronic 
synchronous activation of the perforant path, mild sprouting can be detected by the high Zn2+ 
content of mossy fibers (Sutula et al., 1988), and severe epileptic discharges as for example IHK- 
or pilocarpine-induced SE are able to cause a strong (Okazaki et al., 1995; Bouilleret et al., 
1999). Interestingly, rapamycin was able to suppress mossy fiber sprouting and reduce the 
hypertrophy of dentate GC, however, without having any effect on seizure frequency, granule 
cell proliferation, the occurrence of ectopic cells and the loss of hilar neurons (Buckmaster and 
Lew, 2011). At the same time, ablating mossy cells by an adeno-associated virus (AAV)- 
mediated cell-specific diphtheria toxin (DT) expression did not cause mossy fiber sprouting or 
spontaneous seizures (Jinde et al., 2012).  
Ectopic expression of NPY 
Under physiological conditions, NPY is selectively expressed in interneurons, while epileptic 
activity induces an ectopic expression of NPY in various animal models and patients suffering 
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from TLE. Seizures induced by systemic or intrahippocampal KA (Sperk et al., 1992; Gruber et 
al., 1994; Makiura et al., 1999; Bouilleret et al., 2000b), pilocarpine (Lurton and Cavalheiro, 
1997) or a hilar lesion (White and Gall, 1987) lead to a transient increase in NPY levels in NPY-
positive interneurons, granule cells and mossy fibers (Figure 2). An early study in NPY-deficient 
mice reported an increase in seizure susceptibility, severity and a shortened latency to behavioral 
seizures upon injection of the GABAergic antagonist pentylenetetrazole (PTZ) (Erickson et al., 
1996). While both NPY-deficient mice and mice deficient of the NPY Y5 receptor (Y5R) 
showed more severe behavioral seizures and seizure-associated deaths, similar frequency and 
duration of pure electrographic seizures were reported in NPY-deficient mice (Baraban et al., 
1997; Marsh et al., 1999). As a result, many studies examined the effect of NPY supplementation 
through direct NPY injection (Woldbye et al., 1996; Baraban et al., 1997; Woldbye et al., 1997; 
Vezzani et al., 1999a) or local AAV-mediated overexpression of NPY and Y2R or Y5R in the 
hippocampus (Richichi et al., 2004; Sorensen et al., 2009; Woldbye et al., 2010; Gotzsche et al., 
2012). Summarized in Table 2, the stimulation of the NPY pathway particularly affected seizure 
severity and mortality. 
 
 
 
Figure 2 Ectopic NPY-IR. A. NPY-IR appears already 24 hours after IHK injection in both hemispheres. While 
NPY interneurons are spared in the contralateral hippocampus, the cells are lost on the ipsilateral side. Ectopic 
NPY-IR can be detected in mossy fibers and granule cells of the dentate gyrus (compare also magnification of 
the ipsilateral dentate gyrus). B. In NaCl (or naïve) mice, NPY is almost solely detected in interneurons. Images 
are modified from Bouilleret et al. (2000b). 
  
Table 2 Literature about the seizure leviating effect of NPY 
Ref. 
Treatment/model 
Model 
Acute/  
chronic 
Animals 
latency number 
Seizure 
freq 
duration 
Time in 
seizure 
score (modified Racine 
scale) 
survival AD duration 
Seizure grade over 
progression of 
stimulation 
Number 
of 
seizures 
Number of 
stimulations for 
seizure induction 
Number 
of second 
ADs 
AD 
threshold 
SE 
(contin.; 
>10/30
min) 
1st 
MS 
non-
conv 
conv 
non-
conv 
conv nonconv 
overexpr area 
Gotzsche et 
al., 2012 
NPY 
H  
 
bilat.; 
dorsal 
KA 
(s.c.) 
acute 
Male 
Wistar 
rats 
↑ ↑   -         ↓ ↓               
YR5 - -   -         - -               
NPY/YR5  ↑↑↑ ↑↑↑   ↓         ↓↓↓ ↓↓↓               
Woldbye et 
al., 2010 
YR2 
H  
 
bilat. 
 
dorsal and 
ventral 
rapid 
kindl. 
acute 
Male 
Sprang.
Dawley 
rats 
                      ↓ ↓ 
↓ (for 
Grade 
4-5) 
↑ (for Grade 3-5 of 
5) 
  - 
re-kindl.                         ↓ 
↓ (for 
Grade 
4-5) 
↑ (for Grade 2-5 of 
5) 
↓↓   
KA 
(s.c.) 
Male 
Wistar 
rats 
↑ ↑             ↓   
↑ (from 
25% to 
100%) 
            
NPY/YR2 
rapid 
kindl. 
Male 
Sprang.
Dawley 
rats 
                                ↑ 
Lendri et al., 
2016 
NPY/YR2 
H 
 
unilat. 
 
dorsal and 
ventral 
IHK 
(unilat.) 
chronic 
Male 
Wistar 
rats 
      
steady 
(before/after 
treatment; unlike 
increase in 
control) 
↓ 
↓ (before/after 
treatment; unlike 
steady in control) 
steady 
(before/ after 
treatment; 
unlike 
increase in 
control) 
                
Vezzani et 
al., 2002 
NPY trans. mice 
KA 
(i.c.v.) 
acute 
Sprang.
Dawley 
rats 
- ↓       ↓ ↓ (stage 5 for 30 min)               
kindling                       
↓ (2nd, not 
1st; for Grade 
2) 
    
↑ (for Grade 4-5 of 
5) 
  - 
Richichi et 
al., 2004 
NPY 
H 
 
bilat. 
 
dorsal 
IHK 
(unilater
al) 
acute 
Male 
Sprang.
Dawley 
rats 
  ↑↑ ↓       ↓                 
KA 
(i.c.v.) 
↑ - -       ↓↓ ↓ (stage 5 for 30 min)               
rapid 
kindling 
                      
↓ (sum of all 
AD after 
stimulation) 
    
↑ (for Grade 3-5 of 
5) 
  ↑ 
Sorensen et 
al., 2009 
NPY 
H 
 
bilat. 
 
dorsal and 
ventral 
rapid 
kindling 
acute 
Male 
Sprang.
Dawley 
rats 
                      
↓ (at thr and 
Gr1-4, not 
Gr5) 
    -   - 
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Epileptogenesis-associated neuroinflammation in TLE 
Over the past years, neuroinflammation has received increasing attention in epilepsy research, as 
both clinical (Crespel et al., 2002; Wu et al., 2008; Choi et al., 2009; Varella et al., 2011) and 
experimental studies (Voutsinos-Porche et al., 2004; Fabene et al., 2008; Ravizza et al., 2008a; 
Zattoni et al., 2011) indicate that inflammatory processes are involved in seizure pathology. 
Especially during the early stages of epileptogenesis, the activation of the immune system 
triggered by a brain insult and the subsequent inflammatory reactions can contribute to seizures 
and hence the development of epilepsy (Pitkänen and Sutula, 2002; Vezzani et al., 2011). 
Research in both patients and animal models of TLE revealed that not only local but also 
peripheral immune cells are present in the epileptic focus and potentially involved in 
epileptogenesis (Fabene et al., 2008; Ravizza et al., 2008b; Deprez et al., 2011; Zattoni et al., 
2011). Hence, several different immune cells are accompanying the development of TLE, 
interacting with each other and supposedly shaping the course of the disease. 
Microglia and peripheral macrophages 
Microglia, resident macrophages of the CNS, form the frontline defense of the innate immune 
system and play an important role in several neurological diseases (Glass et al., 2010). 
Neurodegeneration associated with a brain insult causes an immediate and sustained activation of 
microglia in many diseases, including epilepsy. For example, activated microglia engulfing 
fragmented DNA were significantly increased in patients with chronic intractable epilepsy (Choi 
et al., 2009). In several animal models of TLE, the activation of microglia closely reflects the 
neurodegenerative pattern and can thereby be used to assess the severity of the lesion. During the 
first two weeks of the IHK-induced epileptogenesis, an activation of microglia is already evident 
after 24 hours and progressively increases over the next days, while reaching a plateau between 
3-6 dpi (Zattoni et al., 2011; Gfeller, 2015a). However, not only resident macrophages, but also 
peripheral mononuclear phagocytes were detected in the ipsilateral dentate gyrus, specifically in 
the molecular layer and to a lesser extent in the granule cell layer (Zattoni et al., 2011). Between 
1-3 days after the IHK-injection, the peripheral mononuclear phagocytes infiltrate into the 
dentate gyrus and also need until day 3-6 to reach their maximum (Gfeller, 2015a). Spatial and 
temporal specificity suggested that these macrophages might be involved in the dispersion of 
dentate GC. Therefore, Zattoni et al. (2011) were depleting peripheral mononuclear phagocytes 
using repeated systemic injections of clodronate liposomes, overall resulting in a reduced 
dispersion with areas containing pyknotic GCs. In these areas of extensive degeneration of GCs, 
General Introduction 
8 
activated microglia were evident. Two recent studies using the systemic KA or pilocarpine 
model of TLE found that the lesion in CA3 recruits peripheral mononuclear phagocytes within 
24 hours through chemokine C-C motif ligand 2 (CCL2), however, only transiently for about one 
week (Varvel et al., 2016; Tian et al., 2017). In contrast to the IHK model, a depletion of 
peripheral mononuclear phagocytes in CCR2-KO mice lead to a reduction of Iba1+ microglia in 
CA3 and, in one of these studies, to reduced neuronal loss, anxiety, memory decline and SRS 
two weeks after systemic KA. Although there seem to be differences between models of TLE, 
the influence of peripheral on resident monocytes, in particular on their state of activation and 
signal transducer and activator of transcription 3 (STAT3)-mediated interleukin (IL)-1β 
production, are potentially universal and might affect epileptogenesis in the IHK model of TLE. 
Leukocytes and the role of lympocytes 
Previous findings in hippocampal tissue sections of TLE patients and animal models revealed 
intraparenchymal migration of T lymphocytes (Fabene et al., 2008; Zattoni et al., 2011). In the 
IHK model, cluster of differentiation 3 (CD3)-positive T cells were first found in large blood 
vessels between 1-3 dpi, in particular in the hippocampal fissure, and then they start to enter the 
parenchyma in large numbers between 6-10 dpi (Zattoni et al., 2011; Gfeller, 2015a). The 
expression of vascular cell adhesion molecules (intercellular adhesion molecule-1 [ICAM-1], 
vascular cell adhesion molecule-1 [VCAM-1], E-selectin, and P-selectin) was elevated after 
systemic administration of pilocarpine, enabling the rolling and arrest of leukocytes in brain 
vessels near the lesion by their leukocyte counterparts mucin P-selectin glycoprotein ligand-1 
(PSGL-1) and integrins ɑ4β1 and ɑLβ2 (Fabene et al., 2008). Interestingly, Fabene et al. (2008) 
were able to markedly reduce acute seizures, block the onset of SRS, blood-brain barrier (BBB) 
leakage and reduced neuronal loss by inhibiting leukocyte-vascular interactions or neutrophil 
depletion. In line with these findings, recombination activating gene-1 (RAG1)-knockout (KO) 
mice, devoid of B and T lymphocytes, exhibited severe neurodegeneration and early onset of 
SRS between 2-3 days after IHK injection (Zattoni et al., 2011). The exacerbated 
neurodegeneration in mice lacking B and T lymphocytes was caused by an infiltration of Gr-1+ 
neutrophils, which could be rescued by a systemic injection of anti-Gr-1 antibodies (Zattoni et 
al., 2011). While adoptive transfer of specific T lymphocyte populations to immune deficient 
mice had no influence on the seizure onset, they blocked the infiltration of macrophages and 
abolished GC dispersion in mice lacking CD4+ T cells (MHCII-KO) and, in contrast, enhanced 
recruitment of macrophages and increased GC dispersion in mice lacking CD8+ T cells (b2-
microgloblin-KO) (Deprez et al., 2011). Based on these observations, the formation of an 
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epileptic focus and the development of SRS strongly relies on the interplay between innate and 
adaptive immune cells, which are recruited and activated in defined stages during 
epileptogenesis. 
Cytokines, inflammasomes and priming 
Along with the neuroinflammation, specific cytokines and chemokines are detected in epileptic 
patients. Increased levels of IL-1β, IL-8, IL-12p70 and macrophage inflammatory protein (MIP)-
1β were found in postmortem tissue of patients with intractable seizures in childhood epilepsy 
(Choi et al., 2009). Similarly, surgical specimens of TLE patients with hippocampal sclerosis 
revealed a significant increase in IL-1β and tumor necrosis factor TNFɑ in the hippocampus 
(Varella et al., 2011). In both the IHK and the pilocarpine model, IL-1β and ɑ (TNFɑ) were 
immediately upregulated after SE, while the expression slowly declined towards the chronic 
phase ((Benson et al., 2015); collaboration Dr. Rambousek). Besides a direct (chemokines) or 
indirect (cytokines) involvement in the recruitment of peripheral immune cells, cytokines 
(directly) and chemokines (indirectly) were shown to affect neuronal excitability ((Manley et al., 
2007; Fabene et al., 2008; Ravizza et al., 2008b; Fabene et al., 2010; Riazi et al., 2010; Deprez et 
al., 2011; Zattoni et al., 2011; Galic et al., 2012; Balosso et al., 2013; Liimatainen et al., 2013; 
Arisi et al., 2015; Vezzani and Viviani, 2015; Varvel et al., 2016). For example, TNFɑ increases 
synaptic activity at perforant path-granule cell synapses through release of glutamate by 
astrocytic processes in the proximity of presynaptic NR2B+ NMDARs (Santello et al., 2011). 
IL-1β, however, was shown to modulate synaptic transmission through phosphorylation of the 
NMDA NR2A/B subunit (Vezzani et al., 1999c; Viviani et al., 2003). Recent findings revealed 
that damage-associated molecular patterns (DAMPs) from necrotic or distressed cells, while 
causing in glial cells an increased production of IL-1β (Saijo and Glass, 2011), lead to the 
expression and release of high-mobility group box-1 (HMGB1) in neurons (and macrophages 
(Jiang et al., 2007)), which in turn activates toll-like receptor 4 (TLR4) and like IL-1β, and 
mediates, through NR2A/B phosphorylation, a rapid increase in NMDA calcium conduction 
(Maroso et al., 2010; Balosso et al., 2013).  
Several recent findings discovered that inflammasomes, multimeric protein complexes in the 
cytosol, are mediating the production and release of IL-1β and HMGB1 and are important in 
different neurological diseases such as Alzheimer’s disease (Lamkanfi and Kanneganti, 2010; Lu 
et al., 2012; Heneka et al., 2014). Inflammasomes consist of different pattern-recognition 
receptors (PRRs), such as nucleotide-binding domain, leucine-rich repeat containing proteins 
(also known as NOD-like receptors, NLRs) or the absent in melanoma 2 (AIM2)-like receptors 
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(ALRs). After sensing DAMPs, NLRs or AIM2 oligomerize to activate caspase-1, which in turn 
cleaves pro-IL-1β and pro-IL-18 into the bioactive form IL-1β and IL-18 (reviewed in (Latz et 
al., 2013; Walsh et al., 2014; Heneka et al., 2015)). Interestingly, NLRP3 inflammasomes, for 
example in innate immune cells, are activated by various stimuli and can be primed for example 
by lipopolysaccharide (LPS)-induced activation of TLR4 or an activation of TLR3 by 
polyinosinic:polycytidylic acid (PolyI:C), a double-stranded RNA (dsRNA) mimetic (Lu et al., 
2012; Guo et al., 2015).  
Various neurodevelopmental changes are associated with maternal infections during pregnancy 
(Knuesel et al., 2014; Meyer, 2014). Prenatal exposure to systemic PolyI:C at gestation day 17 
was shown to cause sustained increase in proinflammatory cytokine levels, especially of plasma 
IL-1β, cortical IL-10 and TNFɑ (Meyer et al., 2006; Krstic et al., 2012). In addition, Krstic et al. 
(2012) found that a second immune challenge at 12 months of age (“double hit”) exacerbated 
inflammatory response in the CNS of 15-months old wildtype mice. In the “double hit” study, 
prenatally ‘priming’ microglia was sufficient to cause a chronic inflammation and an AD-like 
phenotype, comprising increased levels of hippocampal amyloid precursor protein (APP) and its 
fragments, hyperphosphorylated Tau, and an impairment in working memory (Knuesel et al., 
2009; Krstic et al., 2012; Krstic and Knuesel, 2013). Interestingly, prenatal or acute peripheral 
immune stimulation was shown to affect the seizure threshold and the development of epilepsy. 
An acute systemic immune challenge hours or days prior to a pro-convulsive or electrical 
kindling increased the severity of subsequent seizures (Auvin et al., 2007; Galic et al., 2008; 
Kwon et al., 2010; Kirschman et al., 2011; Lee et al., 2012; Michalovicz and Konat, 2014). 
Maternal immune activation by prenatal immune challenges with PolyI:C during gestation day 
(GD)12-16 increased hippocampal excitability and lowered the seizure threshold, while being 
dependent on IL-1β and IL-6 (Pineda et al., 2013). Moreover, febrile seizures induced by LPS 
and KA were exacerbated and IL-1β levels elevated after maternal restraint stress at GD14 (Qulu 
et al., 2012). Therefore, maternal immune challenge potentially affects the fetal development 
long-term. 
Alzheimer disease and hyperexcitability 
The pathogenesis of Alzheimer disease (AD) is still an enigma and remains a topic of lively 
debate. AD is characterized by the progressive loss of cognitive abilities, network abnormalities, 
severe neurodegeneration and prominent neuroinflammation (Castellani et al., 2010; Palop and 
Mucke, 2016). The neuropathological hallmarks of AD include the formation of senile plaques, 
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containing aggregated amyloid-β (Aβ) peptides, and neurofibrillary tangles (NFTs) consisting of 
hyperphosphorylated tau (Alzheimer et al., 1995; Serrano-Pozo et al., 2011). Several lines of 
evidence support the hypothesis that the dysfunction of the APP and the accumulation of 
amyloid β play a causal role in the development of AD (Huang and Mucke, 2012; Krstic and 
Knuesel, 2013; De Strooper and Karran, 2016). Various mutations in APP, the catalytic γ-
secretase subunit presinilin-1 (PS1) or PS2 were shown to alter the production of Aβ towards 
aggregation-prone species and held responsible for autosomal dominant, early-onset familial AD 
(FAD) (Karran et al., 2011). In this ‘amyloid cascade hypothesis’, a shift towards proteolytic 
cleavage of APP by β-site APP-cleaving enzyme 1 (BACE1 or β-secretase) and γ-secretase leads 
to an increase in Aβ production and Aβ1-42/Aβ1-40 ratio, which in turn promote the assembly of 
monomers to oligomers, fibrils and amyloid plaques (Hardy and Higgins, 1992; Benilova et al., 
2012b). Moreover, a specific mutation in APP (A673T) associated with reduced β-secretase-
mediated cleavage was shown to decrease the risk for late-onset sporadic AD (LOAD) (Jonsson 
et al., 2012; Maloney et al., 2014). Although it remains controversial to which extent the 
pathogenesis of LOAD and FAD overlay (Krstic and Knuesel, 2013), the functional alterations 
remain largely the same (McKhann et al., 1984). Interestingly, both transgenic mice with a 
mutation in the apolipoprotein E4 (APOE4), a risk factor for LOAD (Corder et al., 1993), and 
animal models of FAD display alterations in network activity prior to the occurrence of other AD 
characteristic alterations (reviewed in (Palop and Mucke, 2016). This early time window, before 
the predicted onset of clinical disease when cellular reactions gradually fail to maintain 
homeostasis (De Strooper and Karran, 2016), is important for a mechanistic understanding of the 
impairment and the selection of therapeutic strategies in AD patients.  
The network abnormalities reported in AD comprise abnormal rhythmic activity and network 
hyperactivity, which bear close resemblance with pathological activity seen in epilepsy (Palop 
and Mucke, 2009, 2010). In mice overexpressing human APP (hAPP) with a mutation found in a 
familial form of AD in Sweden (Swe; K670N, M671L), the Tg2576 mouse model, large 
amplitude potentials were found at 5 weeks of age, which had remarkable similarities to 
interictal spikes (Kam et al., 2016). At a later stage, spontaneous seizures were recorded in 7-
months old Tg2576 mice (Kam et al., 2016), at a time when Aβ deposits start to occur (at around 
6 months) (Kawarabayashi et al., 2001). Similarly, in mice overexpressing hAPP carrying the 
Swe and Indiana (Ind; V717F) mutations, the J20 mouse line, frequent, sharp, synchronous 
discharges and intermittent nonconvulsive seizures were found at an age of 3 to 7 months (Palop 
et al., 2007). In 65% of APdE9 mice carrying the hAPP with the Swe mutation cointegrated with 
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human presenilin-1 with a deletion in exon 9 (PS1dE9) at least one seizure was reported during 3 
weeks of continuous video-EEG (vEEG) recording at an age of 3 to 4.5 months (Minkeviciene et 
al., 2008). The hyperexcitable phenotype was associated with an ectopic expression of NPY in 
mossy fibers and axons sprouting into the outer molecular layer (Palop et al., 2007; Roberson et 
al., 2007; Roberson et al., 2011). Interestingly, tau reduction had an antiepileptogenic effect by 
preventing the occurrence of SRS, reducing the severity of PTZ-induced seizures, inhibiting 
bicuculline-induced epileptiform bursting, and normalizing miniature inhibitory postsynaptic 
potentials (mIPSCs) (reducing), miniature excitatory postsynaptic potentials (mEPSCs) 
(increasing), spontanous inhibitory postsynaptic potentials (sIPSCs) (increasing), and sEPSCs 
(decreasing) in dentate granule cells of hAPPJ20 mice (Roberson et al., 2011). In this study, they 
revealed further that a normalization of the excitatory/inhibitory balance is accompanied by a 
lack of ectopic NPY-IR in mossy fibers or the dentate molecular layer. In the same hAPPJ20 
mice, spontaneous epileptiform discharges were primarily found to occur during reduced gamma 
oscillatory activity, which in turn was attributed to a dysfunction of PV-positive interneurons 
caused by the reduced expression of interneuron-specific and PV-cell-predominant voltage-gated 
sodium channel subunit Nav1.1 (Verret et al., 2012). Strikingly, learning and memory 
impairment in knockin mice for human apoE4 (apoE4-KI) could be linked to a disruption in slow 
gamma oscillations during hippocampal sharp-wave ripples (SWR), while a selective elimination 
of apoE4 in GABAergic interneurons prevented cognitive sequelae, the deficit in SWR-
associated slow gamma but not the overall decline in SWRs of aged apoE4-KI mice (Knoferle et 
al., 2014; Gillespie et al., 2016). During awake immobility and slow-wave sleep, the local field 
potential (LFP) in CA1 of freely moving mice revealed that these short bursts of a high-
frequency oscillation (150-250 Hz), the SWRs, mark the firing of pyramidal cell ensembles in a 
time-compressed manner to encode past experiences in so-called replay (Buzsaki et al., 1992; 
Skaggs and McNaughton, 1996; Lee and Wilson, 2002; Buzsaki et al., 2003; Buzsáki, 2015). 
Slow gamma oscillation (20-40 Hz) during SWRs is thought to promote the coordination of 
ensemble activity across CA3 and CA1 from both hemispheres, preserving the sequential activity 
in the SWR (Carr et al., 2012; Colgin, 2012, 2016), which in turn is important for memory 
consolidation and retrieval (Buzsaki, 1989, 1996; Kudrimoti et al., 1999). In regard to the similar 
network abnormalities seen in both AD and epilepsy, GABAergic interneurons, especially NPY- 
and SOM-expressing hilar cells, were shown to be important as they are particularly vulnerable 
in different rodent models of AD (Ramos et al., 2006; Mahar et al., 2016) and epilepsy (Sperk et 
al., 1992; Bouilleret et al., 2000a). For example, in 6- to 7-months-old hAPPJ20 mice, decreased 
CB-IR in the granular and molecular layer of the DG was correlating with behavioral deficits in 
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these mice (Palop et al., 2003). Interestingly, CB-IR in the DG showed a similar pattern 30 days 
after IHK injection, in particular the contralateral side, with a reduced but highly variable 
staining intensity between individual cells (Bouilleret et al., 2000b). As in models of TLE 
(Vezzani et al., 1999c; Vezzani et al., 1999a), NPY is ectopically expressed in CA3 pyramidal 
cells, mossy fibers and the molecular layer of the dentate gyrus in J20 mice (Palop et al., 2007). 
In the same study, it was shown that sprouting axons in the molecular layer are double-
immunoreactive for NPY and SOM, with presumably a hilar origin (Palop et al., 2007). 
However, a recent study reports that fibers of SOM-positive oriens lacunosum-moleculare (O-
LM) cells, which solely project to the striatum lacunosum-moleculare (SLM), start to sprout 
aberrantly after a pilocarpine injection into the outer molecular layer and to innervate granule 
cells of the dentate gyrus (Peng et al., 2013). As pyramidal cells are the main excitatory input to 
O-LM cells (Blasco-Ibanez and Freund, 1995), this aberrant circuit between CA1 pyramidal 
cells, O-LM cells and DG granule cells might lead to an interference with the normal inhibitory 
feedback circuit in the dentate gyrus (Peng et al., 2013). Although its functional implication 
remains to be determined, it might serve as an explanation for the reduced expression of the 
immediate early gene c-Fos detected in dentate GC (Palop et al., 2003), at an age when circuit 
reorganization is already detectable in a mouse model of AD (Palop et al., 2007). 
Neurogenesis 
Adult neurogenesis is the process of generating neurons from neural stem cells (NSCs). Two 
specific neurogenic areas – “niches” – can be distinguished: the subventricular zone (SVZ) of the 
lateral ventricles and the subgranular zone (SGZ) in the DG of the hippocampus (Gage, 2000). 
Neurogenesis is involved in many brain functions from neuronal development, structural 
plasticity and disease progression (Ming and Song, 2011). Therefore, it is no wonder that adult 
neurogenesis is affected in both AD and TLE. For example, some AD transgenics (e.g. pPDGF-
APPSw,Ind) were shown to have increased hippocampal neurogenesis prior to any neuronal loss 
or amyloid deposition, however augmenting with a progress in Aβ pathology (Jin et al., 2004; 
Gan et al., 2008). However, in other AD models (e.g. APP/PS1 mice) the proliferation was not 
affected, but the survival of newborn cells later on was (Verret et al., 2012). In a model featuring 
both (hAPP-J20 mice), the accelerated early development and impaired maturation of adult-born 
granule cells was linked to an increased GABAergic input to these cells and ultimately to 
synaptic reorganization present in these mice (Sun et al., 2009). Interestingly, a selective 
depletion of the APP in GABAergic neurons also lead to an increased progenitor cells 
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proliferation and reduced dendritic length in newborn granule cells (Wang et al., 2014). Recent 
studies revealed that tonic GABA activation maintains NSCs quiescence (Song et al., 2012) and 
promotes the dendritic development of newborn neurons (Ge et al., 2006). Taken together, this 
suggests that a malfunction of local GABAergic circuits is detrimental for adult neurogenesis 
and affected early by the AD pathology (e.g. through Aβ toxicity or APP dysfunction). Similar 
observations were made in other studies and these mechanisms might underlie alterations seen in 
animal models of TLE (Parent et al., 1997; Jessberger et al., 2005). IHK-induced SE lead to a 
massive activation of NSCs, which after symmetrical division cause both mother and daughter 
cells to convert into reactive astrocytes in the ipsilateral hippocampus (Sierra et al., 2015). This 
distinct self-renewal mode exhausts the NSC pool and eventually impairs neurogenesis long term 
(Hattiangady et al., 2004; Kralic et al., 2005; Ledergerber et al., 2006; Sierra et al., 2015). While 
a large body of literature report a direct effect of aberrant excitability on adult neurogenesis, 
recent studies suggest that neurogenesis directly affects the development of seizures, with 
findings showing reduced SRS 5 to 7 weeks after pilocarpine injection due to genetic ablation of 
adult-generated granule cells (Cho et al., 2015) and another group reporting an increased 
susceptibility to KA-induced SE after reducing neurogenesis by X-irradiation (Iyengar et al., 
2015). 
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II. AIM OF THE THESIS 
The overall objective of this thesis was to evaluate the role of neuroinflammation and early 
epileptiform activity in epileptogenesis of TLE, as well as the impact of early pathophysiological 
changes associated with Alzheimer’s disease (AD) on the development of acquired epilepsy, 
using IHK injection as TLE model in wildtype mice and different transgenic mouse lines. 
 
Study I Effects of chronic and acute inflammatory responses on epileptogenesis in 
the intrahippocampal kainic acid model of temporal lobe epilepsy 
In this study, we aimed to characterize the effects of either chronic inflammation (prenatal 
immune challenge) or acute epileptogenesis-associated immune reactions on the formation of an 
epileptic focus in the IHK mouse model of TLE. We used three different approaches in order to 
determine 
 the effect of chronic inflammation on the pathogenesis of TLE, 
 the role of NLRP3 inflammasomes in the activation and recruitment of different immune 
cells during epileptogenesis, and 
 the contribution of infiltrating macrophages to the formation of an epileptic focus. 
We used IHK injection in either wildtype mice prenatally infected with a viral mimic, NLRP3-
KO mice or CCR2-KO mice. To assess the effect of chronic inflammation on epileptogenesis, 
intrahippocampal EEG recordings were acquired and analyzed for occurrence of SRS. We 
performed histological stainings to visualize neurodegenerative patterns at different time points 
during epileptogenesis. We used different antibodies against various immune cells, glial cells and 
markers of axonal reorganization for immunohistochemistry (IHC) to evaluate histopathological 
changes and associated immune response in the developing epileptic focus.     
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Study II Contribution of early Alzheimer-related pathophysiology to the development 
of acquired epilepsy 
Here, we aimed to elucidate the significance of early pathophysiological changes in a mouse 
model of AD for the development of IHK-induced epilepsy. Based on various reports about 
hyperexcitability phenotypes in mouse models of AD, we thereby aimed to answer the following 
questions: 
 Are hippocampal circuits in AD transgenic mice already affected prior to the occurrence 
of amyloid β plaques and more prone to excitatory-inhibitory imbalance? 
 Do early changes associated with an AD predisposition, in particular soluble Aβ species, 
render the hippocampal formation more susceptible to the development of acquired 
epilepsy? 
 Does early AD pathology affect neuronal survival, neuroinflammation, axonal 
reorganization, or adult neurogenesis either prior to or following IHK-induced 
epileptogenesis? 
To address these questions, we compared wildtype mice to ArcticAβ mice, overexpressing 
mutated human APP transgene, employing field and patch-clamp recordings in vitro, 24/7 video-
EEG recordings, histological and IHC measures in naive or IHK-injected mice. Focusing on the 
course of epileptogenesis, we captured changes at different time points during development of 
epilepsy, in particular electrographically and immunohistochemically. To test the contribution of 
Aβ oligomers, an early manifestation of AD pathology, to the development of acquired seizures, 
we injected intracerebrally a neutralizing antibody prior to IHK-induced epileptogenesis. 
Study III Contribution of early aberrant activity to the development of acquired 
epilepsy 
We aimed to understand the contribution of early aberrant activity during the latent period 
following status epilepticus (SE) to the development of spontaneous recurrent seizures (SRS) in 
the IHK mouse model of TLE. To this end, we adapted state-of-the-art closed-loop optogenetic 
intervention (COI) techniques to inhibit brief epileptiform discharges occurring spontaneously 
during early epileptogenesis. Establishing a detection method for fast online COI and an offline 
approach for post-analysis of large data sets, we determined the effect of early, transient COI on 
the emergence of SRS in the long-term, exemplified in a subsample analyzsed four months after 
IHK injection. Further, by applying hippocampal COI through either a brief activation of 
parvalbumin (PV)-expressing interneurons or repeated inhibition of pyramidal cells, we 
determined the role of either cell type for the generation of early epileptiform activity. 
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Abstract 
Research in animal models of temporal lobe epilepsy (TLE) revealed that most histopathological 
features of TLE form early, during the pathogenesis, and render the neuronal network susceptible 
to seizure generation. Neuroinflammation accompanies the early network reorganization, directly 
affects the formation of an epileptic focus and lowers the seizure threshold. The activation of 
innate immune cells can modulate neuronal excitability, in particular, through the release of pro-
inflammatory cytokines (e.g. IL-1). To investigate the contribution of the immune response in 
establishing an epileptic focus, adult mice received a single, intrahippocampal injection of kainic 
acid (IHK). Different components of the epileptogenesis-associated immune reaction were 
examined more closely. First, the effect of a chronic perturbation of innate immunity, ‘priming’, 
on epileptogenesis was studied in mice exposed either prenatally and/or postnatally to a viral 
mimic. Although the results remained inconclusive, they underline the relationship between the 
innate immune response and neuronal excitability. Second, for a better understanding of the 
molecular basis underlying the innate immune response, the pathogenesis of a pro-epileptic 
lesion was examined in mice devoid of NLRP3 inflammasomes. These intracellular sensors were 
shown to be involved in IL-1 production in microglia and macrophages. The neurodegenerative 
pattern and immune response caused by IHK was not affected by the lack of the NLRP3 
inflammasome suggesting an NLRP3-independent production of IL-1. Finally, we tested 
whether recruitment of peripheral macrophages is pivotal for the survival of granule cells in the 
dentate gyrus, as suggested in an earlier study. Selective interference with macrophage 
recruitment in C-C chemokine receptor type 2 (CCR2)-KO mice revealed that infiltrating 
macrophages are not directly responsible for the granule cell survival after IHK.  
We conclude that the immune response mediated by activated microglia and infiltrating 
macrophages contribute to the formation of an epileptic focus. However, both are integrated in a 
broader immune response and certain processes might be compensated for by other immune 
cells, as shown in other models of TLE.  
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Introduction 
Epilepsy affects 65 million people worldwide. Mesial temporal lobe epilepsy (TLE) is one of the 
most common adult seizure disorders and, when associated with hippocampal sclerosis, is the 
most refractory to pharmacotherapy (Engel, 1998; Semah et al., 1998; Browne and Holmes, 
2001; England et al., 2012). Overall, treatment options for epilepsy remain inadequate for many 
patients who suffer from uncontrolled seizures. The pathogenesis of TLE and seizure etiology 
remain unknown, in particular the relationship between histological changes and neuronal 
mechanisms underlying the generation and persistence of spontaneous recurrent seizures (SRS).  
Several neuropathological features of TLE can be replicated in a mouse model receiving a single 
intra-hippocampal injection of kainic acid (IHK). In this model, the IHK-induced status 
epilepticus (SE) causes a focal lesion in the dorsal hippocampus, which in turn leads within two 
weeks to the onset of SRS lasting for the life time of the animal (Suzuki et al., 1995a; Riban et 
al., 2002b). After this latent phase, mice show a high frequency of non-convulsive SRS, which 
are restricted to the dorsal hippocampus (Riban et al., 2002b; Arabadzisz et al., 2005; Dugladze 
et al., 2007). These animals also display pathological high frequency oscillations and, albeit at a 
much lower frequency, secondarily generalized convulsive behavioral seizures (Engel et al., 
2009; Krook-Magnuson et al., 2013). The neuropathological alterations include the degeneration 
of pyramidal cells in CA1, CA3c and the loss of hilar mossy cells in the dentate gyrus (Suzuki et 
al., 1995a; Bouilleret et al., 1999). Impaired Reelin signaling leads in the injected hemisphere to 
a gradual but pronounced dispersion of dentate granule cells through to a point where most of the 
space originally filled by the hippocampal formation is occupied by the dentate gyrus (Bouilleret 
et al., 1999; Heinrich et al., 2006; Müller et al., 2009; Duveau et al., 2011). In addition, various 
hippocampal interneurons are differently affected by IHK, with parvalbumin (PV)-positive 
interneurons (including axo-axonic and basket cells) being the most vulnerable (Bouilleret et al., 
2000b; Bouilleret et al., 2000a). These changes are accompanied by an increased expression of 
neuropeptide Y (NPY), a peptide with anticonvulsive properties (Richichi et al., 2004; Noè et al., 
2012). NPY is expressed in interneurons, where it is often co-localized with GABA and/or 
somatostatin, in mossy fibers and ectopically in dentate granule cells (Vezzani and Sperk, 2004). 
Interestingly, during the latent phase, mossy fibers start sprouting in the dentate gyrus and in 
CA3, which is expected to be involved in formation of an aberrant, recurrent, excitatory circuit 
(Buckmaster, 2012). Despite the knowledge about all these multiple alterations, which are shared 
by different models of TLE, it is unknown if they contribute directly to development of seizures.  
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Increasing evidence from both clinical and experimental studies indicates a link between seizures 
and the concomitant neuroinflammation, in particular during the early stages of epileptogenesis. 
A local inflammatory reaction, which is triggered by a brain insult such as neurotrauma, stroke, 
infection or SE, are associated with acute symptomatic seizures and often followed by the 
development of epilepsy (Pitkänen and Sutula, 2002). The activation of the innate immune 
system and associated inflammatory reactions in the brain have been proposed to contribute to 
the pathogenesis of epilepsy (Vezzani et al., 2011). In the IHK model, the emerging hippocampal 
sclerosis is accompanied by a local inflammation, disruption of the blood brain barrier, 
infiltration of leukocytes, and - in areas of neurodegeneration - a sustained endothelial and 
microglial activation (Deprez et al., 2011; Zattoni et al., 2011). The importance of innate and 
adaptive immunity in epileptogenesis is further corroborated by observations suggesting 
macrophage depletion causes granule cell degeneration, whereas elimination of lymphocytes in a 
mouse model called RAG1-KO curtails the latent period prior to SRS onset (Zattoni et al., 2011). 
To elucidate the role of inflammation, in particular the response of microglia and macrophages, 
in the pathogenesis of TLE, we used three different approaches in the IHK model of TLE. First, 
to study the effect of chronic inflammation on the pathogenesis of TLE, by priming microglia 
and peripheral macrophages, mice were prenatally injected with the viral mimic 
polyriboinosinic-polyribocytidilic acid (PolyI:C) during late gestation prior to the IHK-induced 
epileptogenesis during adulthood. When injected at gestation day (GD) 17, PolyI:C causes an 
acute rise in fetal brain cytokine levels (Meyer et al., 2006), a chronic increase of plasma IL-1 
postnatally, and leads to an increased microglia activation in older mice (Krstic et al., 2012). 
Second, we studied the involvement of NLRP3 (NLR family, pyrin domain containing 3) 
inflammasomes in the activation and recruitment of different immune cells during 
epileptogenesis. NLRP3 inflammasomes are expressed by the innate immune system, important 
for sensing cellular molecules exposed after damaged-induced necrosis and involved in the 
release of IL-1 (Walsh et al., 2014). To examine the role of these intracellular sensors in 
establishing an epileptic focus, NLRP3-KO were injected with IHK. Finally, the role of 
infiltrating macrophages during epileptogenesis was investigated. It was recently shown that 
depleting peripheral macrophages with clodronate causes a degeneration of dentate granule cell 
(Zattoni et al., 2011). However, as clodronate might affect other cells types, the IHK-induced 
lesion was examined in mice lacking the C-C chemokine receptor type 2 (CCR2), which is 
pivotal for monocyte recruitment.  
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Materials and Methods 
Animals 
All experiments performed for this study were carried out in accordance with the Swiss law on 
animal experimentation and approved by the Cantonal Veterinary Office of Zurich.  
Experiments were performed with C57Bl6/JOla (Harlan Laboratories, Horst, the Netherlands), 
NLRP3-KO (Jackson), and CCR2-KO mice (compare table 1). For experiments involving 
prenatal treatment, time-pregnant dams were shipped on gestational day (GD) 14 and injected 
with PolyI:C at GD17. All animals were housed in an in-house hygiene area (Institute of 
Pharmacology and Toxicology, University of Zurich, Switzerland) under a 12-hour light/dark 
cycle, with access to food and water ad libitum. 
Polyriboinosinic-polyribocytidilic acid (PolyI:C) injections 
As described by Notter (2015), 5 mg/kg PolyI:C potassium salt (P9582, 50 mg; Sigma-Aldrich 
Chemie GmbH, Buchs, Switzerland) was dissolved in 0.9% sterile, pyrogen-free NaCl. For both 
the prenatal and postnatal treatment, a single intravenous injection (i.v.) of either PolyI:C or 
NaCl were given at an injection volume of 5 mL/kg body weight to pregnant mouse dams at 
GD17 or 22-weeks old adult mice, respectively.  
Intrahippocampal kainic acid (IHK) injection and electrode implantation 
At the age of 12-weeks or 36-weeks, mice anaesthetized by inhalation of 2.5-3% isoflurane 
(Baxter) in oxygen were injected with 70 nL kainic acid (5mM in NaCl; Tocris biosciences) or 
an equivalent volume of NaCl into the right dorsal hippocampus (anteroposterior -1.8 mm, 
mediolateral -1.6 mm, dorsoventral -1.9 mm relative to Bregma) as described by Bouilleret et al. 
(2000).  
Particular groups of mice were implanted with electrodes for electroencephalographic 
recordings. To this end, a bipolar electrode was implanted immediately after stereotactic 
injection into the same coordinates and a monopolar reference electrode was inserted into the 
cerebellum. The bipolar electrode consisted of two twisted enamel insulated stainless steel wires 
connected to a male connector (for details see (Arabadzisz et al., 2005)). Electrodes were fixed to 
the scull by Prime&Bond (Dentsply) in combination with Tetric EvoFlow (Ivoclar vivadent) 
while the electrode shaft entering the hole was sheathed by Kwik-Cast Silicone Elastomer 
(World Precision Instruments). After surgery, all mice were i.p. injected with 1 mg/kg 
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buprenorphine (Temgesic®, Reckitt Benckiser AG, Switzerland) and placed on a warm pad for 
recovery.  
Table 1 Animals used in this study. 
Genetic 
background 
Age 
(months) 
Prenatal 
treatment (i.v.) 
Postnatal 
treatments (i.v.) 
Hippocampal 
injection 
EEG 
recordings  
Group 
abbreviation 
C57BL/6J 3 - - NaCl No - 
(n=3-6/gr)    KA No - 
C57BL/6J 3  NaCl -   NaCl Yes NN 
(n=6-8/gr)  PolyI:C -  NaCl Yes PN 
  NaCl - KA Yes NK 
  PolyI:C - KA Yes PK 
C57BL/6J 9 NaCl NaCl NaCl No NNN 
(n=6-12/gr)  NaCl PolyI:C NaCl No NPN 
  PolyI:C NaCl NaCl No PNN 
  PolyI:C PolyI:C NaCl No PPN 
  NaCl NaCl KA No NNK 
  NaCl PolyI:C KA No NPK 
  PolyI:C NaCl KA No PNK 
  PolyI:C PolyI:C KA No PPK 
NLRP-3 
KO 
(n=3/gr) 
3 
 
- 
 
- 
 
KA 
 
No 
 
- 
 
CCR-2 KO 
(n=3) 
3 
 
- 
 
- 
 
KA 
 
No 
 
- 
 
 
 
Acute seizures monitoring and electroencephalographic (EEG) recordings 
To assess the acute response to IHK, video recordings were taken during the recovery from 
surgery. During a period of 2 hours, mice were recorded in individual cages before they were 
returned to their home cage. For the analysis, the severity of behavioral seizures was categorized 
according to the Racine, Pinel and Rover scale (table 2) (Racine, 1972; Pinel and Rovner, 1978).  
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Intrahippocampal EEG activity was recorded at 7 and 21 days post-injection (dpi). Freely 
moving mice were placed in a Faraday cage and connected via a swivel to an amplifier and 
digitizer (AcqKnowledge MP100; Biopac Systems). Mice were first habituated for 30 min. 
Subsequently, EEG activity was recorded for 3 hours were taken at a sampling rate of 200 Hz. 
Recordings were always taken between 11 am and 3 pm to minimize potential circadian 
variations. Seizures were defined as paroxysmal events lasting longer than 10 s and only if they 
were separated by intervals of at least 1 s. The average frequency and duration of SRS was 
calculated for each mouse.  
Table 2 Modified Racine scale for behavioral seizures. Adapted from (Pinel and Rovner, 1978) 
Scale Stage Behavior 
Racine behavioral scale 1 Oroalimentary movements 
 2 Head nodding 
 3 Anterior limb clonus 
 4 Dorsal extension (rearing) 
 5 Loss of balance and falling 
Pinel and Rovner behavioral 
scale 
6 Repeated falling 
 7 Strong jumping and running 
 8 Stage 7 with tonic period 
 
Tissue preparation for immunohistochemistry 
Tissue preparation was performed as described by Notter et al. (2014). In brief, anesthetized 
mice (Nembutal; 50 mg/kg; i.p.) were perfused intracardially with 15–20 mL ice-cold, 
oxygenated aCSF [containing (mM) NaCl 125, KCl 2.5, CaCl2, 3.7, MgCl2 2, NaHCO3 26, 
NaH2PO4 1.25, glucose 25], pH 7.4, at a flow rate of 10–15 mL/min. The brain was immediately 
extracted from the skull and divided into 3 blocks: rostral, medial and caudal part. All three parts 
were immediately immersion-fixed for 3 hours in ice-cold fixative [4% paraformaldehyde 
dissolved in 0.15 M sodium phosphate buffer], pH 7.4, then rinsed with PBS (pH = 7.4) and 
cryoprotected overnight in 30% sucrose in PBS at 4°C. 
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The fixed tissue was cut into 40-m thick serial coronal sections collected in ice-cold PBS using 
a sliding microtome. The sections were transferred to a cryoprotectant solution (50 mM sodium 
phosphate buffer, pH 7.4, containing 15% glucose and 30% ethylene glycol; Sigma-Aldrich) for 
storage at -20°C until they were used for immunohistochemistry. 
Immunohistochemistry 
Immunoperoxidase staining was preformed as described earlier (Zattoni et al., 2011). Sections 
were incubated overnight at 4°C under constant agitation with primary antibodies (see table 3) 
diluted in Tris buffer, pH 7.4, containing 0.2% Triton X-100 and 2% normal serum. After 
washing 3 x 10 min in Tris buffer, sections were incubated for 30 min at room temperature in 
biotinylated secondary antibodies (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, 
USA) diluted 1:300 in Tris buffer containing 2% normal serum, followed by 3 washes in Tris-
buffer and an incubation for 30 min in ABC solution (Vectastain Elite kit; Vector Laboratories, 
Burlingham, CA, USA). After washing them again, sections were stained by the 
immunoperoxidase reaction combining 3,3-diaminobenzidine (DAB; Sigma–Aldrich Inc.) in 
Tris, pH 7.7, with hydrogen peroxide for 5-15 min. Finally, sections were washed 3 x 10 min in 
PBS, mounted onto gelatinized glass slides, air-dried overnight, dehydrated through ethanol, 
cleared in xylene and coverslipped with resinous (Eukitt™; Sigma-Aldrich) mounting medium. 
Nissl Staining 
To determine the pattern of degeneration in response to IHK and the placement of EEG 
electrodes, a 1:12 series of sections were Nissl-stained with Cresyl violet. The slides were dipped 
successively in the following solutions: 5 min in dH2O, 5 min in filtered Cresyl violet solution 
(C18H15N3O3, M 321.34, Fluka BioChemika, Cat. no. 10510-54-0), 30 sec in dH2O and cleared in 
96% ethanol containing 0.5% acetic acid until the desired coloration was obtained, 5 min in 
isopropanol, 5 min in isopropanol:Xylene (1:2) and 4 times dehydrated in xylene for 2 min. 
Finally, the slides were coverslipped with Eukitt.  
Visual scoring and image acquisition 
An Axioscop 2 microscope (Carl Zeiss AG, Jena, Germany) with bright-field illumination and 
either a 10x, 20x objective or 40x oil immersion objective was used for visual scoring and 
acquiring images for display. Digital images were taken with a color digital camera (AxioCam 
MRc5) and the corresponding software AxioVision 4.5 (Carl Zeiss AG, Jena, Germany).  
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Merging and cropping of images, adjustments of brightness and contrast were performed using 
Adobe Lightroom CC, Photoshop CC and Illustrator CC. All adjustments made were identical 
for each staining.  
Table 3 List of primary antibodies. 
Target Distributor Description, Ref. no. Dilution Marker of 
CD3 BD Biosciences 
Pharmingen 
Armenian hamster, 
145-2C11, 01081D 
1:1000 CD3+ T-cells 
CD4 BD Biosciences 
Pharmingen 
Rat, L3T4, 09421D  1:1000 CD4+ T-cells 
CD8a BD Biosciences 
Pharmingen 
Rat, monoclonal, 
01041D  
1:1000 Cytotoxic CD8+ T-
cells 
CD68 AbD Serotec Ltd, 
Oxford, UK 
Rat, monoclonal, clone 
FA11, MCA1957GA 
1:2000 (Activated) microglia 
F4/80 Abcam, UK Rat, monoclonal, 
b6640 
1:1000 Monocytic lineage 
(tissue macrophages, 
microglia) 
GFAP Dako Schweiz AG, 
Baar, Switzerland 
Rabbit, polyclonal, 
Z334 
1:20’000 (Activated) astrocytes 
Iba1 Wako Rabbit, polyclonal, 
019-19741 
1:3000 Microglia 
Neuropeptid Y 
(NPY) 
Peninsula Lab. Rabbit, serum, T-4069 1:1000 NPY+ interneurons 
and mossy fiber tract 
Parvalbumin 
(PV) 
Incstar Rabbit, serum, 24428 1:5000 PV+ interneurons 
ZnT3 Synaptic Systems Rabbit, polyclonal, 
197002 
1:1000 Mossy fiber tract 
(focus) 
Densitometry analysis 
Densitometry analyses of immunoperoxidase staining intensity were performed using the MCID 
software (MCID Elite 6.0, InterFocus Imaging Ltd., Cambridge, UK).  Images were digitized 
using a precision illuminator (Nothern light Model B95, Imaging Research Inc., Brock 
University, St.Catharines, Canada) and CoolSnap cf photo-camera (Photometrics, Tuscon, AZ, 
USA) with a Micro-Nikkor (55 mm + 12 mm) objective (Nikon Corporation). After grey values 
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were calibrated (Kodak step tablet no. 310ST607), the intensity values in the different regions of 
interest acquired. Each intensity value was normalized to the intensity of the whole section to 
correct for variations in background staining. 
Stereological analysis  
The number of F4/80+ macrophage-like cells was determined stereologically using an Axioplan 
2 bright-field microscope (Carl Zeiss AG, Feldbach, Switzerland) with 20x (air, NA 0.75) 
objective and an integrated digital camera (MicroFIRE, Optronics AG, Goldach, Switzerland). 
The granule cell layer and molecular layer of the dentate gyrus were outlined and the number of 
macrophage-like cells within these regions were counted with Mercator software (Mercator Pro 
rev. 7.8.2, Explora Nova, La Rochelle, France). The thickness of each layer was estimated by 
dividing the length of the area by its perimeter. For each mouse, the number of macrophage-like 
cells and the estimated thickness was averaged over all sections.  
Statistical Analyses 
Data are presented as mean ± standard error of the mean (SEM). Statistical analyses for multiple 
group comparison was performed by a one-way or two-way ANOVA with a Bonferroni post-hoc 
test. An unpaired t test, two-tailed, was use to compare two groups (Prism software, GraphPad 
version6). Statistical significance was set at p < 0.05 for all data shown.  
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Results 
Characterization of histological changes in the epileptic focus and associated immune 
response in wildtype mice after IHK-induced epileptogenesis 
For a better understanding of the histopathological changes during epileptogenesis and to 
confirm earlier observations emphasizing the importance of concomitant immune reactions, adult 
wildtype mice were injected unilaterally into the dorsal hippocampus with kainic acid (or NaCl 
as control), and histologically characterized at different time points after injection.  Two weeks 
after IHK injection, when the first spontaneous recurrent seizures occur (Riban et al., 2002b), 
several neuropathological changes can be observed when comparing NaCl- (figure 1A) and IHK-
injected mice (figure 1B). In the injected hemisphere, pyramidal cells in CA1 and CA3c, as well 
as hilar mossy cells are lost and dentate granule cells dispersed (figure 1B, red and black boxes), 
while the contralateral hemisphere appears similar to both hemispheres of the NaCl-injected 
control. Already 24 hours after IHK, pyramidal cells in CA1 become pyknotic (figure 1A’), 
whereas hilar mossy cells and most cells of CA3c already disappeared (figure 1B’). As described 
earlier (Bouilleret et al., 2000b; Bouilleret et al., 2000a), IHK injection also causes a focal 
degeneration of different interneurons. For example, PV+ interneurons are only spared in the 
CA3a,b of the ipsilateral dorsal hippocampus (figure 1C) whereas the rest are lost at 1 dpi (figure 
1C’). A similar pattern can be observed for NPY+ interneurons. However, as a result of the IHK-
induce lesion, NPY is also expressed in mossy fibers of both dorsal hippocampi (figure 1D). In 
addition, dentate granule cells, axons and dendrites in the molecular layer show an increased 
NPY-IR after IHK with a peak between 1 and 3 dpi (figure 1D’). Also in the dentate gyrus, 
granule cell axons (i.e. mossy fibers) synapse with granule cell dendrites in the inner molecular 
layer in a process called mossy fiber sprouting (figure 1E). This synaptic reorganization, which is 
assumed to be a consequence of neuronal loss, in particular of hilar interneurons, is gradually 
established and clearly evident at 10 dpi (figure 1E’). The IHK-induced neuronal loss and 
synaptic reorganization is accompanied by a distinct astroglial (Gouder et al., 2004; Ledergerber 
et al., 2006) and immune response (Zattoni et al., 2011). A local astrogliosis emerges over the 
progression of epileptogenesis and is visible at 14 dpi by reactive astrocytes in the ipsilateral 
hippocampus (figure 1F). Similarly, a strong microgliosis can be observed ipsilaterally (figure 
1G), which was reported to form gradually over two weeks in CA1, in contrary to the temporary 
peak at 6 dpi in the dentate gyrus and CA3 (Gfeller, 2015b). The distribution of reactive 
microglia cells with their distinct morphological shape (figure 1G’) closely reflects the 
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Figure 1 Characteristic changes in the epileptic focus induced by an intrahippocampal IHK injection. 
Nissl staining of the ipsi- and contralateral hippocampus 14 dpi after NaCl (A) or IHK injection (B). Higher 
magnification views showing the CA1 pyramidal cell layer (red) and the hilus-CA3c area (black) of the 
ipsilateral hippocampus after NaCl (dashed boxes) and IHK injection (solid boxes). Similarly, the CA1 
pyramidal cell layer (A’) and the hilus-CA3c area (B’) is shown at 1 dpi after IHK.  C. PV+ staining of a IHK 
injected animal at 14 dpi including a higher magnification of the contra- (dashed box) and ipsilateral (solid box) 
hippocampi. For direct comparison, PV-IR within the CA1 pyramidal cell layer is shown at 1 dpi (C’).  D.  
NPY-IR marks interneurons, mossy fibers and depict in higher magnification (arrowheads), single dentate 
granule cells after 14 dpi. At 3 dpi, a strong NPY-IR is seen in dendrites of granule cells reaching into the 
molecular layer (arrowheads in D’).  E. At 14 dpi, mossy fiber sprout into the inner molecular layer passing 
through granule cell layer (arrowheads). This process is already clearly visible at 10 dpi (E’). F. At 14 dpi, an 
astrogliosis is evident ipsilaterally by an increased GFAP-IR in astrocytes. G. The ipsilateral hippocampus 
shows a local microgliosis at 14 dpi. These microglia cells show an upregulation of Iba1-IR (G’), which is 
characteristic for the activated state of microglia cells. H. At 14 dpi, leukocytes that are positive for CD3, CD4, 
and CD8a migrate into the dorsal ipsilateral hippocampus (image of CA1 SR/SLM). I. Macrophages selectively 
occur in the molecular layer and the granule cell layer. Macrophage have a high F4/80-IR and can be 
distinguished from resident microglia cells by their shape. Scale bars, 150 μm. 
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neurodegenerative pattern (figure 1B). Besides the response of resident immune cells, peripheral 
immune cells migrate into the epileptic focus (Zattoni et al., 2011). CD3/4/8a+ leukocytes 
migrate into the ipsilateral hippocampus (figure 1H), first accumulating in large blood vessels (at 
3 dpi), and then at 10 dpi reaching a peak intraparenchymal (Gfeller, 2015b). Peripheral 
macrophages, on the other side, selectively appear in the molecular layer and granule cell layer 
of the dentate gyrus (figure 1I), where they reached their maximum number already at 6 dpi 
(Gfeller, 2015b). The very high concordance between our results and previous studies 
underscores the reproducibility of the model and allow us to test novel specific hypotheses. The 
fact that during epileptogenesis different neuropathological alterations and certain immune 
responses share a specific temporal and spatial pattern raises the question how individual 
immune responses affect the formation of the epileptic focus. 
Effect of prenatal immune stimulation with PolyI:C during late gestation on the 
pathogenesis of IHK-induced TLE in early adulthood 
Maternal infections during pregnancy can cause various neurodevelopmental alterations 
(Knuesel et al., 2014; Meyer, 2014). Unlike many other changes, including alterations in Reelin 
processing and behavioral performance (Knuesel et al., 2009), a sustained increase in pro-
inflammatory cytokine levels, in particular in plasma IL-1 levels, was already reported in 3-
months old mice prenatally exposed to PolyI:C at GD17 (Krstic et al., 2012). To test whether a 
chronic rise in inflammatory cytokines affects epileptogenesis, 3-month-old wildtype mice 
prenatally immune challenged with PolyI:C were unilaterally injected with kainic acid into the 
dorsal hippocampus. The pattern and extent of neurodegeneration induced by IHK was similar 
between mice prenatally exposed to PolyI:C (PK) or NaCl (NK) (figure 2A). However, the 
accompanied microgliosis was less pronounced in the regions undergoing neurodegeneration in 
PolyI:C compared to saline-pretreated mice (figure 2B and B’). Comparing both 
intrahippocampal controls injected with saline revealed that there is no difference in microglial  
Figure 2 IHK-induced epileptogenesis in prenatal immune challenged, 3-month old mice. A. Representative 
images of Nissl-stained sections to compare the neurodegenerative pattern after IHK-induced epileptogenesis in 
mice pretreated with PolyI:C or NaCl at 21 dpi. B. Pattern of CD68-IR showing the microgliosis in ipsilateral 
hippocampus of both groups. B’. Corresponding densitometry analysis of the CD68-IR in 9 hippocampal regions 
comparing different injection groups to each other (i.v.-intrahippocampal): NaCl-NaCl (NN), PolyI:C-NaCl (PN), 
NaCl-KA (NK), PolyI:C-KA (PK). C. Infiltration of peripheral macrophages into the ipsilateral dentate gyrus 
depicted by the F4/80 staining. C’. Corresponding stereological and volumetric analysis quantifying the number of 
macrophages and thickness of the granule cell layer (GCL) and molecular layer (ML). D. Quantitative analysis of 
behavioral seizures during status epilepticus (0 dpi) including (from left to right) percentage of convulsive seizures 
with severity 2-8, number of seizures, latency to first convulsive seizure with a severity grater or equal to 6, and 
duration of seizures. E. Electroencephalographic analysis of the early chronic phase (21 dpi) quantifying number 
and duration of seizures. Statistical significance was set at p < 0.05 (lines). Scale bars, 150 μm. 
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activation in 3-months old mice either prenatally immune challenged or not (NN vs. PN in figure 
2B’). The recruitment of peripheral macrophages, which was previously reported to correlated 
with the thickness of the granule cell layer and the survival of granule cells in the dentate gyrus 
(Zattoni et al., 2011), was reduced in mice prenatally exposed to PolyI:C (figure 2C and C’), 
albeit not significantly. Interestingly, PolyI:C-pretreated mice showed fewer behavioral seizures 
in the range of severity 6-7 directly after IHK during SE (figure 2D). However, there was no 
statistical difference in the number, latency, or duration of seizures compared to NaCl-pretreated 
controls during the acute phase (figure 2D). EEG recordings at 7 dpi during the latent period 
revealed that mice prenatally exposed to PolyI:C did not show any early onset of seizures (data 
not shown) as reported in other immune disturbed mice (Zattoni et al., 2011). In the chronic 
period, when spontaneous recurrent seizures (SRS) occur (Riban et al., 2002b), the number and 
duration of seizures were the same in PolyI:C- and saline-pretreated mice (figure 2E). 
Altogether, it seems that prenatal exposure to PolyI:C during late gestation has almost no effect 
on the seizure pathology in the IHK model of TLE, except for fewer behavioral seizures of high 
severity during SE. However, a prenatal exposure to a viral mimic at GD17 seems to affect the 
innate immune response to an IHK-induced lesion during early adulthood.  
Effect of prenatal and/or postnatal immune stimulation with PolyI:C during late gestation 
on the pathogenesis of acquired epilepsy in middle aged mice 
To evaluate whether the effect of a previous exposure to PolyI:C on the innate immune response 
during IHK-induced epileptogenesis is dependent on the time-point of PolyI:C injection (prenatal 
vs. postnatal) or rather on the interval between the two events (3 vs. 9 months), mice either 
prenatally or postnatally exposed to PolyI:C or NaCl were injected with IHK at an age of 9 
months. In addition, it was reported that a second immune challenge at the age of 12 months 
(“double hit”) exacerbated central inflammatory responses in 15-months old wildtype mice 
prenatally injected with PolyI:C (Krstic et al., 2012). As this “double hit” model was not only 
associated with an increased microgliosis and astrogliosis, but also with changes related to 
Alzheimer’s disease (AD) (Knuesel et al., 2009; Krstic et al., 2012), the postnatal PolyI:C 
injection was performed at the age of 6 months, whereas the IHK-induced epileptogenesis was 
kept 3 months apart from the PolyI:C injection, similar to the previous experiment, and was 
therefore conducted at an age of 9 months (for the groups compare table 1 and section Material 
and Methods).  
At 21 dpi, 9-months old mice showed a similar pattern of neurodegeneration in response to IHK 
as 3-months old mice (figure 3A). Cresyl violet staining of hippocampal sections of IHK-treated 
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Figure 3 IHK-induced lesion and associated immune response at 21 dpi in prenatal and/or postnatal 
immune challenged, 9-month old mice. A. Bright-field microscopy images of Nissl-stained sections comparing 
the IHK-induced lesion in mice prenatally and/or postnatally exposed to either PolyI:C or NaCl. B. Microglial 
activity in the ipsilateral hippocampus depict by CD68-IR. B’. Corresponding densitometry analysis of the 
CD68-IR in 9 hippocampal regions comparing different injection groups to each other (prenatal i.v. – postnatal 
i.v. -intrahippocampal): NaCl-NaCl-NaCl (NNN), NaCl-PolyI:C-NaCl (NPN), PolyI:C-NaCl-NaCl (PNN), 
PolyI:C-PolyI:C-NaCl (PPN), NaCl-NaCl-KA (NNK), NaCl-PolyI:C-KA (NPK), PolyI:C-NaCl-KA (PNK), 
PolyI:C-PolyI:C-KA (PPK). Two-way ANOVA revealed no significant differences between intrahippocampal 
NaCl injected groups or between IHK injected groups (compare text). C. F4/80 staining visualizing infiltrating 
macrophages in the ipsilateral dentate gyrus of IHK injected mice. Scale bars, 150 μm. 
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mice revealed that the extent of both neuronal loss and granule cell dispersion was independent 
from a previous exposure to a viral mimic at GD17, at the age of 6 months or both. In controls 
intrahippocampally injected with saline, no obvious change was visible in the hippocampal and 
cortical cytoarchitecture (data not shown). Similarly, these control groups did not show any 
difference in accompanied microglial activation (figure 3B and 3B’). Therefore, the 9-months 
old control mice of this study, which were immune challenged with PolyI:C both at GD17 and at 
an age of 6 months, did not show an increase in microglia activation as it would have been 
expected from previous findings in 15-months old mice exposed to the “double hit” model 
(Krstic et al., 2012). However, IHK-induced neurodegeneration caused a massive microgliosis in 
the ipsilateral hippocampus of all mice (figure 3B). Two-way ANOVA revealed a significant 
difference in CD68-IR between IHK- and saline-treated mice (in SO, SP, SR, SLM, GCL, HL, 
and CA3c) and between hemispheres of IHK injected mice (in SO, SP, SR, SLM, GCL, HL, and 
CA3c). However, the reactive microgliosis was independent of the history of previously 
experienced immune challenges. Therefore, unlike in the 3-months old cohort, previous exposure 
to PolyI:C had no effect on IHK-induced microgliosis in 9-months old mice (figure 3B).  
Visual analysis of F4/80 staining revealed no change in the invasion of peripheral macrophages 
(figure 3C). Macrophages were found exclusively in the ipsilateral dentate gyrus, and the number 
of cells were comparable between the different groups. In line with observations made in Nissl 
stained sections (figure 3A), the survival of dentate granule cell, which was suggested to rely on 
invading macrophages (Zattoni et al., 2011), was affected neither by previous immune 
challenges nor the age of the animal.  
All groups showed a comparable sprouting of zinc-containing mossy fibers in the inner 
molecular layer and the pyramidal layer of CA3 (figure 4A). Both areas exhibited a clear staining 
for the zinc transporter ZnT3. However, in contrast to naïve 3-month-old wildtype mice at 14 dpi 
(figure 1E), all 9-month-old mice at 21 dpi showed a reduced ZnT3-IR in the ipsilateral hilus 
(figure 4A). In comparison, NPY-IR was strongly increased on the ipsilateral side, in mossy 
fibers and dentate granule cell layer (figure 4B). In some sections, an increased NPY-IR was 
found contralaterally in the most dorsal part of the lucidum, next to CA2. However, unlike the 
ZnT3-IR, the NPY staining was unable to reveal mossy fiber sprouting in IML and CA3, despite 
its presence in mossy fibers otherwise. The focal loss of NPY+ interneurons in the ipsilateral 
CA1 and dentate gyrus was comparable between all groups.  
Altogether, the pattern of neurodegeneration, microglial activation and the extent of macrophage 
invasion, mossy fiber sprouting as well as NPY expression after IHK was unaffected by either a 
prenatal, postnatal or double immune challenge in 9-month old mice.  
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Figure 4 Axonal reorganization and NPY-expression in prenatal and/or postnatal immune challenged, 9-
month old mice at 21 dpi after IHK injection. A. Axonal sprouting of zinc-containing mossy fibers in the inner 
molecular layer (left box) and in the pyramidal cell layer (SP) of CA3 (right box) using the zinc transporter ZnT3. 
All groups show a comparable extend of sprouting at 21 dpi. B. NPY-expression after IHK-induced 
epileptogenesis in mossy fibers and the granule cell layer. All mice show a focal loss of NPY+ interneurons in 
ipsilateral CA1 and dentate gyrus. Scale bars, 150 μm. 
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Role of NLRP3 inflammasomes during IHK-induced epileptogenesis  
Inflammasomes are part of the signaling cascade involved in sensing various types of danger-
signals, including the toll like receptor (TLR)-mediated response to the viral mimic PolyI:C 
(Latz et al., 2013; Walsh et al., 2014). Moreover, inflammasomes were shown to contribute to 
the activation of the innate immune system after sensing damage-signals released by cells 
undergoing necroptosis in different neurological diseases (Heneka et al., 2014; Walsh et al., 
2014). To investigate the role of NLRP3 inflammasomes, one of the best characterized 
inflammasomes, in mediating the immune response after IHK-induced cell death, NLRP3-KO 
mice were injected with IHK. The histopathological outcome was analyzed at three different 
time-points: (1) at 5 dpi, when most immune cells are already present and activated, but the 
immune response not yet reached its maximum (figure 1; (Gfeller, 2015b)), (2) at 14 dpi, around 
the onset of SRS (Riban et al., 2002b), and (3) at 30dpi, when apart from the ongoing granule 
cell dispersion many histopathological changes already reached their final state (Bouilleret et al., 
1999; Bouilleret et al., 2000b).  
The histopathological changes after IHK followed the same pattern in wildtype and NLRP3-KO 
mice, corresponding to those described in previous studies (Bouilleret et al., 1999; Zattoni et al., 
2011). In particular, a profound loss of cells in the hilus and CA3c, as well as pyknotic cells in 
CA1 was evident at 5 dpi, followed by a loss of CA1 pyramidal cells and progressive 
aggravation of the dispersion of dentate granule cells at 14 dpi and 30 dpi (figure 5A-E).  
In both genotypes, the IHK-induced neurodegeneration resulted in a similar astrogliosis (figure 
5A’-E’). The difference between ipsi- and contralateral side became more evident at 14 dpi and 
persisted until 30 dpi (contralateral not shown). GFAP-IR was primarily increased in the stratum 
oriens, pyramidale, radiatum and lacunosum moleculare of CA1, in the lucidum, CA3c and the 
hilus. In some sections, near the injection side CA3a,b was also affected. Interestingly, at 5 dpi, 
the pyramidal cell layer did not show any astrogliosis (figure 5A’), which is in line with earlier 
observations (Gfeller, 2015b).  
In comparison, the pattern of microglial activation remained the same comparing the different 
time points (figure 5A’’-E’’). Increased CD68-IR was found in areas undergoing 
neurodegeneration including CA1, parts of CA3 and the hilus. However, no difference was found 
between wildtype and NLRP3-KO mice.  
Peripheral immune cells were infiltrating the ipsilateral hippocampus in both wildtype and 
NLRP3-KO mice. Peripheral macrophages were present from day 5 until day 30 after the IHK 
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Figure 5 Neurodegenerative pattern and immune response after IHK in NLRP3-KO mice compared to 
wildtype mice. Nissl staining of the IHK-lesion (A-E), astrogliosis (A’-E’) and microglial activation (A’’-E’’) is 
depicted at 5 dpi, 14 dpi, and 30 dpi. The progression of neuronal loss, granule cell dispersion and the associated 
activation of astrocytes and microglia is comparable between the genotypes. The infiltration of peripheral 
macrophages into the dentate gyrus (F-J) and of CD3+ leukocytes into the ipsilateral hippocampus, shown here in 
CA1, (F’-J’) is similar between NLRP-KO and wiltype mice. Scale bars, 150 μm. 
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injection (figure 5F-J). In all animals, their distribution was restricted to the dentate gyrus, 
whereas most of the F4/80+ macrophages were found in the molecular layer. There was no 
obvious difference in the number of invading peripheral macrophages between the two 
genotypes. Similarly, the number of infiltrating CD3+ T cells did not differ between wildtype 
and NLRP3-KO mice (figure 5F’-J’). At 5 dpi, unlike peripheral macrophages, most CD3+ T 
cells were found in large blood vessels particularly of the hippocampal fissure, which is in 
accordance with previous findings (Zattoni et al., 2011; Gfeller, 2015b).  
In conclusion, there was no difference between wildtype and NLRP3-KO mice in the pattern of 
neurodegeneration, astrogliosis, microglial activation, the infiltration of peripheral macrophages 
and of CD3+ T cells. 
Role of macrophage infiltration for hippocampal granule cell survival 
The lesion induced by IHK causes a local activation of the innate immune system, in particular 
of microglia, CNS resident monocytes. In addition, peripheral macrophages are recruited into the 
ipsilateral dentate gyrus and can be visualized together with microglia cells by F4/80 staining 
(Zattoni et al., 2011). Macrophages can be distinguished from microglia by their stronger 
expression of the F4/80 antigen, their larger, often elongated cell bodies, as well as having fewer 
and thicker processes (Andersson et al., 1991). As previously shown (Zattoni et al., 2011), both 
the blockage of leukocyte infiltration by anti-4-integrin treatment and the peripheral ablation of 
macrophages by the toxic bisphosphonate clodronate lead to a reduced macrophage infiltration 
and are correlated with the presence of pyknotic cells in the granule cell layer. However, both 
approaches do not affect only infiltrating macrophages. To unravel the contribution of peripheral 
macrophages to the IHK-induced lesion, CCR2-KO mice were used, which selectively lack a 
chemokine receptor required for recruitment of peripheral macrophages. 
As assumed, CCR2-KO mice did not show any infiltration of peripheral macrophages after IHK 
(figure 6A). In the dentate gyrus, F4/80 staining only revealed resident microglia. The 
distribution and morphology of F4/80+ microglia were similar to those of wildtype mice at 14 
dpi (figure 1I; (Andersson et al., 1991; Zattoni et al., 2011)). However, in contrast to previous 
findings (Zattoni et al., 2011), the lack of peripheral macrophages had no effect on granule cell 
survival. IHK-induced granule cell dispersion in CCR2-KO mice was similar to wildtype mice, 
with no evidence for pyknotic cells in the dentate granule cell layer (figure 6B). Similarly, the 
activation of microglia cells did not differ between the two genotypes (figure 6C). Moreover, 
there was no clear effect on the number or distribution of infiltrating CD3+ T cells (figure 6D). 
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Altogether, CCR2-KO mice show no obvious difference in the IHK-induced lesion despite the 
lack of infiltrating macrophages.  
 
 
 
 
Figure 6 The role of infiltrating peripheral macrophages in the IHK-induced epileptogenesis. A. 
Representative image of the ipsilateral dentate gyrus stained with anti-F4/80 antibodies. Note the lack of peripheral 
macrophages in dentate gyrus of CCR2-KO mice at 14 dpi. B. CCR2-KO mice show a similar granule cell 
dispersion and pattern of neuronal loss as wildtype mice at 14 dpi. C. Lack of peripheral macrophages does not 
cause an excessive microglial activation in CCR2-KO mice, however, activated microglia are occasionally detected 
in the granule cell layer. D. CD3+ leukocytes infiltrating the ipsilateral hippocampus of CCR2-KO similar as in 
wiltype mice. Scale bars, 150 μm. 
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Discussion 
The present study highlights the importance of innate immune responses during epileptogenesis 
and reveals their contribution in the formation of an epileptic focus in a model of TLE. Firstly, 
the course of epileptogenesis was examined in a mouse model of chronic inflammation. Chronic 
inflammation was induced by systemic PolyI:C, prenatally and/or postnatally, shown to ‘prime’ 
microglia (Krstic et al., 2012; Krstic and Knuesel, 2013; Perry and Holmes, 2014). 
Unexpectedly, a prenatal immune challenge had no effect on the development of IHK-induced 
seizures (figure 2). Except fewer behavioral seizures of high severity during SE and a slightly 
reduced microglial activation during the chronic phase, prenatally immune challenged mice 
showed a similar histopathology and number of seizures after IHK injection. Even multiple 
systemic challenges with PolyI:C had no effect on the neurodegenerative pattern and the 
associated axonal reorganization in the IHK model of TLE (figure 3 and 4). A major caveat of 
this study, though, is the lack of independent evidence that the PolyI:C treatment induced the 
expected effect, as published, on immune system activation, precluding any definitive conclusion 
from our negative results. Secondly, the role of NLRP3 inflammasomes during epileptogenesis 
was investigated, in particular their contribution to the inflammatory response following IHK-
induced SE. As part of the signaling cascade sensing foreign and host-derived danger signals, 
inflammasomes mediate the microglial production of pro-inflammatory cytokines and are most 
likely involved in microglial priming (Latz et al., 2013; Heneka et al., 2014; Walsh et al., 2014). 
However, the lack of NLRP3 did not affect the IHK-induced lesion (figure 5). NLRP3-KO mice 
showed a similar activation and infiltration of innate and adaptive immune cells as wildtype 
mice. Thus, NLRP3 seems not pivotal for the inflammation-associated neurodegeneration 
following the IHK-induced SE. Finally, it was never explicitly confirmed whether the presence 
of infiltrating macrophages in the dentate gyrus is responsible for the survival of dentate granule 
cells. Previous findings showed that peripheral depletion of infiltrating macrophages using 
clodronate liposomes leads to a degeneration of dentate granule cell in the IHK model of TLE 
(Zattoni et al., 2011). However, clodronate depletes circulating monocytes (Van Rooijen and 
Sanders, 1994; Tacke et al., 2007) and not only affects the focal infiltration of F4/80+ 
macrophages into the ipsilateral dentate gyrus. Hence, CCR2-KO mice were injected with IHK 
to investigate the pathogenesis of TLE in mouse a model selectively missing an important 
chemokine receptor for the recruitment of macrophages (Boring et al., 1997; Mack et al., 2001). 
Surprisingly, the lack of infiltrating macrophages in CCR2-KO mice did not cause a 
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degeneration of dentate granule cells (figure 6) as previously reported (Zattoni et al., 2011). 
Therefore, the early infiltration of peripheral macrophages selectively into the ipsilateral dentate 
gyrus seems not responsible for the granule cell survival. 
Contribution of peripheral inflammation to seizure susceptibility and its effect on the 
pathogenesis of acquired epilepsy  
Several studies reported that peripheral immune stimulation lowers the seizure threshold and 
affects the pathogenesis of epilepsy. Most studies focussed on the acute effect of a systemic 
immune challenge on the development of evoked seizures, preceding the application of pro-
convulsives or electrical kindling by several hours up to a couple of days (Auvin et al., 2007; 
Galic et al., 2008; Kwon et al., 2010; Kirschman et al., 2011; Lee et al., 2012; Michalovicz and 
Konat, 2014). However, very little research examined the effect of chronic elevation of pro-
inflammatory cytokines on the generation of seizures (Qulu et al., 2012; Pineda et al., 2013). In 
this respect, infectious exposure during pregnancy is of major interest. Clinical and preclinical 
evidence suggest that maternal immune activation, in particular through microglial priming, pose 
a risk for the development of epilepsy (Knuesel et al., 2014). For example, Pineda et al. (2013) 
reported that repeated prenatal immune challenge with PolyI:C from GD12 to 16 increases 
hippocampal excitability, accelerates kindling rate, and prolongs increased seizure susceptibility 
for a few weeks. Moreover, this PolyI:C-induced pro-epileptic phenotype was dependent on IL-
1 and IL-6. Similarly, maternal restraint stress at GD14 exacerbated febrile seizures induced by 
postnatal injection of lipopolysaccharide (LPS) and kainic acid, as well as lead to an increased 
expression of IL-1 (Qulu et al., 2012). In contrast, prenatal stimulation with PolyI:C at GD17 
did not affect the development of acquired epilepsy in the present study. The seizure 
susceptibility and the innate immune response was rather reduced in mice pre-exposed to 
PolyI:C contradicting previous observations made during a pilot study (data not shown). A 
comparable discrepancy was found in 9-month-old mice prenatally and postnatally exposed to 
PolyI:C. While a similar ‘double hit’ with PolyI:C evoked an increased microglial activation in 
previous experiments conducted in our lab (Krstic et al., 2012), there was no effect of PolyI:C 
found in the present study.  
Our observations after a PolyI:C ‘double hit’ are in line with those of another recent study from 
our lab (Notter, 2015), which used a similar cohort of mice as the present study. The inability to 
replicate previous findings made by our lab raised questions how the PolyI:C-treated cohorts in 
the recent studies differ from our earlier once (Krstic et al., 2012). Notter (2015) addressed those 
differences focusing on the mouse strain, the stress exposure of pregnant dams, and a possible 
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litter effect. In brief, the recently used C57Bl/6JOla strain differs from the earlier used 
C57Bl/6JRcc strain (Krstic et al., 2012) in particular by carrying a spontaneous mutation 
associated with a suppressed -synuclein expression. Changes in -synuclein, which were 
shown to be involved in the assembly of the SNARE complex (Burré et al., 2010) and associated 
with glucocorticoid-induced apoptosis in patients with Parkinson’s disease (Kim et al., 2004), 
might be responsible for the different results. Moreover, Notter (2015) indicated that in previous 
experiments (Krstic et al., 2012) time pregnant mice were mated in-house compared to the 
shipment of pregnant dams at GD14 in the present experiment. It was pointed out that a potential 
stress-induced raise in corticosterone levels at GD14, which together with other sequelae can be 
detected for several days after arrival (Landi et al., 1982; Tuli et al., 1995), might interfere with 
the response of a maternal infection at GD17.  
As described above, 3 month-old mice prenatally exposed to PolyI:C showed a trend towards a 
reduced immune activation and neuronal excitability after IHK (figure 2). Although, the effect of 
a previous immune challenge tends in different direction as suspected, the relationship between 
immune activation and neuronal excitability is in line with previous findings. Thus, the present 
study was unable to replicate the increase immune response after pre-exposure to PolyI:C (Krstic 
et al., 2012), probably due to the differences mentioned earlier. However, our results support a 
synchronous mode of behavior between immune activation and neuronal excitability. 
Inflammatory cytokines, neuronal excitability and the role of inflammasomes 
The immune response following IHK is associated with a change in the cytokine profile and the 
release of pro-inflammatory cytokines (Benson et al., 2015). Beside their role in orchestrating the 
inflammatory response, pro-inflammatory cytokines were shown to modulate neuronal 
excitability (reviewed in (Fabene et al., 2010; Riazi et al., 2010; Galic et al., 2012; Balosso et al., 
2013; Liimatainen et al., 2013; Vezzani and Viviani, 2015)). For example, it was shown that 
microglia, astrocytes and endothelial cells in the epileptic focus show an acute increase in the 
pro-inflammatory cytokine IL-1 during seizures (Vezzani et al., 1999b; De Simoni et al., 2000; 
Ravizza et al., 2008b; Ravizza et al., 2008a). Together with other inflammatory cytokines, 
including TNF- and IL-6, which are also upregulated, IL-1 has neuromodulatory properties 
affecting synaptic transmission and neuronal excitability (Viviani et al., 2003; Yang et al., 2005; 
Gardoni et al., 2011a). The pathway underlying IL-1-mediated increase in neuronal excitability 
depends on the myeloid differentiation primary response protein (MyD88), which can also be 
recruited by TRLs (Vezzani et al., 1999b; Viviani et al., 2003; Balosso et al., 2013). In neurons, 
the activation of TLR4 through molecules released by necrotic cells or distressed cells, so-called 
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damage-associated molecular patterns (DAMPs), in particular high-mobility group box-1 
(HMGB1), leads to an increased excitability, which is partially mediated by NMDA receptors 
(Maroso et al., 2010). However, in microglia, the DAMP signaling contributes to a change in the 
activation state of the cell accompanied by an upregulation of the production of IL-1 (Saijo and 
Glass, 2011).  
Recent studies revealed that the production of IL-1 is mediated by inflammasomes (Latz et al., 
2013). However, the lack of NLRP3 inflammasomes, which were shown to be important for an 
excess expression of microglial IL-1 in different neurological disorders (Heneka et al., 2014; 
Walsh et al., 2014), had no effect on the development of a pro-epileptic lesion in the present 
study (figure 5). The lack of a phenotype in IHK-injected NLRP3-KO mice might be explained 
by the complex molecular pathway underlying microglial activation and expression of IL-1. For 
example in an ischemic brain injury model, Denes et al. (2015) showed that AIM2 (absent in 
melanoma 2) and NLRC4 (NLR family, CARD domain containing 4) inflammasomes, but not 
the NLRP3 inflammasome, are involved in inflammation and injury after middle cerebral artery 
occlusion (MCAo). Interestingly, while the number of IL-1+ microglia was similar in all 
genotypes, only AIM2-KO mice and NLRC4-KO mice showed a reduced microglial activation, 
leukocyte recruitment, and infarct size. Thus, in the MCAo model of ischemic brain injury, both 
neurodegeneration and inflammation were found to be independent from the IL-1 production 
and the activation of the NLR3 inflammasome (Denes et al., 2015). Similar to these findings, the 
lesion and inflammation during IHK-induced epileptogenesis were not dependent on the NLRP3 
inflammasome as described in the present study. Although, without following the course of 
epileptogenesis electroencephalographically, no explicit conclusions can be drawn about putative 
changes in neuronal excitability caused by a knockout of NLRP3. Nevertheless, the comparable 
pattern of neurodegeneration and immune activation as well as similar behavioral response 
during SE (data not shown) in NLRP3-KO mice provide evidence that these mice follow the 
same disease progression as wildtype mice after IHK. The comparable histopathology in 
wildtype and NLRP3-KO mice suggest further that NLRP3 signaling is not essential for the IL-
1 production after IHK-induced lesion. This is supported by observations that increased IL-1 
levels exacerbate the initial neuronal loss (Noè et al., 2012) and are involved in the recruitment 
of leukocytes during epileptogenesis (Ravizza et al., 2008b; Zattoni et al., 2011). Together with 
the large body of literature emphasizing the role of IL-1 in establishing an epileptic focus, an 
NLRP3-independent production of IL-1 in the IHK model of TLE seems likely and would need 
to be confirmed by measuring IL-1 levels in epileptic NLRP-KO mice. 
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Recruitment of peripheral immune cells and the role of infiltrating macrophages 
The injury-induced release of cytokines and chemokines is involved in the recruitment of 
peripheral immune cells, which in turn were shown to be pivotal for the course of 
epileptogenesis (Manley et al., 2007; Fabene et al., 2008; Ravizza et al., 2008b; Deprez et al., 
2011; Zattoni et al., 2011; Arisi et al., 2015; Varvel et al., 2016). The contribution of infiltrating 
immune cells in the formation of an epileptic lesion and the occurrence of SRS were studied in 
different animal models of TLE. The anti-4-integrin treatment reduced the infiltration of CD3+ 
T cells and F4/80+ macrophages, while causing a more severe neuronal loss in CA3 and the 
dentate gyrus of IHK-injected wildtype mice (Zattoni et al., 2011). In the same TLE model, 
macrophage depletion by clodronate liposomes was associated with the exact same 
neurodegenerative sequelae. However, Zattoni et al. (2011) showed that both treatments have a 
positive effect on the exacerbated IHK-induced neurodegeneration in a mouse model lacking B 
and T cells, the RAG1-KO strain. In these immune deficient mice, both treatments interfered 
with the invasion of neutrophils into the ipsilateral hippocampus, immune cells which are not 
present in IHK-injected wildtype mice (Zattoni et al., 2011). Similarly, in the pilocarpine model 
of TLE, where wildtype mice exhibit invading neutrophils in areas undergoing 
neurodegeneration, an interference with infiltrating leukocytes or a specific depletion of 
neutrophils reduced both the occurrence of SRS and the neuronal loss (Fabene et al., 2008). 
Apart from the aggravating nature of invading neutrophils, these findings suggested a possible 
protective role of lymphocytes, which is missing in RAG1-KO mice and seems to be responsible 
for the early seizure onset in those mice (Zattoni et al., 2011). More generally, these results 
highlight the importance of a strong interaction between the innate and the adaptive immune 
system during epileptogenesis.  
So far, all treatments or mouse models, which did include a change in macrophage infiltration, 
also influenced the survival and dispersion of dentate granule cells during IHK-induced 
epileptogenesis (Deprez et al., 2011; Zattoni et al., 2011). While none of these approaches solely 
affected the recruitment of macrophages, mice devoid of the chemokine receptor CCR2 were 
used in the present study. Unlike previous findings, the selective interference with macrophage 
recruitment did not affect granule cell dispersion or survival in the IHK model of TLE. There 
was no increase in microglial activation. However, CCR2-KO mice showed a rather low number 
of infiltrating CD3+ T cells compared to wildtype mice 14 days after IHK injection. Although, 
the difference was not unambiguous, it might be interesting to examine the ratio of CD4+ to 
CD8+ T cells in those mice. This might be especially interesting, as Deprez et al. (2011) showed 
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that the adoptive transfer of T lymphocytes in immune deficient mice strongly influenced the 
infiltration of F4/80+ macrophages. Grafting of the missing T cell population blocked the 
macrophage infiltration and abolished the granule cell dispersion in mice lacking CD4+ T cells 
(MHCII-KO), while in mice lacking CD8+ T cells (2-microgloblin-KO) it caused an enhanced 
recruitment of macrophages and an increased dispersion of dentate granule cells (Deprez et al., 
2011). Therefore, positive signals provided by CD8+ T cells and negative signal emanating from 
CD4+ T cells might not only affect the macrophage infiltration as earlier suggested (Deprez et 
al., 2011), but rather could have a direct influence on the survival and dispersion of granule cells, 
for example through regulation of microglial activation or secretion of neurotrophic factors like 
BDNF (Kerschensteiner et al., 1999; Duveau et al., 2011; Chan et al., 2015).  
Varvel and colleagues (2016) recently investigated the contribution of CCR2+ monocytes in two 
models of TLE. They showed that systemic kainic acid-induced SE, which causes a lesion in 
CA3, leads to the recruitment of CCR2+ monocytes through the expression of CCL2 by 
microglia and perivascular macrophages. In contrast to the IHK model, these infiltrating 
macrophages were only detected transiently, at 3 dpi, and were missing later on, at 14 dpi. 
Similarly, CCR2+ monocytes were infiltrating regions undergoing neurodegeneration in the 
pilocarpine model. In both TLE models, CCR2-KO mice showed a similar seizure severity sore 
during SE as wildtype mice. However, CCR2-KO mice showed a reduction in the number of 
Iba1+ microglia in CA3 compared to wildtype mice after systemic kainic acid. While no obvious 
difference in microglial activation between genotypes was noticed in the IHK model (figure 6), 
these discrepancies delineate the peculiarities of the different TLE models. Unlike for the 
systemic application of a pro-convulsive (Varvel et al., 2016), IHK-induced infiltration of 
peripheral macrophages is restricted to the dentate gyrus, an area not affected by conspicuous 
neuronal loss. Despite discrepancies between different models of TLE, the interaction between 
different immune cells seems to be important for the coordination of various processes (e.g. 
neuronal protection or phagocytosis) involved in formation of the epileptic focus.  
Conclusions 
Despite the absence of chronic neuroinflammation after pre-exposure to PolyI:C, our data concur 
with previous findings highlighting the importance of the innate immune response for neuronal 
excitability. Further, we uncovered that the NLRP3 inflammasome, which was proposed to be 
pivotal for the IL-1-mediated increase in neuronal loss and excitability, does not affect the 
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IHK-induced lesion. Finally, we show that the survival and dispersion of dentate granule cells 
are independent of the infiltration of peripheral macrophages. 
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Abstract 
Neuronal network dysfunction is frequently associated with Alzheimer’s disease (AD). In 
patients and in animal models of AD, aberrant epileptic activity is detectable already at early 
disease stages. However, it is unknown whether AD-pathology renders neuronal networks more 
susceptible to development of acquired epilepsy. Here, we report that 3-months-old ArcticAβ 
mice, an AD mouse model without any amyloid deposition at this age, are more susceptible to 
seizures induced by unilateral intrahippocampal injection of kainic acid (IHK). In this temporal 
lobe epilepsy model, IHK-induced status epilepticus is followed by occurrence of spontaneous 
recurrent seizures (SRS) after two weeks. ArcticAβ mice exhibited more severe status epilepticus 
and early onset of SRS. The electrophysiological signature of this hyperexcitable phenotype was 
characterized in CA1 neurons by decreased synaptic strength, increased kainic acid-induced 
LTP, and reduced frequency of spontaneous inhibitory currents. However, ArcticAβ mice did not 
display any major difference in neurodegeneration, neuroinflammation, axonal reorganization or 
adult neurogenesis compared to wildtype littermates, either prior to or following IHK-induced 
epileptogenesis. Expression of neuropeptide Y (NPY) was reduced at baseline and its IHK-
induced elevation in mossy fibers and granule cells was attenuated in 3-months-old ArcticAβ 
mice. However, although alteration in NPY signaling might underlie premature seizure onset, 
neutralization of soluble Aβ species by Aβ-specific antibody (6E10) ameliorated the 
hyperexcitable phenotype of ArcticAβ mice and prevented early SRS onset. These results 
suggest that development of seizures at early stages of AD is mediated primarily by Aβ species 
causing widespread changes in synaptic function. 
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Significance statement 
Although Alzheimer’s disease (AD) and epilepsy are separate syndromes, the pathogenesis of 
AD is associated with a high incidence of aberrant network activity, including unprovoked 
limbic seizures. To unravel the contribution of AD-like pathology to the development of a pro-
epileptogenic environment, we analyzed ArticAβ transgenic mice in a model of temporal lobe 
epilepsy, induced by intra-hippocampal kainic acid injection. We observed that these AD-
transgenic mice are more susceptible than wildtype littermates to the effects of kainate and 
exhibit early onset of spontaneous recurrent seizures. Ameliorating the hyperexcitable phenotype 
of AD-transgenic mice with an antibody against Aβ delayed seizure onset, suggesting that 
soluble Aβ species alter network functions prior to plaque formation, contributing to the 
occurrence of unprovoked seizures. 
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Introduction 
Alzheimer’s disease (AD) is the most prevalent age-related dementia, characterized by 
progressive neuronal dysfunctions. Early stages of AD and other age-related dementia are 
associated with aberrant network activity, including a high incidence of unprovoked epileptic 
seizures (Hesdorffer et al., 1996; Amatniek et al., 2006; Scarmeas et al., 2009; Vossel et al., 
2013; Vossel et al., 2016). Early neurochemical alterations render neuronal networks susceptible 
to seizure generation (Palop and Mucke, 2016). Indeed, different AD mouse models exhibit 
neuronal hyperactivity and even interictal spikes long before the occurrence of plaques (Busche 
et al., 2012; Kam et al., 2016). While hyperexcitability reduces seizure threshold in AD-
transgenic mice (Palop et al., 2007; Roberson et al., 2007; Westmark et al., 2008; Born et al., 
2014), it is unknown whether it is causally related to onset of  spontaneous recurrent seizures 
(SRS).  
AD and epilepsy, in particular temporal lobe epilepsy (TLE), share major pathogenic 
mechanisms, including neurodegeneration, synaptic dysfunction, inflammation, and altered adult 
neurogenesis. In mouse TLE models, loss of parvalbumin- (PV), calbindin- (CB), somatostatin- 
(SOM) and neuropeptide Y (NPY) -expressing interneurons occurs in CA1 and dentate gyrus 
early during epileptogenesis (Bouilleret et al., 2000b; Bouilleret et al., 2000a; Andre et al., 
2001). Similarly, different AD mouse models show reduced numbers of interneurons in these 
regions (Ramos et al., 2006; Mahar et al., 2016); and functional impairments of PV interneurons 
were directly related to network hypersynchrony in parietal cortex (Verret et al., 2012). In 
dentate gyrus granule cells (GC), calbindin expression is disease stage-dependently reduced in 
AD mouse models and AD patients (Palop et al., 2003; Stefanits et al., 2014). Moreover, TLE is 
characterized by recurrent sprouting of mossy fiber collaterals (Buckmaster, 2012) and by 
ectopic expression of NPY in GCs (Marksteiner et al., 1990; Tonder et al., 1994; Vezzani et al., 
1999c). AD-transgenic mice revealed a similar adaptation to a hyperexcitable network, including 
mossy fibers sprouting onto GABAergic basket cells and hilar interneurons (Palop et al., 2007). 
In both TLE and AD, activation of innate immunity is an important pathogenic feature. For 
instance, in TLE, secreted cytokines render the neuronal network hyperexcitable and thereby 
more susceptible to seizures (Viviani et al., 2003; Maroso et al., 2010; Gardoni et al., 2011b). 
Likewise, amyloid β recruits microglia (Alzheimer et al., 1995; Meyer-Luehmann et al., 2008; 
Wang et al., 2015) and thus triggers inflammatory cytokine release, causing various sequelae 
associated with AD (Heneka et al., 2013). Finally, neurogenesis is altered in both TLE and AD. 
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Prolonged seizure activity transiently increases precursor cell proliferation (Parent et al., 1997; 
Jessberger et al., 2005), followed by neurogenic niche destruction and impaired hippocampal 
neurogenesis (Kralic et al., 2005; Ledergerber et al., 2006; Sierra et al., 2015). In AD, survival of 
newborn neurons is impaired in mice with plaque-burden (Verret et al., 2007), while in young 
AD transgenic, accelerated development of newborn GC leads to impaired dendritic maturation 
(Sun et al., 2009).  
It is difficult to disentangle which AD-related changes directly contribute to seizure development 
and which are by-products of a hyperexcitable environment. Therefore, we investigated TLE-
related epileptogenesis in ArcticAβ mice (Knobloch et al., 2007), overexpressing human APP 
transgene containing the Swedish and Arctic mutations. Since neuronal dysfunctions associated 
with Aβ pathology occur prior to plaque deposits (Billings et al., 2005; Busche et al., 2012; Kam 
et al., 2016), it is possible to separate the two phenomena. We monitored the clinical course of 
epileptogenesis induced by intrahippocampal injection of kainic acid (IHK) in young adult 
ArcticAβ mice and wildtype littermates. IHK induces a status epilepticus followed by a seizure-
free 2-week latent period preceding SRS onset (Suzuki et al., 1995b; Bouilleret et al., 1999; 
Riban et al., 2002a), allowing to causally determine the role of early AD-related neurochemical 
alterations for epileptogenesis and TLE development, as assessed by chronic EEG recordings 
and immunohistochemical analysis. Finally, we tested the possible role of soluble A species 
(Benilova et al., 2012a) by inactivating them intracerebrally with a neutralizing antibody.  
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Materials and Methods 
Animals 
All experiments performed for this study were carried out in accordance with the Swiss law on 
animal experimentation and approved by the Cantonal Veterinary Office of Zurich. 
Experiments were performed with arcAβ transgenic mice (Knobloch et al., 2007) and age-
matched wildtype (wt) littermates, bred at the Laboratory Animal Sciences Center of the 
University of Zurich. They were genotyped by PCR analysis from ear biopsies. All animals were 
housed at standard conditions (20-24℃; minimum 40% relative humidity) under a 12-hour 
light/dark cycle, with access to food and water ad libitum. Experiments were performed in males 
unless indicated otherwise and all group sizes are reported with the statistical analyses. 
Stereotactic injection  
Intrahippocampal kainic acid (IHK) injection 
At the age of 12-to-15-weeks, mice anaesthetized by inhalation of 2.5-3% isoflurane (Baxter) in 
oxygen were injected (Nanoject II, Drummond Scientific) with 70 nL kainic acid (5 mM in 
NaCl; Tocris biosciences) or an equivalent volume of NaCl into the right dorsal hippocampus 
(anteroposterior [AP] -1.8 mm, mediolateral [ML] -1.6 mm, dorsoventral [DV] -1.9 mm relative 
to Bregma) as described by (Bouilleret et al., 2000b). For analgesia, mice were i.p. injected with 
1 mg/kg buprenorphine (Temgesic®, Reckitt Benckiser AG, Switzerland) prior and after 
surgery. 
Intrahippocampal retrovirus injection 
Adult mice (2 months old) were anesthetized as described above. Retrovirus encoding enhanced 
green-fluorescent protein (eGFP; 1 μL) was bilaterally injected into the hilus of the dentate gyrus 
(AP -2.0 mm, ML +/- 1.5 mm, DV -2.3 mm relative to Bregma) and the tissue was collected at 
21 or 42 days post injection (dpi). eGFP-encoding retrovirus was produced “in house”, as 
described in (Deprez et al., 2016). HEK 293T cells were transfected with three different plasmids 
containing the capsid (CMV-vsvg), viral proteins (CMV-gag/pol) and the transgene (CAG-
eGFP) under the control of the CAG promoter (including the CMV CMS enhancer and chicken 
β-actin promoter). 
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Antibody injection 
A subset of mice was intracerebroventricularly injected with purified mouse anti-Aβ antibody 
(6E10, Aβ3–8, IgG1; Covance) or control immunoglobulin G (IgG; 4 mg/mL; kindly provided 
by Britta Engelhardt, Theodor Kocher Institute, University of Bern) for a local neutralization of 
soluble Aβ species (Sudduth et al., 2013). A bilateral infusion (5 μL each, 500 nL/min, 10 min 
wait prior to retraction) into the lateral ventricles (AP -1.8 mm, ML +/-2.75 mm, DV -2.5 mm 
relative to Bregma) was performed under general anesthesia 3 days prior to the IHK injection. 
The tissue was collected at 18 dpi (IHK injection) for histological analysis.  
5′-bromo-2′-deoxyuridine (BrdU) treatment 
Three weeks prior BrdU treatment adult female mice were housed together (5 per cage) and 
bedding containing male mouse urine was introduced to the cages to induce Lee-Boot and 
Whitten cycle-synchronizing effects. At the age of two months mice received two intraperitoneal 
injections of 90 mg/kg BrdU (Sigma-Aldrich, #B5002, dissolved in 0.9% NaCl) on two 
consecutive days. The tissue was collected at 1 dpi to assess cell proliferation and at 28 dpi to 
evaluate cell survival and cell fate. 
Electroencephalographic (EEG) recordings 
Electrode implantation 
For EEG recordings, mice were implanted immediately after stereotactic injection of KA with a 
bipolar electrode into the same coordinates as the injection and a monopolar reference electrode 
was placed into the cerebellum of the left hemisphere. Two enamel insulated stainless steel wires 
were connected to a male connector and twisted to a bipolar electrode for EEG recordings (for 
details see (Arabadzisz et al., 2005)), while two gold wires were inserted into the neck muscles 
for EMG recordings (for details see (Palchykova et al., 2010)). Electrodes were connected 
through a board-to-board connector (M52-5050545, Harwin) and fixed to the skull by a 
combination of Prime&Bond (Dentsply) and Tetric EvoFlow (Ivoclar vivadent) while the 
entering electrode shaft was sheathed by Kwik-CastTM Silicone Elastomer (World Precision 
Instruments). 
Data acquisition and analysis 
Continuous video-EEG (vEEG) recordings were acquired after the injection until 18 days post-
injection (dpi) or once at 21 dpi. To this end, mice were placed into custom-made recording 
cages within a Faraday cage. A custom-made vEEG system was used for continuous 
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synchronous video and EEG recordings, consisting of a custom-made swivel, an amplifier and 
digitizer (AcqKnowledge MP100; Biopac Systems), infrared-switchable video cameras (Vivotek 
Inc., New Tapei City, Taiwan), NAS server (Synology), and a custom-made timer for 
synchronization (BASIC Stamp 2, Parallax Inc, Rocklin, CA, USA). EEG and EMG data was 
acquired at a sampling rate of 200 Hz. To assess the acute response to IHK, vEEG recordings of 
the first 4 hours were manually analyzed (open source software Polyman, EDF+). The severity 
of behavioral seizures was categorized according to the Racine, Pinel and Rovner scale (Table 1) 
(Racine, 1972; Pinel and Rovner, 1978). For each day, one hour was analyzed during the activity 
phase (around 1 AM) and during the resting phase (around 1 PM). For seizure quantification 
during the chronic phase, a three-hour recording (11 am to 2 pm) was analyzed. Seizures were 
defined as paroxysmal events lasting longer than 20 s that were separated by intervals of at least 
1 s. The average frequency and duration of SRS was calculated for each mouse. 
Table 1 Modified Racine scale for behavioral seizures. Adapted from (Pinel and Rovner, 1978) 
Scale Stage Behavior 
Racine behavioral scale 1 Oroalimentary movements 
 2 Head nodding 
 3 Anterior limb clonus 
 4 Dorsal extension (rearing) 
 5 Loss of balance and falling 
Pinel and Rovner behavioral 
scale 
6 Repeated falling 
 7 Strong jumping and running 
 8 Stage 7 with tonic period 
Electrophysiology 
Acute brain slice preparation 
Mice were anesthetized with sodium pentobarbital (Nembutal®; 50 mg/kg; i.p.) and decapitated. 
300 µm – thick sagittal slices were cut on a vibratome (Leica VT 1200 S) in ice-cold cutting 
solution and then stored in ACSF at room temperature in an interface type holding chamber for 
at least 1 h. Cutting solution contained (in mM) NaCl 87, KCl 2.5, CaCl2 0.5, MgCl 7, NaH2PO4 
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1.25, NaHCO3 25, glucose 10 and sucrose 75. ACSF contained (in mM) NaCl 120, KCl 3, CaCl2 
2.5, MgSO4 2, NaH2PO4 1, NaHCO3 25, and glucose 20, and was bubbled with 95% O2, 5% CO2 
(pH 7.4).  
Field recordings 
For the recording of extracellular population spikes glass microelectrodes of approx. 1.5 MΩ 
were filled with saline and placed near the border of CA1 stratum radiatum. Population spikes 
were evoked at 0.05 Hz with two pulses (50 ms apart) through a bipolar stimulating electrode 
positioned in CA3. A 15 min stable baseline was acquired before the application of 1µM KA for 
10 min. The amplitudes of the population spikes were measured using Clampfit 10 (Molecular 
Devices, LCC, Sunnyvale, California, United States). To evaluate changes induced by kainic 
acid (KA) application, mean baseline values (mean of all amplitudes 5 min before the application 
of KA, i.e. 15 consecutive responses) were compared to those elicited 30 min after the washout 
of KA (mean of 15 consecutive responses). 
Patch clamp recordings 
For whole cell patch clamp recordings CA3 area was cut away. CA1 hippocampal cells were 
visualized with an upright microscope (Axioscope Examiner.A1, Carl Zeiss; 63x water 
immersion objective). Whole-cell pipettes were pulled from thin wall glass capillaries (1.5 O.D. 
X 1.17 I.D., Harvard Apparatus, Massachusetts, USA) using a Zeitz DMZ Puller (Martinsried, 
Germany). Electrode resistances in the bath were 3–6 mV. Series resistance was monitored by a 
–5mV step, and cells were discarded if this changed significantly (~20%). The intracellular 
solution consisted of (in mM) CsCl 140, HEPES 10, EGTA 10, MgATP 2, Na3GTP 0.3, pH 7.3, 
290 mOsM. Cells were clamped at a holding potential of –70 mV to register spontaneous 
postsynaptic currents (sPSC). Currents were recorded with a multiclamp 700B (Molecular 
Devices, Pennsylvania, USA), and digitized at 10 kHz using a Digidata 1550 digitizer 
(Molecular Devices) and Clampex 10.0 (MolecularDevices). Traces were recorded with pClamp 
10 and analysis of sPSCs frequencies and amplitudes were performed with MiniAnalysis 
(Synaptosoft, New Jersey, USA). KA (250 nM) was added for 5 min. For each condition (i.e. 
before the addition of KA and in the presence of KA) traces of one-minute duration were used 
for statistical analysis. The one-minute period where the effect of KA was maximal, was chosen 
for the statistical analysis. 
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RNA isolation and quantitative real-time PCR 
Adult mice were anesthetized, decapitated, brains were extracted rapidly on ice and hippocampus 
dissected. Whole cell RNA from brain tissue was extracted using NucleoSpin RNA kit 
(Macherey-Nagel). cDNA was prepared using random hexamer primer (Thermo Scientific) and 
MuLV Reverse Transcriptase (Thermo Scientific). 1 g of total RNA was amplified in CFX384 
Touch™ Real Time PCR detection system (Biorad) using the SYBRgreen PrecisionPLUS qPCR 
Mastermix (Primerdesign). The relative levels of each RNA sample were calculated by the 2-
ΔΔCT method using Biogazelle, qBase plus software (Livak KJ, 2001) and were normalized to 
that of HPRT and eEF1a1 mRNA. Each CT value used for these calculations was the mean of 
triplicates of the same reaction. All primers were synthesized by Eurofins genomics. Sequences 
of all primers are listed in Table 2. 
Table 2 List of primers for RT-qPCR. 
Target Forward sequence 5’ → 3’ Reverse sequence 5’ → 3’ 
Y1 receptor CAAGATATACATTCGCTTGA AGATTGTGGTTGCAGG 
Y2 receptor CCATCTTCCGGGAATAC TGACGTGGTTCCTCAG 
Y5 receptor TCAAGCGTTCCCTCAC ACAACAGGACATCATGC 
NPY TGGACTGACCCTCGCTCTAT TGTCTCAGGGCTGGATCTCT 
IL-10 GGGAAGAGAAACCAGGGAGAT GCCACAGTTTTCAGGGATGA 
IL-6 TCCATCCAGTTGCCTTCTTG GGTCTGTTGGGAGTGGTATC 
TNFα AGCCAGGAGGGAGAACAGA CAGTGAGTGAAAGGGACAGAAC 
SCN1a CTCGTTCCTGATCGTGTTCC ATCCTGTCCACAGCAATCTG 
BDNF TGCAGGGGCATAGACAAAAGG CTTATGAATCGCCAGCCAATT 
IL-1β CAACCAACAAGTGATATTCTCCAT GGGTGTGCCGTCTTTCATTA 
Eef1a1 AAGCCCATGTGTGTTGAGAG CTCCAGCAGCCTTCTTGTC 
HPRT1 TCCTCCTCAGACCGCTTTT AGGTATACAAAACAAATCTAGGTCAT 
 
Tissue preparation for immunohistochemistry 
Tissue was collected and prepared similar to the protocol of Notter et al. (2014). In brief, mice 
were anesthetized (Nembutal®; 50 mg/kg; i.p.) and perfused intracardially with 15–20 mL ice-
cold, oxygenated aCSF [containing (mM) NaCl 125, KCl 2.5, CaCl2 3.7, MgCl2 2, NaHCO3 26, 
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NaH2PO4 1.25, glucose 25], pH 7.4, at a flow rate of 10–15 mL/min. The brain was extracted 
and divided into 3 blocks: rostral, medial and caudal part. All three parts were immediately 
immersion-fixed for 3 hours in ice-cold fixative [4% paraformaldehyde dissolved in 0.15 M 
sodium phosphate buffer], pH 7.4, then rinsed with PBS (pH = 7.4) and cryoprotected overnight 
in 30% sucrose in PBS at 4°C. 
The fixed tissue was cut into 70-μm (dendritic morphology) or 40-μm (rest) thick serial coronal 
sections using a sliding microtome and collected in ice-cold PBS. For storage, sections were 
transferred to a cryoprotectant solution (50 mM sodium phosphate buffer, pH 7.4, containing 
15% glucose and 30% ethylene glycol; Sigma-Aldrich) and kept at -20°C. 
Immunohistochemistry 
Sections were washed three times in Tris buffer (50 mM Tris, 150 mM NaCl, 0.05% Triton X-
100, pH 7.4) for 10 min each and incubated overnight at 4 ℃ under continuous agitation with 
primary antibodies (Table 3) diluted in Tris buffer containing 2% normal goat serum (NGS) and 
0.2% Triton X-100. Sections were rinsed three times in Tris buffer and incubated with the 
secondary antibody solution (2% NGS, Tris buffer) for 30 min at room temperature with 
secondary antibodies raised in goat. For immunofluorescence, secondary antibodies conjugated 
to AlexaFluor-488 (Invitrogen) were diluted to 1:1000 and those conjugated to Cy3 or Cy5 
(Jackson ImmunoResearch Laboratories) to 1:500. After washing three times in PBS, sections 
were mounted to gelatin-coated glass slides and cover-slipped using Fluorescence Mounting 
Medium (Dako). For immunoperoxidase staining, biotinylated secondary antibodies (Jackson 
ImmunoResearch Laboratories) were diluted 1:300 and after washing three times in Tris buffer, 
incubated with avidin-peroxidase-complex solution (Vectastain Elite kit, Vector Labs) at room 
temperature. After washing them again three times in Tris buffer, sections were stained by 
combining 3,3-diaminobenzidine (DAB; Sigma–Aldrich Inc.) in Tris buffer (pH 7.7) with 
hydrogen peroxide for 5-15 min. Sections were immediately transferred to ice-cold PBS and 
washed three times. Finally, sections were mounted onto gelatinized glass slides, air-dried 
overnight, dehydrated through ethanol, cleared in xylene and coverslipped with resinous 
(Eukitt™; Sigma-Aldrich) mounting medium. 
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Table 3 List of primary antibodies (IF, immunofluorescence; IP, immunoperoxidase) 
Target Distributor Description, Ref. no. Dilution Marker of 
BrdU Oxford Biotech Rat, OBT0030 1:1000 IP 
CD68 AbD Serotec Rat, MCA1957GA 1:2000 IP/IF 
DCX Chemicon Guinea pig, AB2253 1:2000 IF 
F4/80 Abcam Rat, b6640 1:1000 IP 
GFAP Dako Rabbit, Z334 1:20’000 IF 
Neuropeptide Y Peninsula Lab. Rabbit, T-4069 1:1000 IP 
ZnT3 Synaptic Systems Rabbit, 197002 1:1000 IP 
Nissl staining 
The IHK-induced pattern of degeneration and the placement of EEG electrodes was determined 
by Nissl staining with Cresyl violet. To this end, slides with air-dried sections were dipped in the 
following solutions: 5 min in dH2O, 5 min in filtered Cresyl violet solution (C18H15N3O3, M 
321.34, Fluka BioChemika, Cat. no. 10510-54-0), 30 sec in dH2O and cleared in 96% ethanol 
containing 0.5% acetic acid until the desired coloration was obtained, 5 min in isopropanol, 5 
min in isopropanol:Xylene (1:2) and 4 times dehydrated in xylene for 2 min. Finally, the slides 
were coverslipped with Eukitt. 
Image acquisition and analysis 
Visual scoring and image acquisition 
For visual scoring of the neurodegenerative pattern (Nissl), 3-4 sections per mouse were 
examined using an Axioscop 2 microscope (Carl Zeiss) with bright-field illumination and either 
a 10x, 20x objective or 40x oil immersion objective. All images for display were acquired with a 
color digital camera (AxioCam MRc5) and the corresponding software AxioVision 4.5 (Zeiss). 
Densitometry analysis 
Immunoperoxidase staining (CD68, NPY) intensity was assessed by densitometry analysis (3-4 
sections per mouse) using the MCID software (MCID Elite 6.0, InterFocus Imaging Ltd., 
Cambridge, UK). First, images were digitized using a precision illuminator (Northern light 
Model B95, Imaging Research Inc., Brock University, St.Catharines, Canada) and CoolSnap cf 
photo-camera (Photometrics, Tuscon, AZ, USA) with a Micro-Nikkor (55 mm + 12 mm) 
objective (Nikon Corp.). Then, the grey values were calibrated (Kodak step tablet no. 310ST607) 
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and the intensity was measured in the different regions of interest. To correct for variations in 
background staining, the intensity value was normalized to the intensity of the whole section. 
Stereological analysis 
The number of immunoreactive cells (F4/80+ macrophage-like cells) was determined 
stereologically in 3-4 sections per mouse using an Axioplan 2 bright-field microscope (Carl 
Zeiss AG, Feldbach, Switzerland) with 20x (air, NA 0.75) objective and an integrated digital 
camera (MicroFIRE, Optronics AG, Goldach, Switzerland). The size of the granule cell layer 
and molecular layer of the dentate gyrus as well as the number of macrophage-like cells within 
these outlined regions were estimated using the Mercator software (Mercator Pro rev. 7.8.2, 
Explora Nova, La Rochelle, France). For each mouse, the number of macrophage-like cells and 
the estimated thickness was averaged over three to four equidistant coronal sections. 
Quantification of cell proliferation and survival 
BrdU+ cells in the subgranular zone (SGZ) and granule cell layer (GCL) of the dentate gyrus 
were counted in 4-5 sections per mouse in dorsal hippocampus using the Axioscop 2 (Carl Zeiss; 
40x oil-immersion lens, NA 1.3). Dorsal hippocampal volume was estimated using Mercator 
software (compare above). 
Sholl analysis 
Fluorescent Z-stacks (spaced by 0.7 μm) throughout the entire thickness of the section were 
acquired with a confocal microscope (LSM710) using a 40x oil immersion objective (NA, 1.4) 
and ZEN 2012 black edition (Carl Zeis MicroImaging GmbH, Goettingen, Germany) software. 
Images were analyzed with ImageJ (version 1.49o; Java 1.6.0_12 (Wayne Rusband, National 
Institutes of Health, USA). Sholl analysis (Sholl, 1953) (concentric circles spaced at 10 μm 
intervals, centered on the cell body) was used to analyze the complexity of the dendritic trees. 
First, neurons were traced using NeuronJ plugin (NIH ImageJ; (Meijering et al., 2004)). Further 
Sholl analysis plugin (Anirvan Ghosh Laboratory, University of California, San Diego, La Jolla, 
CA, USA) was used to calculate the number of intersections between dendrites and concentric 
circles. For the number of intersections as a function of distance from the soma, area-under the 
curve (AUC) was calculated and used for further statistical analysis. Dendritic morphometry 
(primary dendrite length, total dendrite length) was assessed with the NeuronJ plugin. In total 14-
36 cells from the groups of 5 to 8 mice per time point were quantified. 
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Spine density 
Z-stacks for spine density morphology analysis of randomly selected eGFP-positive dendritic 
segments were obtained with a 40x oil immersion objective using a 2.7 digital zoom. Spines 
density quantification and spine type classification were performed using CellCounter (ImageJ). 
The length of each segment was measured and the number of spines/μm was quantified. 
Statistical analysis 
Data are presented as mean ± standard error of the mean (SEM). Statistical analyses for multiple 
group comparison was performed by a one-way or two-way ANOVA with a Bonferroni post-hoc 
test. An unpaired t test, two-tailed, was used to compare two groups (Prism software, GraphPad 
version6). For KA-induced LTP a two-way repeated measure ANOVA was performed with a 
Sidak´s multiple comparisons test. To compare the distribution of spontaneous currents (inter-
event interval and amplitude) a Kolmogorov–Smirnov test was used (differences were 
considered significant if p<0.01). 
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Results 
Acquired epilepsy and increased seizure-associated mortality in ArcticAβ mice 
To determine whether an AD-like predisposition prior to detectable plaque pathology renders the 
limbic neuronal network more vulnerable to excitotoxicity and affects the development of 
acquired epilepsy, 3-months-old ArcticAβ mice and wildtype littermates were injected with IHK 
(Fig. 1A). Both genotypes exhibited the characteristic neurodegenerative pattern 3 weeks after 
IHK: loss of pyramidal cells in CA1 and CA3c as well as loss of hilar mossy cells in the dentate 
gyrus (Fig. 1B) as previously described (Bouilleret et al., 2000b; Bouilleret et al., 2000a). The 
severity and region-specificity of the cell loss were not different between the genotypes. IHK-
induced GC dispersion in the dentate gyrus was similar in ArcticAβ and wildtype littermates, as 
determined by measuring the thickness of the GC layer (GCL; t20 = 1.13, P = 0.27) and the 
molecular layer (ML; t20 = 1.4, P = 0.18; unpaired two-tailed t-test) (Fig. 1C). The number of 
invading macrophages, which was shown to correlate with the extent of GC dispersion (Zattoni 
et al., 2011), did not differ between genotypes (ML: t20 = 1.9, P = 0.07; GCL: t20 = 0.2, P = 0.85; 
unpaired two-tailed t-test). In line with observations about the neurodegenerative pattern induced 
by IHK, microglial activation was not altered by the ArcticAβ transgene in the injected 
hemisphere (Fig. 1D).  
IHK led to the development of acquired epilepsy in both genotypes, with mice exhibiting similar 
seizure frequency three weeks after the injection (t7 = 0.04, P = 0.97; unpaired two-tailed t-test) 
(Fig. 1E). Unexpectedly, however, mortality of ArcticAβ mice was observed acutely (𝜒2(1) = 
13.4, P = 0.0003; Mantel-Cox test), due to strong convulsive seizures during status epilepticus as 
well as during the transition from the latent to the chronic period, when SRS start to appear (Fig. 
1F). Thus, the AD-like predisposition in 3-months-old ArcticAβ mice increases seizure severity 
possibly by altering the response to excitotoxicity and causing aberrant activity during early 
epileptogenesis, while having no effect on the frequency of SRS and associated histopathological 
changes in surviving mutant mice. 
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Figure 1 Increased response of ArcticAβ mice to IHK-induced epilepsy. . A, Schematic representation of the 
experimental design to assess acquired epilepsy. Kainic acid injection and electrode implantation were 
performed in the right dorsal hippocampus, while EEGs were recorded and tissue was collected for histological 
analysis at 21 dpi. B, Cresyl violet staining of the ipsilateral hippocampus. Neurodegeneration in CA1, CA3c, 
and the hilus, along with the dispersion of dentate granule cells, show a similar pattern in both IHK-injected 
wildtype (WK) and ArcticAβ mice (AK) (SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum; 
SLM, stratum lacunosum moleculare; ML, molecular layer; GCL, granule cell layer; HL, hilus). C, F4/80+ 
macrophages invading the ipsilateral dentate gyrus and the dispersion of dentate GC. Stereological quantification 
of F4/80+ macrophages and measuring the layer thickness of GCL and ML revealed no differences between 
genotypes (n = 6/genotype; unpaired t-tests). D, Densitometric analysis of CD68 staining. Microglial activation 
was increased 3 weeks after IHK injection in the ipsilateral hemisphere of both genotypes (n = 6/genotype; *** p 
< 0.0001, two-way ANOVA). E, Frequency of SRS. Both genotypes show a similar number of seizures three 
weeks after IHK. Representative traces of intrahippocampal recordings reveal a high frequency of SRS in the 
IHK model of acquired epilepsy (box outlines 10 s and 15 mV). F, Survival curve during epileptogenesis. 
ArcticAβ mice (n = 20) exhibit an increased mortality rate during the status epilepticus and during the transition 
from the latent to the chronic period with SRS in comparison to their wildtype littermates (n = 8) (*** P = 
0.0003, Mantel-Cox test). Quantitative data represent mean ± SEM. Scale bars, 150 μm.  
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Increased response to excitatory stimulation in the hippocampal network 
To study the differential impact of IHK-induced status epilepticus on the hippocampal neuronal 
network of ArcticAβ mice, we recorded field population spikes (PS) in the main hippocampal 
output region, CA1, in tissue slices (Fig. 2A). A current-voltage plot illustrates the significantly 
different slope (p < 0.01) of recorded PS as a function of stimulus intensity in wildtype compared 
to ArcticAβ mice (Fig. 2B). This difference suggests that the strength of synaptic transmission in 
CA1 is reduced in ArcticAβ mice, which is consistent with previous findings in other AD 
transgenic mice (Palop et al., 2007).  
KA has recently been shown to induce an NMDA-independent form of long term potentiation 
(LTP) (Petrovic et al., 2017). Similarly, we observed that a 10-min application of KA (1 µM) 
produces a stable potentiation of CA1 PS, which remained unchanged for at least 30 min after 
the drug had been washed out, in both wildtype (98.7 % ± 0.9 before KA to 116.7 % ± 7.4 after 
30 min washout, 9 slices from n = 7 different animals) and ArcticAβ mice (101.1% ± 3,36 before 
KA to 177.7 % ± 26.10 after 30 min washout, 6 slices from n = 5 different animals) (Fig. 2C). 
The KA-induced potentiation was significantly higher in ArcticAβ mice compared to wildtype 
littermates (Fig. 2D) (two-way ANOVA repeated measure ANOVA; significant effect of 
treatment 30 min after wash-in, F(1, 10) = 8.6, p < 0.01, and genotype, F(1, 10) = 8.6, p < 0.05). The 
latter difference was due to the stronger effect of KA in slices of ArcticAβ mice (Sidak´s 
multiple comparison post-hoc test). Although not significant, we observed a tendency towards 
reduced paired pulse ratio after KA in ArcticAβ mice (Fig. 2E), suggesting some degree of 
presynaptic involvement in their enhanced response to KA. 
Impairment of the inhibitory circuit in CA1 
In order to examine the response of the inhibitory CA1 microcircuit to KA application without 
interfering pharmacologically with KA receptors, we isolated the CA1 region from CA3 by 
cutting out the latter with a scalpel and performed whole cell patch clamp recordings of CA1 
pyramidal cells (Fig. 3A). To measure predominantly GABA currents, we used an intracellular 
solution consisting of a high Cl

 concentration (see Materials and Methods). Most spontaneous 
events recorded were inhibitory (sIPSCs), as the addition of ionotropic glutamate receptor 
blockers did not change the frequency of baseline activity, whereas the application of 20 µM 
bicuculline blocked most spontaneous activity (data not shown). Therefore, we will henceforth 
refer to the recorded spontaneous events as sIPSCs. 
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Figure 2 Decreased synaptic strength and increased KA-induced LTP in slices of ArcticAβ mice.                    
A, Schematic diagram showing electrode placement (Stim = bipolar stimulation electrode, Rec = recording 
electrode) and hippocampal regions (S. coll = Schaffer collateral, DG = dentate gyrus, CA1 and 3 = areas Cornu 
Ammonis 1 and 3 respectively). B, Current - voltage relationship.  ArcticAβ mice show a decreased synaptic 
strength compared to wildtype littermates (** p < 0.01). Linear regression lines used for statistical comparison 
are dashed. C, KA-induced LTP is more pronounced in ArcticAβ mice. Upper inset: representative traces of 
population spikes before (black traces) and 30 mins after (blue trace) a 10-min application of 1 µM KA. Paired 
pulses were given 50 msec apart. Stimulation artifacts were removed for visual clarity. D, Percent change per 
cell before and 30 mins after a 10-min application of 1 µM KA. The increase in PS amplitude is significant for 
both groups after application of 1µM KA (P = 0.02, two-way repeated measure ANOVA), and between wildtype 
and ArcticAβ mice in the degree of potentiation after a 30-min washout period (P = 0.01, two-way repeated 
measure ANOVA). E, Paired-pulse ratio before and 30 min after a 10-min application of 1 µM KA. Quantitative 
data represent mean ± SEM. 
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Hippocampal network hyperactivity is an early symptom in AD (Palop and Mucke, 2016), and 
an increase in inhibitory activity in the dentate gyrus of hAPPFAD mice has been postulated as a 
compensatory mechanism (Palop et al., 2007). We observed no difference in baseline frequency 
of sIPSCs between wildtype and ArcticAβ mice in CA1 cells. However, the application of 250 
nM KA significantly diminished the frequency of events in the mutant (Fig. 3B). In slices from 
wildtype mice, KA increased the frequency of sIPSCs (data not shown), as shown previously 
(Fisher and Alger, 1984). In line with this finding, we observed that the clustering of these events 
before and after KA application differed between genotypes. To quantify this phenomenon, 
clusters of activity were defined as groups of sIPSCs occurring within less than 100 ms from 
each other, and binned them into four main groups, containing up to 3 events, 4-6 events, 7-9 
events or >10 events (Fig. 3C). ArcticAβ mice showed more clusters with a higher number of 
events during baseline, which disappeared in the presence of KA, whereas the opposite occurred 
for wildtype mice. 
We also explored how KA affects oscillations in these mice, since inhibitory networks generate 
gamma and theta rhythms that regulate and shape hippocampal oscillatory patterns (Whittington 
et al., 2000; Reich et al., 2005). Although, we did not find any significant difference in gamma or 
theta power, the KA-induced increase in gamma oscillations (relative gamma power of 0.2 ± 
0.07 in baseline vs 0.6 ± 0.24 in KA) seemed attenuated in ArcticAβ mice (relative gamma 
power of 0.19 ± 0.07 in baseline vs 0.2 ± 0.12 in KA; two-way ANOVA, interaction: F(1, 7) = 2.0, 
p = 0.2) (Fig. 3D-E). 
Severe status epilepticus and early seizure onset during epileptogenesis 
Having observed an increased mortality in ArcticAβ mice during early stages of epileptogenesis 
(Fig. 1F), we used video-EEG (vEEG) monitoring to determine whether ArcticAβ mice suffer 
from more severe seizures during status epilepticus and die from convulsive seizures during the 
latent phase (Fig. 4A). During the first four hours of status epilepticus, ArcticAβ mice had more 
severe behavioral seizures (stage 6-7 of the Racine-Pinel-Rovner scale; Table 1) than wildtype 
littermates even after reducing the dose of KA by half to 2.5 mM (Fig. 4B; left panel). Tonic-
clonic seizures (stage 8) were only observed in ArcticAβ mice (Fig. 1F), and were lethal in some 
cases (data not shown). However, neither the number (Fig. 4C) nor the duration (Fig. 4D) of 
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seizures differed between genotypes. In addition, mortality of ArcticAβ mice was not associated 
with reduced latency to the first seizure (data not shown). Mortality was a major confounding 
factor in our study, because it implied that ArcticAβmice that survived the status epilepticus 
might have only mild lesions induced by KA. Therefore, we decided to administer all mice a 
protective dose of diazepam (5 mg/kg) immediately after the end of IHK injection (Fig. 4A). As 
 
Figure 3 Reduced frequency of spontaneous inhibitory currents after KA application in slices of ArcticAβ 
mice. A, Schematic diagram of a hippocampal slice after removal of the CA3 area. B, Top inset: representative 
traces. Bottom graphs: Cumulative frequency distribution plots illustrating the frequency and amplitude of 
sIPSCs. Frequency of events is similar in wildtype and ArcticAβ mice, but a 5-min application of KA decreases 
the inter-event interval in ArcticAβ mice significantly (p < 0.0001, Kolmogorov–Smirnoff test). The sIPSC 
amplitude is higher in ArcticAβ mice under baseline conditions (p < 0.0001, Kolmogorov–Smirnoff test), but not 
after KA application. C, Distribution of clustered activity, consisting of events that are separated by <100 ms. 
KA uncovers clusters with a higher number of events in wildtype mice, whereas the opposite is found in 
ArcticAβ mice. D, Relative fast gamma (90-100 Hz) power. There is a tendency for impaired upregulation of 
gamma power in ArcticAβ mice in the presence of KA. E, Relative theta (4-14 Hz) power. Wildtype (n = 5), 
ArcticAβ mice (n = 4). 
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expected, diazepam treatment strongly reduced seizure severity (stage 2-3 of the Racine-Pinel-
Rovner scale; Fig. 4B; right panel) and frequency (convulsive: F1 = 52.94, P < 0.0001; non-
convulsive: F1 = 6.16, P = 0.025; Fig. 4C), while having no effect on seizure duration (Fig. 4D). 
Moreover, diazepam treatment after IHK injection averted status epilepticus-associated 
mortality, but not mortality occurring during the latent phase (Fig. 4F). Thus, increased 
susceptibility to severe behavioral seizures can not only be evoked by a proconvulsant, but also 
by spontaneous aberrant network activity in a later stage of epileptogenesis. 
To determine whether abnormal EEG activity during early epileptogenesis is associated with 
mortality during the latent phase, we acquired continuous vEEG recordings during the progress 
of epileptogenesis. As reported (Riban et al., 2002a; Arabadzisz et al., 2005), wildtype mice 
exhibit initially low voltage spikes or sharp waves (200-800 μV, 1-3 Hz), whereas SRS (800-
1500 μV, 3-5 Hz, duration > 20 s) appear two weeks after IHK injection (Fig. 4E). ArcticAβ 
mice, however, showed a mixture of low voltage spikes and sharp waves (200-800 μV, 1-3 Hz) 
up to 3-4 dpi, with a subsequent early onset of SRS-like events (800-1500 μV, 3-5 Hz, duration 
10 - 20 s) at 4-5 dpi (Fig. 4E). These early short SRS were progressively replaced by regular 
SRS (duration > 20 s) from 12 dpi on. Interestingly, mortality of ArcticAβ mice during the latent 
phase (Fig. 4F) was associated with early onset of SRS at 3 dpi (Fig. 4E). Thus, ArcticAβ mice 
are more susceptible to the development of seizures, even when they are “protected” with 
diazepam during the IHK-induced status epilepticus. These findings suggest that early onset of 
SRS in ArcticAβ mice is due either to a missing anticonvulsive protection or a premature 
proconvulsive environment during the otherwise seizure-free latent period. 
 
 
Figure 4 Severe status epilepticus and early onset of SRS in ArcticAβ mice. A, Schematic representation of 
the experimental design to monitor EEG activity during early epileptogenesis. Continuous vEEG recordings 
were performed for 18 days after IHK injection. B, Percentage of convulsive seizures with severity 2-8 
according to the Racine-Pinel-Rovner scale during status epilepticus (Table 1). While ArcticAβ mice had more 
severe seizures than wildtype mice after IHK injection (left), both genotypes had seizures with severity 2-3 when 
treated with diazepam immediately after IHK injection (right). C, Total number of convulsive (left) and non-
convulsive (right) seizures during status epilepticus. Diazepam significantly reduced the number of seizures (n = 
4-6 mice/genotype; * p < 0.05, **** p < 0.0001, two-way ANOVA). D, Duration of convulsive behavioral 
seizures of severity 2-8. There was no difference between genotypes (unpaired t-test). E, Characterization of 
EEG pattern during the latent phase and beginning of chronic phase. An early onset of short SRS-like events 
(defined as seizures with a duration of 10-20 s) occurred in ArcticAβ mice at 5-8 dpi, while regular SRS were 
detected already at 3 dpi in the two mice that died later on. Bottom traces depict representative examples of an 
SRS-like event (10 s < Δt < 20 s), a regular SRS (≥ 20 s), and a tonic-clonic seizure leading to the death of the 
animal. The spectrogram in the bottom left corner depicts the increase power in the frequency range of 20-100 
Hz that is characteristic for seizures. F, Mortality rate for mice receiving diazepam after IHK injection. With 
diazepam, status epilepticus-associated mortality in ArcticAβ mice is abrogated, but some transgenic mice still 
died during the transition from the latent to the chronic phase. Quantitative data represent mean ± SEM. 
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Gradual progression of neurodegeneration and microgliosis during epileptogenesis 
Neurodegeneration and inflammation play an important role in the pathogenesis of both AD 
(Heppner et al., 2015) and TLE (Vezzani and Viviani, 2015). To test whether the hyperexcitable 
phenotype observed in ArcticAβ mice accelerates the development of a pro-epileptogenic lesion, 
we determined the course of neurodegeneration and microglial activation (CD68 
immunoreactivity) in the dorsal hippocampus at different time-points (1, 3, 6, 14 dpi) of 
epileptogenesis (Fig. 5). Cresyl violet staining was used to assess the neurodegenerative pattern 
(data not shown). As expected (Bouilleret et al., 1999), hilar cells in the dentate gyrus were lost 
and pyramidal cells in CA1 became pyknotic within 24 h. During the progression of 
epileptogenesis, pyramidal cells in CA1 and in CA3c gradually degenerated, starting at 3 dpi up 
to an almost complete disappearance at 14 dpi. Dentate gyrus GC dispersion was clearly evident 
at 14 dpi (data not shown) and progressed further at 21 dpi (Fig. 1B). Similarly for microglial 
activation, both genotypes showed a gradual increase of CD68-IR compared to control animals 
over a two-week period in the ipsilateral hippocampus (in all layers of CA1, the stratum 
lacunosum moleculare, CA3c and the strati pyramidale and radium of CA3 a,b; Fig. 5 and Table 
3). Microgliosis peaked between 1 and 6 dpi in the hilus and the stratum lucidum, while being 
very low in the molecular layer and GC layer (besides a minor peak at 3 and 6 dpi; Fig. 5B). 
Interestingly, ArcticAβ mice exhibited a less enhanced CD68-IR compared to wildtype mice in 
the stratum oriens of CA3a,b at 1 dpi, and at 6 dpi in the hilus of the ipsilateral hippocampus. 
The contralateral hemisphere showed increased CD68-IR except in stratum pyramidale of CA1, 
the stratum lacunosum-moleculare, or CA3c (Fig. 5B and Table 3). 
In addition, tissue of ArcticAβ mice that died during status epilepticus (~45 min after injection; 
Fig. 1F) was compared to a group of wildtype littermates perfused 45 min post-injection (“SE 
group”). We evaluated whether these ArcticAβ mice belonged to a subgroup with particularly 
pronounced sequelae associated with the AD pathology (including ectopic cell death and 
aggravated inflammation). Cresyl violet (data not shown) and CD68 (Fig. 5B) immunoreactivity 
revealed no difference between genotypes or between hemispheres suggesting that neither an 
AD-like predisposition nor the IHK injection affected cellular integrity or microglial activation 
during early status epilepticus. Thus, the general progression of neurodegeneration and 
microgliosis does not reflect increased vulnerability to aberrant excitation and does not predict 
early onset of SRS in AD transgenic mice during IHK-induced epileptogenesis. 
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Figure 5 Reduced microgliosis in ArcticAβ mice during epileptogenesis. A, Representative images of a 
marker for microglial activation (CD68) at 3, 6 and 14 dpi compared to control levels. Scale bar, 250 μm. B, 
Densitometric analysis of CD68-IR in controls, as well as at 1, 3, 6, and 14 dpi. Both ArcticAβ mice (n = 4-5/ 
time point; red stars) and wildtype littermates (n = 5-7/ time point; black stars) showed an increased CD68-IR 
compared to baseline control over the time course of early epileptogenesis in all layers of the ipsilateral and in 
some layers of the contralateral hippocampus (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; two-way 
ANOVA, Bonferroni post-hoc test). Analysis revealed a significant group difference in the SO of CA3a,b and 
the hilus (green stars; compare Table S1 for details). Data represent mean ± SEM normalized to control for each 
region. 
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Genotype-specific differences and epileptogenesis-associated changes in hippocampal adult 
neurogenesis 
A large body of literature suggests a direct link between aberrant excitability and adult 
neurogenesis (Jessberger et al., 2005; Kralic et al., 2005; Ledergerber et al., 2006; Song et al., 
2012; Sierra et al., 2015). We explored the hypothesis that ArcticAβ mice, like other AD-
transgenic mice (Sun et al., 2009), show impaired neurogenesis, which has been reported to 
exacerbate KA-induced status epilepticus (Iyengar et al., 2015). In order to assess proliferation 
and survival rate of newborn cells in the subgranular zone (SGZ) of the dentate gyrus, mice were 
injected with BrdU and tissue was collected at 1 and 28 dpi to assess proliferation and cell 
survival, respectively (Fig. 6A). At 1 dpi, ArcticAβ mice showed significantly more BrdU+ cells 
in the SGZ compared to wildtype littermates (14039 ± 1243 cells/mm
3
, N = 8; 10415 ± 728 
cells/mm
3
, N = 8; data shown as mean ± SEM; P = 0.03, paired, two-tailed Student’s t-test), 
while there was no difference between genotypes at 28 dpi (ArcticAβ: 2663 ± 261.8 cells/mm3, 
N = 9; wild-type: 3384 ± 491 cells/mm
3
, N = 9; data shown as mean ± SEM; P = 0.21, paired, 
two-tailed Student’s t-test) (Fig. 6B). To determine the fate of BrdU+ cells at 28 dpi, we used 
neuronal (NeuN+) or astroglial (GFAP+) markers. In both genotypes a similar proportion of 
neuronal (NeuN/BrdU; wildtype: 89.4% ± 2.6%, N = 9; ArcticAβ: 91.5% ± 3.5%, N=7) and 
astroglial (GFAP/BrdU; wildtype: 7.5% ± 2.5%, N = 9; ArcticAβ: 5.9% ± 3.1%, N=7) 
progenitors were observed. Further, we examined the morphological development of immature 
(21 dpi) and mature (42 dpi) newborn neurons infected with a retrovirus expressing eGFP (Fig. 
6C). Sholl analysis of adult-born GC at 21 and 42 dpi revealed a tendency towards a reduced 
 
Figure 6 Increased proliferation of newborn cells and reduced spine density in ArcticAβ mice.                   
A, Schematic representation of the experimental design to quantify newborn neurons. Mice received BrdU 
injections of two consecutive days and brain tissue was collected at day 1 and 28 post-BrdU injection to evaluate 
cell proliferation and survival rate, respectively. B, Quantification and representative images of BrdU 
immunostaining 1 and 28 days after the last BrdU treatment. BrdU+ cells were located in the inner part of the 
GCL. Higher density of BrdU+ cells was common in ArcticAβ mice at 1 dpi, but there were no differences at 28 
dpi (* p > 0.05, unpaired t-test). Scale bar, 160 μm. C, Schematic representation of the experimental design to 
assess the dendritic arborization and spine density in adult-born neurons. Brain tissue of both genotypes was 
collected 21 and 42 days after the intrahippocampal injection of eGFP retrovirus. Quantification of dendritic 
arborization was done by Sholl analysis measuring the number of intersections between eGFP+ dendrites and 
virtual concentric circles centered on the cell body and spaced by 10 μm (bottom). D, Fluorescent images of 
representative examples of eGFP+ cells in each genotype at 21 and 42 dpi. Quantitative result of Sholl analysis 
showed no significant difference, but a trend towards a reduced dendritic arborization in ArcticAβ compared to 
wildtype mice at 21 dpi. There were no differences between genotypes at 42 dpi. Scale bar, 50 μm. E, Dendritic 
spine classification analysis. Representative images of dendritic segments from eGFP expressing GCs of wild-
type and ArcticAβ mice at 21 and 42 dpi (Scale bar, 5μm). Quantification of mushroom, stubby, thin and overall 
spine density. ArcticAβ mice had significantly reduced overall spine density and specifically thin spine density 
at 21 dpi and a reduced stubby spine density at 42 dpi with no difference in the overall spine density (* p > 0.05, 
unpaired t-test). There were no genotype differences for the proportion of the three types of spines. Quantitative 
data represent mean ± SEM. 
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dendritic arborization between genotypes (Fig. 6D). However, further away from the soma, 
starting from 150μm, this difference was statistically significant at both 21 dpi (wildtype: 197.4 
± 31, N = 27; ArcticAβ at 21 dpi: 70 ± 23, N = 14; P = 0.0094) and 42 dpi (wildtype: 359 ± 25, 
N=36; ArcticAβ: 258 ± 34, N=17; P = 0.0221; data displayed as area under the curve (AUC), 
mean ± SEM, paired, two-tailed Student’s t-test). Moreover, dendritic spine density was assessed 
and spines were classified in three subgroups (Fig. 6E). Overall spine density was significantly 
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reduced in ArcticAβ mice at 21 dpi, with a specific reduction in thin spines. At 42 dpi, adult-
born GC of ArcticAβ mice had significantly fewer stubby spines, while overall spine density was 
normalized. At both time-points, the proportion of spine types did not differ between animals. 
Although ArcticAβ mice had increased cell proliferation, the survival of both neuronal and glial 
progenitors seems to be reduced. Together with the reduced spine density in adult-born GC, 
these findings point towards a slight impairment of neurogenesis in 3-months-old ArcticAβ mice.  
Neuronal stem cells (NSCs) divide into reactive astrocytes after IHK-induced status epilepticus, 
which ultimately leads to depletion of the NSCs pool and thereby, long-term impairment of adult 
neurogenesis (Sierra et al., 2015). To evaluate whether the alterations in proliferation and 
survival of progenitor cells in ArcticAβ mice accelerates the disruption of neurogenesis during 
epileptogenesis, we analyzed DCX+ neuronal precursor cells at different time points (1, 3 , 6, 14 
dpi) after IHK-induced status epilepticus (Fig. 7). DCX-IR decreased over time in both 
genotypes (F(4, 40) = 38.9, p < 0.0001, two-way ANOVA) , and at a similar rate (Fig. 7A), as 
previously described in wildtype mice (Ledergerber et al., 2006). In controls, DCX+ cells, which 
are located close to the SGZ, send their dendrites into the molecular layer (Fig. 7A). Ipsilaterally, 
DCX+ processes disappear within 1 dpi, followed by a gradual disappearance of most cell bodies 
until 14 dpi. Contralaterally, DCX-IR remained unchanged until 6 dpi, and increased at 14 dpi. 
However, there was no difference between ArcticAβ mice and wildtype littermates. Similarly, 
both genotypes exhibited a comparable number of ectopic cells in the hilus (F(11, 96) = 1.20, p = 
0.2964, two-way ANOVA; Fig. 7B). In addition, ArcticAβ mice that died during status 
epilepticus did not differ from wiltype mice at 45 min post-injection with regard to DCX-IR or 
number of ectopic cells in the ipsilateral hilus (Fig. 7B). Taken together, the decline of neuronal 
progenitors after IHK-induced epileptogenesis follows a similar course in both genotypes. 
Impairment in status epilepticus-induced upregulation of neuropeptide Y in ArcticAβ mice 
Neuropeptide Y has anticonvulsive properties and is immediately upregulated in mossy fibers 
after increased excitation (Guo et al., 2002; Tu et al., 2005; Gotzsche et al., 2012). Reduced NPY 
expression has been reported in patients (Beal et al., 1986; Minthon et al., 1990) and animal 
models of AD (Ramos et al., 2006). Therefore, we determined whether AD-like pathology in 3-
months-old ArcticAβ mice interferes with seizure-induced upregulation of NPY during early 
epileptogenesis (Fig. 8 and Table 3). In wildtype mice, NPY-IR was increased bilaterally, 
reaching significance in a region- and time-dependent manner across the various regions of the 
hippocampal formation (Fig. 8B). The increase was seen in both the GC and mossy fibers, as 
well as in interneurons contralaterally in CA1 and CA3. In comparison, ArcticAβ mice only 
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displayed a moderate increase of NPY-IR at 1-3 dpi ipsilaterally and at 1-14 dpi contralaterally 
in the hilus and CA3c (Fig. 8 and Table 3). In the early SE group, there was no difference 
between wildtype mice perfused 45 min after injection and ArcticAβ mice that died due to a 
severe status epilepticus (Fig. 8B). Thus, while status epilepticus provokes a transient increase in 
NPY in dorsal hippocampus of wildtype mice, peaking after 24 hours and gradually declining 
 
Figure 7 Gradual decrease of DCX+ progenitor cells in the ipsilateral SGZ during epileptogenesis.                 
A, Representative images of the neurogenic niche in the dentate gyrus of wildtype and ArcticAβ mice. Over the 
course of epileptogenesis, DCX-IR in the SGZ of the ipsilateral dentate gyrus gradually decreases in both 
genotypes up to almost complete disappearance at 14 dpi, while it remains unchanged on the contralateral side 
(*** p < 0.001, **** p < 0.0001; two-way ANOVA). Scale bar, 200 μm. B, Ectopic cell in the hilus. The 
number of ectopic cells in the hilus is similar between ArcticAβ mice and wildtype littermates. Triple 
immunofluorescence labeling for glial and early neuronal markers ensured that ectopic cells are indeed newly 
born neurons. Quantitative data represent mean ± SEM. 
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over two weeks, this mechanism seems to be partially impaired in ArcticAβ mice. SE group, 
there was no difference between wildtype mice perfused 45 min after injection and ArcticAβ 
mice that died due to a severe SE (Figure S5). Thus, while status epilepticus provokes a transient 
increase in NPY in dorsal hippocampus of wildtype mice, peaking after 24 hours and gradually 
declining over two weeks, this mechanism seem to be, at least partially, impaired in ArcticAβ 
mice. 
Impairment of NPY expression as an early sequelae of AD pathology 
To determine whether differences in microglial activation and NPY levels during epileptogenesis 
in ArcticAβ mice rest upon sequelae and immune system activation associated with AD 
pathology, we examined 3-months- and 9-months-old naive ArcticAβ mice (Fig. 9). While 
intracellular Aβ deposits have been reported in 3-months-old ArcticAβ mice (Knobloch et al. 
(2007), plaques appear between 7 and 9 months of age (Fig. 9A) with a progressive increase 
thereafter. Aβ plaques are surrounded by reactive microglia, but up to the age of 9 months, there 
is no general microglia activation, as seen by CD68-IR (two-ANOVA; Table 5; Fig. 9B). qPCR 
analysis of inflammatory cytokines in hippocampal samples revealed a decreased expression of 
IL-10 over time in both genotypes (one-way ANOVA, F(1,16) = 11, P = 0.004; Fig. 9C) and a 
different expression of IL-1β between genotypes (one-way ANOVA, F(1,16) = 4.7, P = 0.047; Fig. 
9D). No difference was detected in TNFexpression between wildtype and ArcticAβ mice at the 
age of 3 and 9 months (F(1,16) = 1.19, P = 0.291; two-way ANOVA; Fig. 9E), whereas the 
expression of triggering receptor expressed on myeloid cells 2 (Trem2)  a cell surface receptor 
expressed on microglia cells that was proposed to be important for phagocytosis and removal of 
apoptotic cells and β-amyloid without being accompanied by inflammation (Colonna and Wang, 
2016)  was increased concomitant with the appearance of Aβ plaques in 9-months old ArcticAβ 
mice (F(1,16) = 6.8, P = 0.02; two-way ANOVA, Bonferroni post-hoc test; Fig. 9F). Interestingly, 
when we determined the hippocampal expression of markers involved in NPY signaling, 
ArcticAβ mice showed a significantly reduced expression of NPY at both 3 and 9 months of age 
(F(1,16) = 4.7, P = 0.047; two-way ANOVA, Bonferroni post-hoc test; Fig. 9G). The NPY 
receptor 1 (YR1) expression was not affected (F(1,16) = 1.12, P = 0.3064; two-way ANOVA; Fig. 
9H), but ArcticAβ mice exhibited an increase in YR2 expression at 9 months (F(1,16) = 1.12, P = 
0.3064; two-way ANOVA; Fig. 9H) and a reduced YR5 expression at 3-months of age (F(1,16) = 
1.12, P = 0.3064; two-way ANOVA; Fig. 9G). 
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Figure 8 Impaired epileptogenesis-associated increase of neuropeptide Y in ArcticAβ mice.                         
A, Representative images of NPY staining at different time points during epileptogenesis. NPY-IR increases 
bilaterally particularly in mossy fibers in the hilus and CA3 at 1 dpi and declines thereafter gradually until 14 
dpi. B, Densitometric analysis of NPY-IR. IHK-injected mice show a significant increase in NPY levels in the 
ML, GCL, HL and CA3c. A comparison of both genotypes (green) reveals a significantly higher NPY-IR in the 
contralateral ML, HL, and CA3c as well as ipsilateral hilus of wildtype mice compared to ArcticAβ mice at 1 
and 3 dpi (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; two-way ANOVA, Bonferroni post-hoc test). 
Quantitative data represent mean ± SEM. 
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Previous studies in hAPP-J20 mice reported sprouting of NPY+ axons in the molecular layer, 
ectopic expression of NPY in mossy fibers, increased recurrent sprouting of mossy fiber 
collaterals (Timm staining or zinc transporter ZnT3-IR) and depletion of calbindin (CB) in GC 
(Palop et al., 2003; Palop et al., 2007). Increased levels of neuropeptides, most notably NPY in 
areas with high plaque burden, might reflect an attempt to counteract degeneration 
Figure 9 Reduced NPY expression is an early, pre-plaque sequelae of AD pathology. A, Representative 
images of tissue section stained for β-amyloid (6E10-IR) from 15-months-old ArcticAβ and wildtype mice. Only 
transgenic mice show plaques with their characteristic dense core morphology (red and black boxes). B, 
Representative images and densitometric analysis of CD68-IR in hippocampal sections from 3- and 9-months-
old ArcticAβ and wildtype mice. From their appearance in ArcticAβ mice at 9 months of age, plaques are 
surrounded by activated microglia (black box). Densitometric analysis revealed no difference between genotypes 
at both the pre-plaque (3 months) and the early-plaque (9 months) stage (n = 6/group; one-way ANOVA). C-E, 
Hippocampal expression of cytokines IL10, IL1β, and TNF. While the expression of IL10 decreased over time 
(F(1,16) = 10.96, P = 0.0044) and IL1β differed between genotypes (F(1,16) = 4.655, P = 0.0465), TNF 
expression did not change. F, The expression of Trem2, a marker for microglial phagocytosis of β-amyloid 
peptides and apoptotic neurons without inflammation. ArcticAβ mice show a significant increase in Trem2 
expression at 9 months of age, when β-amyloid plaques start to appear (n = 4-7; * p < 0.05, ** p < 0.01; two-way 
ANOVA, Bonferroni post-hoc test). Quantitative data represent mean ± SEM. Scale bars, 250 μm. 
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Figure 10 Neuropeptide Y, zinc transporter 3 and calbindin immunoreactivity in naive ArcticAβ mice 
during early AD pathology. A-D. Hippocampal expression of genes related to NPY signaling. The expression 
of NPY is reduced in both 3- and 9-months-old ArcticAβ mice. Regarding NPY receptors, YR1 expression does 
not change, while the expression of YR2 is increased at 9 months and YR5 decreased at 3 months in ArcticAβ 
mice (n = 4-7; * p < 0.05, ** p < 0.01; two-way ANOVA, Bonferroni post-hoc test). Quantitative data represent 
mean ± SEM.. E. Representative images of NPY-IR from 3-months and 9-months-old wildtype and ArcticAβ 
mice. Both genotypes reveal a similar NPY-IR at both time points. However, at 9 months, three of seven 
ArcticAβ mice reveal weak ectopic NPY-IR in mossy fibers visible in the hilus and CA3a,b (arrowhead). F, 
Representative images of ZnT3-IR in 3-months-old wildtype and ArcticAβ mice. There is no obvious axonal 
sprouting in the molecular layer in either genotype (dashed box). G, Representative images of CB-IR in 
ArcticAβ mice and wildtype littermates at 3 months. CB-IR in mossy fibers of CA3 (solid box) and in the 
granule cell layer of the dentate gyrus (dashed box) are comparable between genotypes. Scale bars, 250 μm. 
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(Diez et al., 2003). Therefore, we determined whether NPY, ZnT3 and CB were changed in 
naive ArcticAβ mice before (3 months) or after (9 months) occurrence of Aβ plaques (Fig. 10). 
Compared to wildtype littermates (n = 6-8 / time point) no difference in NPY-IR in the hilus and 
molecular layer of the dentate gyrus (Fig. 10A). Similarly, qualitative assessment of ZnT3-IR 
and CB-IR in GCs and in CA3 showed no difference between genotypes (Fig. 10B). Together, 
these observations suggest that gene expression involved in NPY signaling, specifically the 
expression of NPY and YR5, is impaired prior to occurrence of Aβ plaques and associated 
inflammatory reactions, but the presence of the transgene does not influence NPY-IR in 9-
months-old mutants. 
Soluble Aβ species contribute to the early onset of SRS during IHK-induced epileptogenesis 
Given that 3-months-old ArcticAβ mice do not show any plaques while constitutively 
overexpressing Aβ (Knobloch et al., 2007), we aimed to determine whether a clearance of 
soluble Aβ species might prevent the early onset of SRS in these mice. Three days prior to the 
IHK-induced status epilepticus, a mouse anti-Aβ antibody (6E10) or a control IgG were 
bilaterally injected into the lateral ventricles on the anterio-posterior plane of the IHK-injection 
side (Fig. 11A). Mice were then subjected to continuous vEEG during the next three weeks and 
seizure-like events were analyzed. Interestingly, injection of Aβ antibody alleviated the epileptic 
phenotype in comparison to an IgG injection in ArcticAβ mice (Fig. 11B). While three out of 
four IgG-injected ArcticAβ mice exhibited regular SRS from 3-4 dpi, as shown above (Fig. 4E), 
and one died from convulsive seizures at 12 dpi, the four mice treated with Aβ antibody only had 
a few SRS-like events and did not develop SRS during the first 14 days post-IHK. In addition, 
several mice injected with IgG showed tonic-clonic seizures whereas only one of the ArcticAβ 
mice injected with Aβ antibody had a convulsive seizure. One IgG-injected animal exhibited 
multiple short clusters of spikes that were considered to be SRS-like events (B1 in Fig. 11B). In 
contrast, one mice injected with Aβ antibody had a transient phenotype, with only two short 
SRS-like events at 3 dpi, while otherwise the EEG pattern was characterized by short clusters of 
spikes (B2 in Fig. 11B). Noteworthy, this mouse (C3 in Fig. 11C), like the others, revealed the 
normal neurodegenerative pattern of the IHK-model (Bouilleret et al., 1999): degeneration of 
pyramidal cells in CA1 and C3c, as well as of hilar cells in the dentate gyrus (Fig. 11C). In the 
eight mice administered with IgG or Aβ antibodies, no GC dispersion was seen, suggesting a 
potential interference between the two processes. Taken together, antibody-mediated 
neutralization of soluble Aβ species prevented the occurrence of SRS during the latent phase in 
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3-months-old ArcticAβ mice, suggesting that Aβ overexpression promotes epileptogenesis in 
these mice. 
 
 
 
Figure 10 Clearance of soluble Aβ species ameliorates epileptic phenotype in 3-months-old ArcticAβ mice 
during early epileptogenesis. A, Schematic representation of the experimental design using the anti-Aβ 
antibody, 6E10. Three days before the unilateral IHK injection, ArcticAβ mice were intracerebroventricularly 
(icv) injected with either 6E10 or control IgG into both hemispheres near the dorsal hippocampus. After injecting 
IHK, mice were monitored by vEEG to assess early onset of seizures in ArcticAβ mice. B, Characterization of 
EEG pattern during the latent period. IgG-treated ArcticAβ mice exhibited multiple SRS-like events and regular 
SRS, whereas mice injected with 6E10 showed only a few SRS-like events and short single or grouped spikes. 
B1, Example of IgG-injected mouse that had few SRS-like events within the analysis window; this animal had a 
high number of spikes clusters that were sometimes followed by a SRS-like event occurring outside of the 
window chosen for analysis. B2, This 6E10-injected mouse showed almost exclusively single or grouped spikes 
with typical frequency and power characteristics (spectrogram below). Scale bars, 500 μV, 5 s. C, Cresyl violet 
staining of the ipsilateral hippocampus. Both IgG and 6E10 pre-treated animals showed the characteristic 
neurodegenerative pattern seen after IHK injection, including degeneration of pyramidal cells in CA1 (black 
arrowheads), CA3c (red arrowhead), and the cells in the hilus (yellow arrowheads). The mouse illustrated in 
(B2) shared these typical histopathological hallmarks (C3). Note the absence of GC dispersion in both groups. 
Scale bars, 150 μm. 
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Discussion 
The results indicate that transgenic expression of mutant APP in ArcticAβ mice leads to 
increased susceptibility towards KA-induced hyperexcitability long before the stage of plaque 
formation. In these mice, the strength of GABAergic inhibition in the CA1 region is reduced, 
facilitating LTP and altering the power of gamma oscillations. Hyperexcitability in ArcticAβ 
mice leads to lethal convulsions during status epilepticus, which can be prevented by diazepam. 
In addition, it leads to the premature onset of SRS, and in some mice, to lethal convulsive 
seizures during the first three weeks post-IHK. This increased seizure susceptibility does not 
correlate with aggravated neurodegeneration, altered synaptic reorganization, immune responses 
or adult neurogenesis, but is paralleled by a reduced basal expression and upregulation of NPY in 
dentate gyrus GC, a neuropeptide with anti-convulsant properties. Importantly, hyperexcitability 
could be reversed upon neutralization of soluble Aβ species, arguing against constitutive 
adaptation mechanisms and in favor of a direct effect on synaptic, in particular GABAergic, 
transmission in the hippocampal formation. 
Hyperexcitability and epileptogenesis in AD mouse models 
AD is associated with network abnormalities, characterized by hypersynchrony and altered 
oscillatory activity that precede clinical disease onset (Palop and Mucke, 2016). Epileptiform 
activity has been reported in AD patients, in particular at early stages (Amatniek et al., 2006; 
Scarmeas et al., 2009; Vossel et al., 2013; Vossel et al., 2016) and with a higher incidence during 
sleep (Horvath et al., 2017; Lam et al., 2017). Recent studies confirmed that hyperexcitability in 
AD mouse models appears prior to plaque and tangle pathology. For example, 25% CA1 
pyramidal cells are hyperactive in mice overexpressing human APP with a Swedish mutation and 
mutant human presinilin 1 (APP/PS1) already at an age of 1.5 months (Busche et al., 2012). This 
neuronal dysfunction was rescued by acute treatment with a ɣ-secretase inhibitor and neuronal 
hyperexcitability was induced in wildtype mice by applying soluble Aβ. Although which cell 
types are most vulnerable and therefore first affected by Aβ is not fully clarified, interneurons 
are among the earliest cells affected. Axonal loss of SOM+ interneurons in CA1 was reported in 
APP/PS1 mice at pre-plaque stage, and at later stages correlating with proximity to Aβ plaques 
(Schmid et al., 2016), suggesting that GABAergic boutons are affected early by soluble Aβ 
species. In line with these findings, we found in young ArcticAβ mice that decreased synaptic 
strength and increased KA-induced LTP are associated with changes in sIPSCs in CA1 
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pyramidal cells. Unlike previous studies using mice overexpressing human APP with a Swedish 
mutation (hAPP-J20) at plaque-bearing stage (Palop et al., 2007), we did not find any increase in 
inhibitory activity at baseline. As suggested by Palop et al. (2007), increased inhibitory activity 
might be a compensatory response to an hyperexcitable phenotype. Such compensatory 
mechanism might explain clustered sIPSCs at baseline in ArcticAβ mice (Fig. 3). Ectopic 
expression of NPY and sprouting of GABAergic axons has been reported in different AD mouse 
models (Chin et al., 2004; Palop et al., 2007; Roberson et al., 2007). Our results indicate that 
these effects differ between models, especially in the timing of their appearance. Nevertheless, 
plaque-independent Aβ toxicity appears as a predominant feature altering local inhibitory circuits 
and increasing network excitability during early stages of the AD pathogenesis. 
Increased susceptibility to induced seizures have been reported in different mouse models of AD 
(Palop et al., 2007; Roberson et al., 2007; Roberson et al., 2011; Sanchez et al., 2012; Verret et 
al., 2012; Kam et al., 2016). AD transgenic mice show age-dependent, and therefore disease-
stage-dependent, occurrence of SRS with hippocampal origin (Palop et al., 2007; Minkeviciene 
et al., 2008; Kam et al., 2016). In our model, it is unclear which mechanisms underlie the 
development of SRS. We have shown previously in mutant mice lacking lymphocytes (RAG1-
knockout), which exhibit SRS within 24 h of IHK, that the latent period can be massively 
curtailed (Zattoni et al., 2011; Deprez et al., 2011). Our present results indicate a key role for 
soluble Aβ species, but the reduced overexpression of NPY in mutant mice compared to their 
wildtype littermates might also be an important contributing factor, along with the differential 
regulation of cytokines seen in our qPCR analysis. 
The role of NPY during epileptogenesis 
A body of literature examined the effect of NPY on modulating excitatory transmission and its 
role during different stages of epileptogenesis (Baraban, 2002; El Bahh et al., 2005). Erickson et 
al. (1996) reported that NPY-deficient mice are more susceptible to seizures induced by the 
GABAergic antagonist pentylenetetrazole (PTZ). Moreover, status epilepticus induced by 
repeated intraperitoneal injection of low dose kainic acid led to convulsive seizures in both 
genotypes at a similar concentration and within the same latency, but being lethal for 90% NPY-
deficient mice compared to 22% wildtype littermates (Baraban et al., 1997). Similarly, Y5R-
deficient mice are more susceptible to KA, having more severe seizures and increased mortality 
(Marsh et al., 1999). Here, we found a similar phenotype after IHK in young ArcticAβ mice 
accompanied by weaker expression of NPY and Y5R at the age of injection (Fig. 9). In contrast, 
NPY application (Woldbye et al., 1996; Baraban et al., 1997; Woldbye et al., 1997; Vezzani et 
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al., 1999c) or hippocampal overexpression of NPY and Y2R or Y5R using rAAV vectors 
(Richichi et al., 2004; Sorensen et al., 2009; Woldbye et al., 2010; Gotzsche et al., 2012) were 
shown to have an alleviating effect on electrically or chemically induced acute seizures. In 
particular, seizures of higher severity and seizure-associated death were reduced upon activation 
of NPY signaling, while mild seizures remained unchanged. We likewise found no difference in 
the latency, number or duration of non-convulsive seizures in ArcticAβ mice during IHK-
induced status epilepticus (Fig. 4). Moreover, at 9 months of age, hippocampal Y2R expression 
is increased in ArcticAβ mice, similar to plaque-bearing hAPP-J20 mice (Palop et al., 2007), 
suggesting a compensatory mechanism after months of increased excitability.  
Although, the similarities between NPY-deficient animals and ArcticAβ mice are compelling, 
additional experiments are needed to evaluate if the decrease in NPY expression is directly 
responsible for the hyperexcitable phenotype of the AD model. To this end, it would be 
interesting to test whether neutralization of soluble Aβ species (e.g. with the 6E10 antibody) 
would restore NPY expression and signaling in ArcticAβ mice, and thereby ameliorate the 
excitability in vivo and in slices. 
The role of inflammation during epileptogenesis 
Perhaps the least expected finding of this study is that inflammation that accompanies 
neurodegeneration in the dorsal hippocampus after IHK was not more severe in ArticAβ mice, 
despite on-going stimulation of innate immunity by increased Aβ species and their accumulation 
in the brain (Knobloch et al., 2007). In our previous work in RAG1-KO mice (Zattoni et al., 
2011), we showed that in the absence of adaptive immunity by T and B lymphocytes, IHK 
causes a stimulation of innate immunity mediated by neutrophils, leading to extensive 
neurodegeneration in CA1-CA3 and eventually complete atrophy of the injected hippocampus. 
We also observed that this phenotype is accompanied by a dramatic shortening of the seizure-
free latent phase that follows IHK, with RAG1-KO mice exhibiting SRS at 1-2 dpi (Zattoni et 
al., 2011). Therefore, the disrupted balance between adaptive and innate immunity induces a 
condition in the brain of IHK-treated mice that favors SRS onset, presumably mediated by 
inflammation-related secreted or blood-born factors. Our present results show that the AD-like 
predisposition in ArticAβ mice also induces a condition that favors the occurrence of SRS during 
the latent phase, which is due, at least in large part to Aβ overexpression in the brain, and which 
does not stimulate further inflammatory mechanisms that would aggravate neurodegeneration. 
Both studies relativize the importance of neuronal circuit reorganization that takes place during 
the latent phase for SRS onset. Rather, they favor the view that the latent phase is seizure-free 
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because of unknown protective mechanisms preventing seizure onset. These mechanisms can be 
overruled by immune factors or by hyperexcitability. 
Therefore, despite the fact that temporal lobe epilepsy and AD share common pathogenic 
mechanisms and exhibit comparable alterations in inhibitory neuronal networks in the 
hippocampal formation, as outlined in the Introduction, there appears to be little cross-over 
between the two disease conditions. In AD patients, like in mice subject to IHK, epileptogenic 
activity and unprovoked seizures are most likely related to toxic Aβ species affecting synaptic 
transmission and favoring a state of chronic hyperexcitability. 
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Supplementary Information 
 
Table S1 Results of statistical tests performed for immunohistochemical stainings (1) 
CD68 (Figure 5) NPY (Figure 8) 
Area Source of 
Variation 
F (DFn, DFd) P value Area Source of 
Variation 
F (DFn, DFd) P value 
CA1 - SO Interaction F (9, 80) = 1.486 P=0.1674 ML Interaction F (9, 78) = 3.062 P=0.0034 
Genotype F (1, 80) = 3.723 P=0.0572 Genotype F (1, 78) = 13.97 P=0.0004 
Time F (9, 80) = 28.97 P<0.0001 Time F (9, 78) = 8.029 P<0.0001 
CA1 - SP Interaction F (9, 80) = 1.282 P=0.2598 GCL Interaction F (9, 78) = 1.757 P=0.0901 
Genotype F (1, 80) = 3.237 P=0.0758 Genotype F (1, 78) = 13.6 P=0.0004 
Time F (9, 80) = 56.68 P<0.0001 Time F (9, 78) = 15.85 P<0.0001 
CA1 - SR Interaction F (9, 80) = 1.338 P=0.2309 HL Interaction F (9, 78) = 4.85 P<0.0001 
Genotype F (1, 80) = 4.28 P=0.0418 Genotype F (1, 78) = 67.47 P<0.0001 
Time F (9, 80) = 16.5 P<0.0001 Time F (9, 78) = 15.52 P<0.0001 
SLM Interaction F (9, 80) = 0.7 P=0.7070 CA3c Interaction F (9, 78) = 2.584 P=0.0116 
Genotype F (1, 80) = 1.492 P=0.2256 Genotype F (1, 78) = 44.9 P<0.0001 
Time F (9, 80) = 25.7 P<0.0001 Time F (9, 78) = 12.48 P<0.0001 
ML Interaction F (9, 80) = 0.7915 P=0.6249 CA3a,b - 
SO 
Interaction F (9, 77) = 0.6358 P=0.7631 
Genotype F (1, 80) = 0.06475 P=0.7998 Genotype F (1, 77) = 2.937 P=0.0906 
Time F (9, 80) = 12.13 P<0.0001 Time F (9, 77) = 1.16 P=0.3322 
GCL Interaction F (9, 79) = 1.006 P=0.4425 CA3a,b - 
SP 
Interaction F (9, 77) = 0.7915 P=0.6250 
Genotype F (1, 79) = 1.653 P=0.2023 Genotype F (1, 77) = 0.1921 P=0.6624 
Time F (9, 79) = 8.004 P<0.0001 Time F (9, 77) = 1.48 P=0.1703 
HL Interaction F (9, 79) = 1.738 P=0.0940 CA3a,b - 
SR 
Interaction F (9, 77) = 0.4054 P=0.9286 
Genotype F (1, 79) = 4.389 P=0.0394 Genotype F (1, 77) = 3.654 P=0.0597 
Time F (9, 79) = 17.29 P<0.0001 Time F (9, 77) = 0.8237 P=0.5963 
CA3c Interaction F (9, 80) = 0.4201 P=0.9208 Lucidum Interaction F (9, 77) = 0.5332 P=0.8461 
Genotype F (1, 80) = 2.593 P=0.1112 Genotype F (1, 77) = 2.248 P=0.1379 
Time F (9, 80) = 36.45 P<0.0001 Time F (9, 77) = 3.357 P=0.0016 
CA3a,b - 
SO 
Interaction F (9, 77) = 2.006 P=0.0498     
Genotype F (1, 77) = 1.286 P=0.2602     
Time F (9, 77) = 11.22 P<0.0001     
CA3a,b - 
SP 
Interaction F (9, 77) = 0.7629 P=0.6506     
Genotype F (1, 77) = 0.6179 P=0.4342     
Time F (9, 77) = 11.91 P<0.0001     
CA3a,b - 
SR 
Interaction F (9, 77) = 0.9621 P=0.4777     
Genotype F (1, 77) = 8.415 P=0.0048     
Time F (9, 77) = 11.61 P<0.0001     
Lucidum Interaction F (9, 77) = 1.263 P=0.2707     
Genotype F (1, 77) = 0.3842 P=0.5372     
Time F (9, 77) = 16.16 P<0.0001     
 
The results of two-way ANOVA tests assessing changes in CD68- and NPY-IR in ArticAb mice 
and wildtype littermates. Source of variation includes interaction (Int), genotype (Geno) and 
time. The degrees of freedom numerator (Dfn) and denominator (Dfd) of the F distribution are 
indicated in brackets. SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum; SLM, 
stratum lacunosum moleculare; ML, molecular layer; GCL, granule cell layer; HL, hilus. 
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Table S2 Results of statistical tests performed for immunohistochemical stainings (2) 
CD68 (Figure 9) 
Area Source of 
Variation 
F (DFn, DFd) P value 
CA1 - SO Inter F (1, 20) = 2.40 P=0.1369 
Geno F (1, 20) = 2.34 P=0.1417 
Age F (1, 20) = 3.08 P=0.0943 
CA1 - SP Inter F (1, 20) = 2.55 P=0.1259 
Geno F (1, 20) = 2.07 P=0.1652 
Age F (1, 20) = 18.05 P=0.0004 
CA1 - SR Inter F (1, 20) = 1.60 P=0.2206 
Geno F (1, 20) = 1.26 P=0.2756 
Age F (1, 20) = 1.51 P=0.2334 
SLM Inter F (1, 20) = 0.60 P=0.4485 
Geno F (1, 20) = 1.61 P=0.2195 
Age F (1, 20) = 14.00 P=0.0013 
ML Inter F (1, 20) = 1.49 P=0.2362 
Geno F (1, 20) = 2.68 P=0.1174 
Age F (1, 20) = 2.84 P=0.1073 
GCL Inter F (1, 20) = 2.61 P=0.1217 
Geno F (1, 20) = 3.69 P=0.0692 
Age F (1, 20) = 11.83 P=0.0026 
HL Inter F (1, 20) = 0.09 P=0.7701 
Geno F (1, 20) = 0.68 P=0.4192 
Age F (1, 20) = 0.77 P=0.3921 
CA3c Inter F (1, 20) = 1.03 P=0.3229 
Geno F (1, 20) = 2.98 P=0.0995 
Age F (1, 20) = 2.89 P=0.1044 
CA3a,b Inter F (1, 20) = 1.41 P=0.2483 
Geno F (1, 20) = 3.77 P=0.0664 
Age F (1, 20) = 49.70 P<0.0001 
 
The results of one-way ANOVA tests assessing changes in CD68-IR in ArticAb mice and 
wildtype littermates. Source of variation includes interaction (Int), genotype (Geno) and time. 
The degrees of freedom numerator (Dfn) and denominator (Dfd) of the F distribution are 
indicated in brackets. SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum; SLM, 
stratum lacunosum moleculare; ML, molecular layer; GCL, granule cell layer; HL, hilus. 
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Abstract 
Temporal lobe epilepsy (TLE) is one of the most common forms of epilepsy in adults and often 
medically refractory. The development of TLE is associated with multiple alterations, like 
neurodegeneration and the formation of new recurrent excitatory circuits, rendering the network 
susceptible for the generation of spontaneous recurrent seizures (SRS). Many of these features 
can be replicated by inducing status epilepticus (SE) in mice through a single intrahippocampal 
kainic acid (IHK) injection. While this and other animal models of TLE are well suited to study 
different facets of epileptogenesis, it remains difficult to identify the mechanisms that directly 
contribute to the formation of an epileptic focus. Interestingly, however, during the latent, 
seizure-free period directly following SE, when most of these processes occur, brief epileptic 
discharges precede the first occurrence of SRS. In order to determine whether this early 
epileptiform activity drives network reorganization during epileptogenesis, we used closed-loop 
optogenetic intervention (COI) in the IHK model during the first two weeks post-injection, prior 
to the onset of SRS. Our preliminary data suggest that early epileptic discharges during the latent 
period contribute to the development of SRS.  
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Introduction 
Temporal lobe epilepsy (TLE) belongs to one of the most common adult partial seizure disorders 
and is often refractory to current anti-epileptic drugs (Engel, 1998; Semah et al., 1998; Browne 
and Holmes, 2001). Traditionally, epilepsy research focused on seizure control and reduction in 
chronic, already established epilepsy. However, a major research interest resides in elucidating 
the mechanisms underlying the development of epilepsy and uncovering possibilities to interfere 
early on during the process of epileptogenesis, by disrupting processes that lead to the emergence 
of spontaneous recurrent seizures (SRS) after a brain insult. While there have been notable recent 
advances in this field, e.g., by applying agents that alter various signaling pathways like BDNF 
(McNamara and Scharfman, 2012), mTOR (Lasarge and Danzer, 2014) or NRSF (McClelland et 
al., 2014), the etiology and pathogenesis of the histological changes and their relationship with 
neuronal network alterations underlying the generation and the persistence of recurrent seizures 
in TLE remain unknown.  
Several lines of evidence indicate that “seizures beget seizures” in TLE (reviewed in (Ben-Ari et 
al., 2008)). Severity and frequency of seizure can be directly linked to neuronal loss in certain 
limbic areas (e.g. (Buckmaster et al., 2017)). Moreover, selective cell loss, for example of 
interneurons (Antonucci et al., 2012; Spampanato and Dudek, 2017) or hilar mossy cells in the 
dentate gyrus (Jinde et al., 2012), is associated with aberrant neuronal discharges and substantial 
neuronal reorganization. In animal models of acquired epilepsy, such short epileptic discharges 
are characteristic for the latent period (Riban et al., 2002a), the phase between a precipitating 
brain insult and the onset of SRS. As a consequence of a chemically or electrically induced status 
epilepticus (SE), neuronal loss, synaptic reorganization and other neuropathological changes can 
be observed, notably during the latent period (Suzuki et al., 1995b; Bouilleret et al., 1999; 
Bouilleret et al., 2000b; Bouilleret et al., 2000a; Duveau et al., 2011). However, it still remains to 
be determined whether epileptiform activity during this period, prior to onset of SRS, is a mere 
manifestation of functional alterations or a driver of epileptogenesis.  
Hence, rather than investigating different pathways potentially contributing to epileptogenesis, 
we determined whether control of aberrant neuronal activity during the initial phases of 
epileptogenesis is able to significantly decrease seizure frequency and prevent the structural and 
functional changes associated with epilepsy. To this end, a closed-loop optogenetic approach had 
to be designed to intervene selectively upon brief aberrant activity and curtailing these 
epileptiform events. In the intrahippocampal kainic acid (IHK) mouse model of TLE, a multi-
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algorithm based detection software was previously used for on-demand seizure suppression 
during the chronic phase, starting 2 weeks after IHK injection (Armstrong et al., 2013; Krook-
Magnuson et al., 2013; Krook-Magnuson et al., 2014; Ewell et al., 2015; Krook-Magnuson et al., 
2015) The existing system was adapted for closed-loop optogenetic intervention (COI) to inhibit 
low-voltage spikes, spike-and-wave events and bursts of high frequency that were previously 
found to be characteristic for the latent period, which lasts for approximately two weeks after an 
IHK-induced SE (Riban et al., 2002a). Preliminary results of this early COI suggest that activity-
dependent pathological plasticity processes contribute to the emergence and frequency of SRS.  
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Materials and Methods 
Animals 
All procedures were approved by the Stanford University’s Animal Care and Use Committee. 
The molecular Cre-lox system was enabled the selective expression of the excitatory 
channelrhodopsin (ChR2) and the inhibitory halorhodopsin (HR) into specific cell populations. 
To this end, mice expressing Cre either in PV-containing GABAergic interneurons (PV-
Cre;B6;129P2-Pvalbtm1(Cre)Arbr/J; stock 008069 from Jackson labs (Hippenmeyer et al., 
2005)) or in principal cells  (CamK-Cre; B6.Cg-Tg(Camk2a-cre)T29-1Stl/J; stock 005359 from 
Jackson labs (Tsien et al., 1996)) were crossed with either floxed-STOP ChR mice (Ai32; Rosa-
CAG-LSLChR2H134R-EYFP-deltaNeo; Jackson labs, stock 012569 (Madisen et al., 2012)) or 
floxed-STOP HR mice (Ai39; B6;129S-Gt(ROSA)26Sortm39(CAGHOP/EYFP)Hze/J; Jackson 
labs, stock 014539 (Madisen et al., 2012)), respectively. Similar to Krook-Magnuson et al. 
(2013), all experiments were performed with these two cohorts, mice expressing ChR in all PV+ 
cells (PV-ChR) and mice expressing HR in principal cells (Cam-HR). Littermates that do not 
express the opsin were used as controls. All animals were housed at standard conditions (20-
24℃; minimum 40% relative humidity) under a 12-hour light/dark cycle, with access to food and 
water ad libitum. 
Intrahippocampal kainic acid (IHK) injection and implantation of optrodes and electrodes  
The stereotactic surgeries were performed similar to Krook-Magnuson et al. (2013), however, 
including minor adjustments to investigate epileptogenesis. Mice were anaesthetized with 2.5-
3% isoflurane in oxygen and 70 nL kainic acid (5mM in NaCl; Tocris biosciences) was injected 
into the right dorsal hippocampus (anteroposterior [AP] -1.8 mm, mediolateral [ML] -1.6 mm, 
dorsoventral [DV] -1.9 mm relative to Bregma) as described by Bouilleret et al. (2000b). A 
bipolar depth electrode (PlasticsOne) was inserted at the same location. Optrodes, optic fibers 
(0.37NA, Low OH, 200 μm diameter, ThorLabs) attached to ceramic ferrulas (Kientec Systems, 
Inc.), were build as described in Armstrong et al. (2013) and placed into the striatum oriens of 
CA1 to provide light to the hippocampal formation. In PV-ChR mice, optrodes were implanted  
ipsilaterally (AP -2.3 mm, ML 1.75 mm, DV -1.25 mm), posterior to the epileptic focus, and 
contralaterally (AP -1.8 mm,  ML -1.75 mm, DV -1.25 mm) on the same plane as the IHK 
injection. In Cam-HR mice, optrodes were placed near the IHK injection on the ipsilateral side 
(AP -2.3 mm, ML 1.75 mm, DV -1.25 mm). Two screws were used for additional support and 
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Figure 1 Online, fast detection of short epileptic events and close-loop optogenetic intervention (COI). (A) 
The signal was sampled at 5 kHz, buffered and one frame of 100 samples (20 ms) was processed at a time. In 
order to detect epileptic activity online, gain factors for thresholds of different signal properties were selected by 
the user. Thresholds were obtained by calculating the standard deviation of the signal and two first order unit 
gain IIR-filter integrators (Slow and Fast integrator). These integrators were used to threshold the different signal 
properties by specifying the rate of change over time. (B) Changes in energy of different frequency bands are 
characteristic for epileptic activity. Therefore, their contribution to the frequency spectrum of the signal was 
tracked by computing an FFT (Fast Fourier Transform). The different frequency bands could be selected and 
their ratio was compared to a predefined threshold. (C) As the signal of most spikes are of high amplitude and 
high frequency, the sum of distances between consecutives data points, the coastline, was calculated. (D) During 
early epileptogenesis, spikes were often characterized by an initial raise in amplitude followed by a small spike-
train-like, high frequency activity. Predefining the width and distance between these small spikes, peaks were 
detected above a specific threshold. (E) The raw signal is saved for post-analysis and processed online for COI. 
A state-machine approach was used to define the trigger conditions. A first state (S1) consisting of a sum of 
different criteria (i.e. defined signal features) had to be met and followed by a second state (S2) with different 
conditions before the laser was triggered.  
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together with optrodes and electrodes fix to the skull by a combination of Prime&Bond 
(Dentsply) and Tetric EvoFlow® (Ivoclar vivadent). 
Electroencephalographic (EEG) recordings and online closed-loop intervention (COI) 
Directly after surgeries, mice were placed into a recording cage for EEG monitoring and later 
closed-loop optogenetic intervention. As earlier described (Armstrong et al., 2013; Krook-
Magnuson et al., 2013), an electric commutator (PlasticsOne) connected the mouse to the 
amplifier (NeuroPhase 440) and signals sampled at 5 kHz were digitized (NI USB-6229 M 
Series DAQ) and analyzed in real-time by a custom-made MATLAB program (see below). Up to 
8 animals could be recorded in parallel, while hourly files were saved (i.e. a recording file). After 
24 hours, when the status epilepticus ended and the latent period began (Riban et al., 2002a), the 
closed-loop optogenetic intervention was conducted for 12 days to curtail short clusters of 
spikes. The light was applied by different fiber-coupled diode lasers (Shanghai Laser & Optics 
Century Co., Ltd), which each were connected to the implanted optrode of an animal by a 
ceramic split sleeve (Precision Fibre Products, Inc.), optical patch cords (Thorlabs, Doric lenses) 
and optical commutator (Doric lenses). Lasers with a wavelength of 473 nm were used for PV-
ChR mice, while Cam-HR mice were connected to lasers with a wavelength of 589 nm. As the 
laser power at the source differed between different diode lasers (20-50 mW), optrodes were 
selected prior the implantation to provide a laser power at the tips of the optical fiber of 
approximate 10 mW.  
For a fast intervention upon short epileptic events, the online seizure detection software used for 
closed-loop optogenetic seizure intervention (Armstrong et al., 2013; Krook-Magnuson et al., 
2013; Krook-Magnuson et al., 2015) was modified. A state-machine approach, where several 
conditions have to be true in sequential manner, enabled a fast online detection of epileptic 
activity within approximately 40 ms (Figure 1) to detect and inhibit during single or small 
clusters of spikes. Thresholds for several signal features were selected, including power 
(magnitude and rate of change), spike (amplitude and width) and frequency (changes in energy 
within different frequency bands) properties (for details compare (White et al., 2006; Krook-
Magnuson et al., 2013)). Inclusion or exclusion criteria were formulated for each animal 
individually by combining these features using Boolean operators and defining their sequential 
appearance in order to maximize sensitivity and specificity of the detection. Once the specific 
criteria were met, the program triggered the activation of the laser for an immediate intervention. 
Short light pulses (50 ms on, 100 ms off) were applied for 2 s. To avoid constant triggering over 
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a long period of time, an intermission of 5s to the next trigger was implemented and in only 50% 
of detected events (in a random sequence), the laser was actually triggered.  
 
 
 
Figure 2 Analysis pipeline and software for offline detection of single spikes, short spike clusters and 
seizures. (A) The offline analysis pipeline is divided into two main steps: analyzing single files (step 1) and 
combining the result of an individual animal over a specific time period and form (treatment) groups for 
statistical analysis (step 2). (B) Step 1 of the analysis software is subdivided into three main steps: the detection 
of spikes, the formation of clusters, and the delimitation from artefacts. Inputs of step 1 comprise the credentials 
of an animal (ID, recording date, etc.), the settings for the analysis (examples in red), a master template with up 
to 8 spike templates and the raw data. After the analysis (compare text for details), a output file is saved 
containing the results of almost every interim step, as for example the number of positive, negative and paired 
clusters before and after artefact rejection.  
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Offline data analysis 
While we used the online spike and cluster spike detection for fast optogenetic intervention, we 
established an offline analysis pipeline to accurately detect spikes, short clusters of spikes and 
seizures in order to enable validation of our online detection and quantification of different forms 
of epileptic activity during the development of epilepsy. In contrast to the online spike (or cluster 
spike) detection described in the previous paragraph, offline analysis described in this paragraph 
is different in many regards, in particular concerning the available options to filter. While we had 
to use infinite impulse response (IIR) filters for the online detection, for the offline analysis here, 
the more stable finite impulse response (FIR) filters could be implemented. During offline 
analysis, we used for many applications zero-phase digital filtering, processing the input data in 
both the forward and reverse directions, to minimize distortion (Oppenheim et al., 1999). Besides 
filtering, the processing time during offline analysis is of lower priority, enabling a more 
elaborate analysis. The analysis pipeline (Figure 2A) can be divided into two main steps: the 
analysis of a single recording file (step 1) and the collection of the results for statistical analysis 
(step 2). In step 1, key information (i.e. credentials) about the animals together with a range of 
settings for the analysis is selected using a custom-made settings GUI. The settings for spike 
detection included a second-order bandpass Butterworth filter with a lower (typically at 2 Hz) 
and a higher cutoff frequency (typically at 500 Hz) (Figure 2B). In order to exclude baseline and 
large amplitude artefacts, a minimum and maximum threshold was specified for peak detection 
(Figure 2B and 3A). Adapted from Quiroga et al. (2004), thresholds were semi-automatically set 
to 
 𝑇ℎ𝑟 = 𝑘𝜎𝑛;  𝜎𝑛 = 𝑚𝑒𝑑𝑖𝑎𝑛 {
|𝑥|
0.6745
},  (3.1) 
where k is a constant scale factor selected separately for a positive and negative threshold, x is 
the filtered signal and the standard deviation of the background noise is estimated by σn (Donoho 
and Johnstone, 1994). Spikes were defined when the width in a certain distance (threshold down) 
below the peak was within the range of preset thresholds (i.e. minimum and maximum width) 
similar to the online detection (Krook-Magnuson et al., 2013). In addition to a threshold-guided 
spike detection, a pattern matching approach was used to find spikes that were otherwise hard to 
identify. To this end, up to 8 templates, i.e. short pieces of data, could be selected by hand and 
saved in a master template to detect matching patterns (Figure 3B). The positive and negative 
spikes from both sources were pooled. As many spikes had a positive and a negative peak, we 
formed pairs (Figure 3C). We found that the distance between the negative and positive peak of a 
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Figure 3 Spike and spike cluster detection with the offline analysis software. (A) For offline spike detection, 
local extrema (peaks) were identified using a positive (red) and negative (blue) threshold (inset). A rejection 
threshold (black) was specified to exclude artefacts of high amplitude. Spikes were defined by the width of the 
waveform at a specific distance from the peak (threshold down). (B) Another approach for spike detection was 
using pattern matching. Top: a predefined template of a spike (red) was run through the entire signal and the 
locations of matches (colors) were saved. Bottom: different templates could be run in parallel and single or joint 
matches were marked. (C) Most spikes featured a pair of peaks. Calculating the distance between peaks and 
specifying a maximum distance between peaks enabled the identification of these pairs. (D) Spikes (blue 
asterisk) were classed as cluster spikes (red) defining a minimal distance between spikes (compare also spike 
distance in A), while starts and stops of clusters were determined by the minimal cluster gap. (E) The overlap of 
clusters that were detected using either positive, negative or paired spikes were compared to exclude artefacts 
and identify true clusters for each type (i.e. positive, negative and paired clusters). 
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spike pair was in most cases smaller than to the previous or next peak of the respective other 
sign. This pertains particularly for clusters of spikes, where spikes often have a highly uniform 
appearance. Separately for each of the three groups of spikes (i.e. positive, negative and paired), 
clusters were defined by specifying the distance between spikes and a maximal cluster gap, with 
the option to exclude short clusters by specifying a minimal cluster size (Figure 2B and 3D). 
While paired clusters were detected with high precision (i.e. identifying an actual cluster), the 
accuracy to detect the actual start and stop of a cluster and include all spikes within this time 
window was rather low. Therefore, a logical condition and threshold specifying the overlap of 
clusters from different groups was used to identify true spike clusters in all groups (Figure 2B 
and 3E). In addition, within this overlap, positive and negative peaks were compared to 
determine the dominant side.  
The settings for spike and cluster detection, albeit harboring great potential for artefact rejection, 
were rather selected in a manner to increase the sensitivity of the detection (i.e. avoiding false 
negatives). A second approach included different filters and determined various signal properties 
to increase the specificity (i.e. avoiding false positives) of the spike cluster detection (Figure 
4A). Based on an algorithm written in Tcl (Tool Command Language) and Pascal by Open 
Source Instruments (http://alignment.hep.brandeis.edu/Software/Sources/), we implemented in 
our MATLAB code an assessment of different signal properties including amplitude, coastline, 
intermittency, spikiness, asymmetry, periodicity and frequency (Figure 4B). The amplitude, 
 
 
 
 
 
 
Figure 4 Signal features and artefact rejection for offline analysis. (A) Artefact rejection is collaterally 
handled in the analysis pipeline. Signal features and four different filters were combined through a logic 
conjunction to specify areas in the signal that should be excluded from the analysis. In addition, in a later step, 
clusters could be selectively removed by determine more restrictive criteria using the same signal properties 
(compare text for details). (B) The signal properties encompassed amplitude, coastline, intermittency, spikiness, 
asymmetry, periodicity, and frequency. (C) For each of these signal properties (magenta; normalized) thresholds 
(red) could be selected as shown here for asymmetry and intermittency. A logical conjunction of these different 
conditions could be used to distinguish areas of interest with clusters (magenta) from artefacts and the baseline. 
(D) A band-pass filter could be used to select areas predominated by a certain frequency band. Specifying the 
filter center frequency, the bandwidth and the stopband limit determined filtered signal (black). A threshold 
number of standard deviations for the envelope (magenta) was prescribed to define the active areas (orange). Up 
to four filters could be combined by logical conjunction to highlight different frequency bands and thereby select 
areas of interest.  
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coastline, intermittency and asymmetry were calculated as follows: 
 𝐴𝑚𝑝 = √
1
𝑁
 (∑ 𝑥2𝑁𝑖=1 −
1
𝑁
(∑ 𝑥𝑁𝑖=1 )
2) (3.2) 
 𝐶𝑜𝑎𝑠𝑡 = ∑ |𝑥𝑖+1 − 𝑥𝑖|
𝑁
𝑖=1  (3.3) 
 𝐼𝑛𝑡𝑒𝑟 =  
∑ 𝑥𝑖
𝑁
𝑖=1
∑ |𝑥𝑖+1−𝑥𝑖|
𝑁
𝑖=1
 (3.4) 
 𝐴𝑠𝑦 =  
max(𝑥)− 
∑ 𝑥𝑖
𝑁
𝑖=1
𝑁
∑ 𝑥𝑖
𝑁
𝑖=1
𝑁
− min(𝑥)
, (3.5) 
where x is the filtered signal and N the number of samples. While the coastline describes the 
absolute change in signal value over time, the intermittency defines how concentrated the 
coastline is at specific points in time. Similar to frequency variation (called frequency in Figure 
4), the asymmetry metric highlights sudden fluctuations in the signal. For periodicity, a measure 
of the oscillatory fraction of the signal, and spikiness, a metric of the variation in amplitude of 
local extrema, minima and maxima greater than the mean absolute deviation of signal are 
assessed. Thresholds for the different properties could be specified and a logic condition was 
formulated to distinguish periods with spike clusters from those with artefacts and baseline 
activity (Figure 4C). In a similar incentive, up to four different filters could be selected to 
identify changes in frequency bands (Figure 4D). Through a logical conjunction, these two 
different approaches of signal classification were combined to define periods that should not be 
considered (i.e. rejected areas) for spike and cluster detection (Figure 4A). Although a selection 
of artefact-specific signal properties would in principle be possible, in our hands it turned out 
that defining spike cluster-specific signal properties and specifying exclusion criteria ex negativo 
were more effective for artefact rejection. An example of the necessity of artefact rejection for 
cluster detection is shown in Figure 5.  
However, under certain circumstances, when many artefacts appear within spike clusters, this 
rejection approach interfered with cluster detection by rejecting many correctly identified 
clusters. Therefore, we implemented an additional step after the detection of clusters to define 
more restrictive cluster-specific signal properties and remove falsely identified clusters in 
retrospect (Figure 4A). The results of each individual step were saved separately (e.g., positive 
clusters with and without the rejected area). This is particularly important, when analyzing (in 
step 1) several hundred files in parallel on a high performance computing (HPC) cluster. In this 
case, settings can be chosen for a few recording files, while the other are analyzed with settings 
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Figure 5 An example of detecting a cluster of spikes using the custom-made MATLAB algorithm of step 1 
for offline analysis. (A) A LFP signal (black) of a mouse 4 months after IHK injection was analyzed. Manual 
scoring of the signal with the aid of the corresponding video revealed that a spike cluster (highlighted in orange) 
is following a movement artefact. Signal properties and filters were selected to determine the rejection area 
(magenta). (B-E) After spike (blue asterisk) detection and cluster spike (red asterisk) classification, clusters were 
formed (red and blue lines). (B) Spikes with positive peaks formed five clusters. (C) Using the rejection area, 
some of the falsely detected clusters (in B) were removed. (D) As for positive clusters, the algorithm detects 
negative clusters (i.e. clusters formed using negative spikes) that either entirely or partially comprise of artefacts. 
(E) Only clusters of paired spikes in combination with the rejected area represent an accurate approximation of 
the manual scoring. 
Results Study III: Materials and Methods 
104 
of the file that match closest their own date of acquisition. A custom-made Python script using 
GC3Pie (http://gc3pie.readthedocs.io/en/master/) was written to submit and control batch jobs to 
HPC clusters in order to analyze several files (i.e. run step 1) in parallel, while each job created 
an output file containing all the results of one channel of a particular recording file (typically an 
hour long recording of one animal). These results can be checked and clusters if necessary 
manually corrected using a custom-made analysis GUI (Figure 2A). After this verification, all 
results can be collected and grouped for statistical analysis using another custom-made 
MATLAB script (step 2).  
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Results and Discussion 
Several clinical features of TLE can be reproduced through IHK injection in adult mice. In the 
course of the first two weeks after injection, a progressive cell loss in the ipsilateral CA1, CA3c 
and hilus, occurs, which is associated with reactive gliosis, a strong granule cell dispersion in the 
dentate gyrus, and mossy fiber sprouting (Bouilleret et al., 1999). As reported earlier (Riban et 
al., 2002a), hippocampal activity during early epileptogenesis can be divided into three phases 
(Figure 6A). Immediately after injection, EEG activity was characterized by an almost 
continuous train of spikes (approx. 3-7 Hz), while the amplitude increased (200-900 µV) as the 
animal recovered from anesthesia. This SE lasted several hours, and gradually phased into the 
latent period, which in turn is characterized by the loss of theta activity and the occurrence of 
isolated or grouped low voltage spikes and spikes-and-waves (500-1000 µV) (Figure 6A). After 
approximately two weeks, progressively more and longer clusters of spikes emerged, eventually 
resulting in the appearance of spontaneous recurrent non-convulsive seizures (SRS; 1200-4800 
µV) lasting for tens of seconds (Figure 6A), and thereby heralding the beginning of the chronic 
phase. During SE and the chronic period, mice showed occasionally behavioral seizures of 
different severity, including behavioral arrest, mastication, vocalisation, clonic limb movements 
right up to jumping and running with tonic periods (data not shown). The progressive course of 
emerging aberrant activity towards the end of the latent period suggests that epileptogenesis is a 
continuous process with a gradual increase in seizure probability. Although the end of the latent 
period and the occurrence of the first clinical seizure might not be the final milestone of the 
epileptogenesis process (Williams et al., 2009), the latent period probably corresponds to an 
important phase and promising target to prevent the development of acquired epilepsy. 
Despite meticulous research into different aspects of epileptogenesis in TLE, the mechanisms 
underlying the development of SRS still remain unknown. However, the fact that overexcitation 
during SE triggers a series of reactions culminating in the development of seizures suggest that 
similar excitatory-inhibitory imbalance during the latent period is not just a manifestation of a 
yet complete pathogenesis. Rather, it might be an active constituent of the epileptogenic process. 
Therefore, we took advantage of recent advances in optogenetics to inhibit epileptiform activity 
selectively during the latent period to unravel its contribution to the formation of an epileptic 
focus (Figure 6B). While closed-loop optogenetic intervention (COI) was already used 
previously to inhibit long-lasting seizures in chronic models of thalamocortical (Paz et al., 2013) 
and temporal lobe epilepsy (Armstrong et al., 2013; Krook-Magnuson et al., 2013; Krook-
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Magnuson et al., 2014; Ewell et al., 2015; Krook-Magnuson et al., 2015), we implemented a 
system for fast inhibition of epileptiform activity occurring during the latent period in the IHK 
model of TLE (Figure 1). Exemplified by the analysis of a randomly selected hourly recording 
(at 4 dpi), a brief laser stimulation (for 2 s, in 50% of the cases) reduced the number of spikes 
detected in this 2-second time window (10000 samples) in a mouse expressing the opsin 
compared to its opsin-negative littermate (Figure 6C). However, for an adequate evaluation of 
COI during the latent period (i.e. determining accuracy and precision of the online detection) and 
assessing if it has any long term effect on seizure pathology, a much larger sample of data 
(animals and recording hours) will have to be analyzed at different time points during the latent 
phase. This holds particularly true as any early and continuous intervention might have an effect 
already within the period of intervention; for example when, similar to Figure 6C, the number of 
spikes is used to assess the efficacy of COI during the late latent period, the absolute number or 
(potentially) form of shape activity might have been changed. Therefore, we developed an 
offline analysis program to support the handling of a larger amount of data (Figure 2). Selecting 
settings for spike and spike cluster detection (Figure 3), as well as signal features and artefact 
rejection (Figure 4) enabled a reasonably accurate detection of clusters even within noisy signal 
(Figure 5). Hence, we analyzed a 24-hour window four months after the injection to test the 
program, selecting settings for each animal individually without knowledge about their group 
affiliation (Figure 6D). While these preliminary results have to be verified manually using the 
analysis GUI (Figure 2A), they indicated that Cam-HR mice, where COI was delivered through 
inhibition of pyramidal cells, showed a reduction in the number of spikes four months after the 
injection compared non-opsin expressing controls or PV-ChR mice, where COI was delivered 
through activation of PV+ interneurons. If these results hold true, it would suggest that early 
epileptiform activity in the surviving CA1 pyramidal cells during the latent phase directly 
contributes to the development of 
Figure 6 Closed-loop optogenetic intervention (COI) during early epileptogenesis. (A) Early epileptogenesis 
is characterized by an initial status epilepticus with continuous high frequency activity (30 s, inset 3 s), followed 
by a latent period with single or short clusters of spikes (30 s, inset 6 s), and finally the occurrence of 
spontaneous recurrent seizures during the chronic period (60 s, inset 3 s). (B) Experimental design of COI during 
early epileptogenesis. Mice are injected with kainic acid and both an optrode and an electrode were implanted 
into the dorsal hippocampus. After 24 hours, closed-loop optogenetic intervention was started for the next 12 
days. Thereafter, EEG recordings were continued for another week and once again four months later. (C) 
Proximate effect of COI on spike clusters. The number of spikes (normalized and binned) in the 2-s window 
after triggering the laser is reduced in an opsin-expressing mouse compared to a control animal. (D) Preliminary 
results of the long-term effect of COI during the latent period on the number of seizures four months after 
injection. Recordings in a 24 hour window of PV-ChR (n = 5), Cam-HR (n = 3) and opsin negative littermate 
controls (n = 4) were analyzed (blinded and without manual correction) on the cluster computer. This 
preliminary analysis reveals an ameliorating effect of inhibiting pyramidal cells during the latent period on the 
number of electrographic seizures during the chronic phase. 
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epilepsy, and the time window between a precipitating brain insult and the occurrence of the first 
clinical seizure should be considered for antiepileptogenic therapies. In addition, the inefficacy 
of a PV-mediated inhibition of short events could be explained by the time delay that arises using 
an indirect pathway for intervention. Krook-Magnuson et al. (2013) reported approximately 60% 
of seizures were stopped in Cam-HR mice within 1 s, while in PV-ChR mice within 5 s. 
Moreover, recent findings in a mouse model of optogenetically inducible seizures in the primary 
motor cortex showed that inhibition of PV+ (and SOM+) interneurons consistently reduced 
seizure duration, while inhibiting VIP+ interneurons disrupted both seizure initiation and 
maintenance (Khoshkhoo et al., 2017). While differences in the role of interneurons during 
seizures (i.e. beneficial inhibition vs. beneficial excitation) might be explained by differences in 
the epilepsy model and the fact that the preceding brain state affects the optogenetic curtailment 
of seizures (i.e. only non-theta state emerging hippocampal seizures can be curtailed by PV+ 
interneuron stimulation) (Sedigh-Sarvestani et al., 2014; Ewell et al., 2015), these findings by 
Khoshkhoo et al. (2017) suggest that other types of interneurons (than PV+ cell), which might 
not be secondarily recruited during epileptic discharges, are potentially more suitable targets for 
fast intervention. 
Conclusions 
We established a technique for fast closed-loop optogenetic intervention upon short epileptiform 
discharges and a program to analyze large data sets in order to study role of early epileptic 
discharges in acquired epileptogenesis. Preliminary results suggest that a closed-loop inhibition 
of epileptic activity during the latent period, through silencing of pyramidal cells, affect the 
seizure pathology later on. While these findings have to be confirmed using the analysis pipeline 
proposed and tested in this study, they might open new avenues to study the underlying 
mechanisms of epileptogenesis in TLE and define therapeutic windows for antiepileptogenic 
therapies.  
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IV. GENERAL DISCUSSION 
The overall objective of this study was to investigate the mechanisms underlying epileptogenesis 
in TLE to unravel potential targets in order to prevent the epilepsy early on. Being listed among 
the nine top research priorities in the fourth edition of Jasper’s Basic Mechanisms of the 
Epilepsies, we constrained this objective by focusing on three major topics employing the IHK 
model of TLE: the role of the monocytic immune response (study I), the effect of a comorbid 
AD-like pathology (study II) and the contribution of an early aberrant activity (study III) to the 
development of acquired epilepsy. While the first and the last study mainly focused on factors 
considered to be important in the ordinary course of epileptogenesis, the second study addressed 
the contribution of AD-like pathology on the development of a pro-epileptogenic environment. 
Although the clinical comorbidity of AD and epilepsy still remains underestimated, our 
observation of a curtailed latent period in AD transgenic mice turned out to be extremely fruitful 
to investigate the significance of the latent period prior to SRS onset.  
In the first study, we confirmed previous reports that the innate and adaptive immune system 
tightly follows the course of neurodegeneration and the development of SRS (e.g. (Deprez et al., 
2011; Zattoni et al., 2011)). However, we found no changes in the IHK-induced epileptogenesis 
after pre-exposure to the viral mimic PolyI:C (Figure 2-4), nor in a knockout model of NLRP3 
inflammasomes (Figure 5) and in mice lacking infiltrating peripheral macrophages (Figure 6), 
contrary to our expectations based on previous findings (Vezzani et al., 1999c; Zattoni et al., 
2011; Krstic et al., 2012). Different reasons (e.g. wildtype strain, non-canonical inflammasome 
pathway, epilepsy model) can potentially explain these discrepancies (see Discussion, study I). 
However, negative findings have to be interpreted with caution and our results should not be 
taken as evidence against a role for innate immune responses in the formation of an epileptic 
focus.  
Investigations in the second study not only revealed an early onset of SRS in AD transgenic 
mice, but also showed, to our knowledge for the first time, that an early onset of SRS is not 
dependent on the severity of the preceding SE. While these mice were more susceptible to KA, 
application of diazepam reduced seizure severity and frequency during IHK-induced SE, 
however, without preventing seizure induced mortality during the latent period. In addition, we 
did not find any changes in innate (Figure 1, 5, and 8) or adaptive immune response (data not 
shown), axonal reorganization (Figure 7 and 9) or adult neurogenesis (Figure 6) in this AD 
mouse model that could explain differences in epileptogenesis. We revealed that NPY signaling 
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is affected early in AD mice (Figure 8). Most strikingly, we were able to alleviate the 
exacerbated seizure pathology seen in AD transgenics by neutralization of soluble Aβ species 
prior to the induction of epileptogenesis.   
In the third study, we focussed on electrographic patterns appearing during early epileptogenesis, 
notably during the latent period. Previous studies have argued for early epileptiform activity 
being important for axonal reorganization (Sutula et al., 1988). Interfering with early epileptic 
discharges during the latent period using COI, our preliminary data show that early COI leads to 
reduced frequency of SRS four months after IHK injection (Figure 6). Although these findings 
have to be confirmed by further experiments, they suggest that early aberrant activity directly 
contribute to the emergence of spontaneous seizures later on. 
Stages of epileptogenesis 
In order to comprehend the mechanisms of epileptogenesis, the time course of events is crucial. 
Epileptogenesis in TLE is generally divided into consecutive stages, comprising a preclinical 
latent period after an insult and a clinical phase following the first seizure (Engel, 1996b, a). As a 
model of TLE, the IHK model shares not only many histopathological and electrographic 
features with TLE with hippocampal sclerosis (TLE-HS), but is also considered to be a valid 
representation of the progression of the disease in humans. The development of seizures in the 
IHK model is generally divided into three main stages, starting with the SE induced by KA, 
followed by the latent period that ends with the onset of SRS (Riban et al., 2002a). However, a 
study using a similar model, the “repeated low-dose kainate” model of TLE (Hellier et al., 1998; 
Hellier and Dudek, 1999), in which a SE is induced by multiple i.p. injections of kainic acid, 
emphasized that seizure frequency increases in a sigmoid function of time (Williams et al., 
2009). Hence, four stages can be distinguished: the latent period, a slow growth phase, an 
exponential growth phase, and the plateau phase. Many other models of acquired epilepsy 
studied over several weeks report a similar course comprising a SE, a latent period, and a chronic 
period with a growth and a plateau phase, as for example in the pilocarpine model (Cavalheiro et 
al., 1991), the rat IHK model (Ledri et al., 2016), and models inducing a self-sustained status 
epilepticus (SSSE) by an electrical tetanic stimulation of the angular bundle (Gorter et al., 2001) 
or the lateral nucleus of the amygdala (Nissinen et al., 2000). As pointed out by Williams et al. 
(2009), the end of the latent period does, therefore, not coincide with the completion of 
epileptogenesis, and the therapeutic window to suppress acquired epilepsy potentially extends 
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beyond the first clinical seizure. In our third study, we recorded in two separate phases after 
surgery, continuously for three weeks following the SE and after four months again continuously 
for 2 weeks. Hence, we were able to confirm the three main periods (Figure 6, study III) 
previously reported in the first month of IHK-induced epileptogenesis (Riban et al., 2002a; 
Arabadzisz et al., 2005; Zattoni et al., 2011). Far from being the end of epileptogenesis, the latent 
period (also called silent or quiescent period) remains of particular importance when studying the 
development of epilepsy. The fact that no seizures occur during this period suggests that the 
generation of seizures only occurs after completion of an essential network reorganization or 
upon suppression of an inhibitory process that prevents prolonged epileptiform activity, for 
example the putative expression of an endogenous agent with anticonvulsant properties. We will 
discuss either possibility in the next paragraphs in detail. 
Neuronal network reorganization 
We were able to replicate in the first (Figure 1) and the second study (Figure 1, 5, 6, 8) a few of 
the many neuropathological alterations reported during the latent period. In the ipsilateral 
hippocampus, pyramidal cells in CA1, CA3c and hilar mossy cells start to degenerate after the 
IHK-induced SE (Suzuki et al., 1995b; Bouilleret et al., 1999). Moreover, within the first 24 
hours of this initial insult follows a selective loss of PV-, CB-, SOM- and NPY-positive 
interneurons in the DG, CA1, and, to a lesser extent, in CA3, while CR-positive cells (except 
mossy cells) are largely spared (Bouilleret et al., 1999; Bouilleret et al., 2000b). Reelin-positive 
interneurons also disappear within 24 hours after IHK injection, while reelin- and CR-positive 
Cajal-Retzius cells located along the hippocampal fissure become gradually more visible due to 
an intracellular accumulation of truncated reelin (Duveau et al., 2011). This BDNF-mediated 
impairment in reelin secretion in the injected hemisphere causes a dispersion of GC (Bouilleret et 
al., 1999; Heinrich et al., 2006; Müller et al., 2009; Duveau et al., 2011). In the dentate gyrus, 
mossy fibers start to sprout aberrantly into the inner molecular layer (Buckmaster, 2012). In 
addition, SE causes an impairment of hippocampal adult neurogenesis (Kralic et al., 2005; 
Ledergerber et al., 2006; Sierra et al., 2015) after an initial, transient increase in cell proliferation 
(Parent et al., 1997; Jessberger et al., 2005). Notably, all these changes (or at least those which 
were tested) could be found after IHK injection in all the different animal models used in this 
study, apart from the GC dispersion, which was strongly reduced after i.c.v. injection of anti-Aβ 
antibody or control IgG in ArcticAβ mice (Figure 10, study II). However, it is unknown which of 
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these multiple alterations directly contribute to the development of SRS and which are 
concomitant sequelae. Based on the fact that in our second study we found a curtailment of the 
latent period in AD transgenic mice (Figure 4) without any difference in the gross 
neurodegenerative pattern (Figure 1), innate immune response (Figure 1 and 5), NPY-positive 
axonal sprouting (Figure 7) or adult neurogenesis (Figure 6), suggests that other alterations 
might be more important for the generation of SRS. Therefore, we will focus in the next two 
paragraphs on the dysfunction of interneurons and axonal reorganization, two potentially critical 
alterations during the latent period for the generation of SRS. 
Dysfunction of interneurons 
An important function of inhibitory GABAergic interneurons is to support network synchrony 
and oscillatory rhythmic activity (Buzsaki and Draguhn, 2004). Any dysfunction has supposedly 
a profound effect on the network performance, characterized by dysrhythmias and cognitive 
impairment. Previous studies reported that dysfunction of interneurons contribute to 
abnormalities in oscillatory rhythms and network synchronicity in both AD and epilepsy 
(reviewed in (Palop and Mucke, 2016)), thus affecting similar cognitive functions such as 
encoding of memory (Jokeit and Ebner, 1999; Sinforiani et al., 2003; Ito et al., 2009). In patients 
(Amatniek et al., 2006; Scarmeas et al., 2009; Vossel et al., 2013; Vossel et al., 2016) and animal 
models of AD (Busche et al., 2012; Kam et al., 2016; Schmid et al., 2016), aberrant activity and 
spontaneous seizures were found at an early stage of the pathogenesis. Similarly, we found in our 
second study that ArcticAβ mice are more susceptible to excitotoxicity (Figure 1-4), supposedly 
through the presence of Aβ oligomers. We have not tested if a pretreatment with the anti-Aβ 
antibody would reverse the hyperexcitable phenotype in ArcticAβ mice before and immediately 
after KA (in slice or in vivo). It has been shown, however, that neuronal hyperexcitability can be 
induced in wildtype mice by soluble Aβ (Busche et al., 2012) and that axons of CA1 O-LM 
interneurons are lost in young APP/PS1 mice (Schmid et al., 2016). We found decreased 
synaptic strength, increased KA-induced LTP and reduced frequency of sIPSCs (Figure 2-3, 
study II), assuming the inhibitory input is impaired or obstructed. We also discovered in these 
mice that the latent period was curtailed and the onset of SRS occurred within a few days (Figure 
4, study II). One possible explanation could be that sudden local dysfunction in inhibition is 
sufficient to render the network susceptible to the generation of SRS. Interestingly, two recent 
studies support this assumption. Unilateral injection of an AAV containing DT receptors in 
dorsal CA1 of a Gad2-ires-Cre mice lead to a focal ablation of interneurons and the transient 
occurrence of regular SRS (with a mean duration of 45 seconds) for a few days, without the 
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appearance of an initial SE (Spampanato and Dudek, 2017). As SRS appeared within the 
timeframe required for a DT-mediated ablation, the authors assumed that there was no latent 
phase present. Another recent study showed that selectively silencing parvalbumin interneurons 
in the subiculum and hippocampal CA1 (irregularly inclusive in adjacent regions) injecting AAV 
expressing tetanus toxin light chain (TeLC) in PV-cre mice induced clusters of spike-wave 
discharges and regular SRS (with a mean duration of 25 seconds) (Drexel et al., 2017). The 
seizures occurred around 10 days after the AAV injection, however, at a low frequency (around 
5 seizures per month). In addition, the attempt to induce SRS through a transient silencing of 
PV-positive interneurons (for about 1-2 hours) using DREADD (designer receptor exclusively 
activated by designer drugs) failed. Both studies reported on average below 10 seizures and in 
majority convulsive seizures (47% after CA1 ablation and 93-100% after subiculum/CA1 
silencing) during the recording period of 1-2 months. In comparison, in the IHK model most 
seizures are non-convulsive with a frequency of around 9 per hour after 3 weeks (Zattoni et al., 
2011), while convulsive seizures are rare and strongly vary between animals (Soltesz lab, 
personal communication). A possible explanation for this discrepancy could be that besides CA1 
and the subiculum, the rest of the hippocampus is mostly unaffected in those two studies. In 
addition, a recent study showed that in the subiculum, depolarized GABAergic signaling caused 
by changes in chloride transporters mediates secondary generalized seizures in IHK model of 
TLE, with PV-positive interneurons being particularly vulnerable to become depolarized during 
secondary generalized seizures (Wang et al., 2017). Together, these findings suggest that 
although important, GABAergic and in particular PV-positive interneurons in CA1 or the 
subiculum are not solely responsible for the electrographic characteristics seen in the IHK model.  
Different types of interneurons are affected in models of TLE while playing different roles for 
seizure generation. As in the IHK model, the number of SOM-, NPY- and PV-positive 
interneurons was found to be decreased in the first few days after pilocarpine injection (Lurton 
and Cavalheiro, 1997; Dinocourt et al., 2003). A lowered seizure-threshold was proposed to be 
mediated by a deficit in dendritic feedback inhibition, as for example by O-LM cells, while 
epileptiform activity is limited by somatic feed-forward inhibition (Cossart et al., 2001). A 
subset of NPY-positive cells in the hippocampus shows both dendritic feedforward and feedback 
inhibition, and belong to two related classes of interneurons, ivy and neurogliaform cells. 
Besides NPY, these cells of the neurogliaform family can express nitric oxide (NO) and high 
levels of GABAA receptor α1 subunits, but neither PV nor CCK (Fuentealba et al., 2008; 
Tricoire et al., 2010). Further, ivy cells can be distinguished from neurogliaform cells through 
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the lack of reelin (Fuentealba et al., 2010). Cells of the neurogliaform family are characterized by 
a dense local axonal plexus through which they mediate GABAergic non-synaptic volume 
transmission (Olah et al., 2009). As one of the most abundant types of interneurons in CA1 
(Fuentealba et al., 2008) and known for their consistent firing rate across different behavioral 
states and network oscillations (Lapray et al., 2012), ivy cells provide a slow GABAergic input 
to principal cells, which was proposed to be important for maintaining network homeostasis and 
guarding against increased excitability. Thus, the firing rates of ivy cells increase upon enhanced 
network activity and synchrony, as for example seen during an increase in frequency and 
amplitude of field theta oscillations (Lapray et al., 2012). Similar properties were found in 
neurogliaform cells, and both ivy and neurogliaform cells provide potent feedforward inhibition 
to principal cells of the dentate gyrus, CA3 and CA1, while only ivy cells show direct feedback 
inhibition in CA1 and CA3 (Armstrong et al., 2012; Milstein et al., 2015). Moreover, both ivy 
and neurogliaform cells display persistent firing, a recently described phenomenon, where action 
potential firing in distal axons continues after cessation of depolarizing input (Krook-Magnuson 
et al., 2011; Sheffield et al., 2011). Whereas the physiological function of persistent firing is still 
a matter of open debate, a recent study emphasizes the potential of persistent firing for 
suppressing undesirable neuronal hyperactivity (Suzuki et al., 2014). These authors focused on 
neurogliaform cell-mediated feedback inhibition of pyramidal cells in the cerebral cortex, a 
conjunction only observed in ivy cells in the hippocampus (Price et al., 2005). However, 
hippocampal neurogliaform and ivy cells might provide a similar seizure alleviating effect by 
feedforward inhibition, interfering for example with the propagation speed of epileptic events 
(Trevelyan et al., 2007). Interestingly, in CA1, this feedforward inhibition can be abolished 
through activation of the Mu opioid receptors (μORs) (Krook-Magnuson et al., 2011). In a 
mouse model of AD, the endogenous μORs agonist enkephalin (ENK) was shown to be 
significantly upregulated already at an early age (2-4 months old), and contribute to neuronal and 
behavioral impairments in both young (3-5 months old) and old AD transgenic mice (9-10 
months old) (Meilandt et al., 2008). Similarly, in a model of TLE, ENK-IR starts to increase in 
mossy fibers and in the inner molecular layer of the dentate gyrus 2-3 weeks after a single 
systemic injection of KA, during a the time when the first SRS occur, and ENK-IR was reported 
to remain elevated for at least 1 year (Bing et al., 1997). It would need to be determined if young 
ArcticAβ mice show elevated ENK-IR prior to IHK injection to assess if this pathway might 
serve as an explanation for the hyperexcitable phenotype and the early onset of SRS in our 
transgenic mice (Figure 4, study II). In our second study, we furthermore found a reduced 
expression of NPY in naïve adult ArcticAβ mice (Figure 8). Furthermore, we observed impaired 
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IHK-induced elevation in NPY-IR (Figure 7). Although we would first need to analyze whether  
levels of NPY are actually reduced in interneurons, it would be interesting to determine what 
implications a reduction has on the function of NPY-expressing interneurons, such as from the 
neurogliaform family, and consequently on the hippocampal network. 
Axonal reorganization: loss of hilar mossy cell and mossy fiber sprouting 
Mossy fiber sprouting, the synaptic innervation of GC axons (i.e. mossy fibers) with GC 
dendrites in the inner molecular layer, is initiated during SE and largely established still within 
the latent period (Figure 1, study I). Besides seizures, aberrant activity as chronic synchronous 
activation of the perforant path is reportedly capable of inducing mild mossy fiber sprouting, 
even in the absence of evoked epileptic discharges or neuronal loss (Sutula et al., 1988). 
Rapamycin was shown to abolish mossy fiber sprouting without affecting the frequency of 
seizures (Buckmaster and Lew, 2011). Unexpectedly, selective DT-mediated ablation of mossy 
cells does neither induce mossy fiber sprouting nor SRS (Jinde et al., 2012). Although the loss of 
hilar mossy cells is one of the first changes seen after IHK-induced SE (Figure 1, study I), the 
study by Jinde et al. (2012) revealed that a selective hilar mossy cell loss induces an acute GC 
hyperexcitability (4-11 days post-DT), which disappeared 6-8 weeks after DT, supposedly due to 
sprouting of GABAergic interneurons into the inner molecular layer of the dentate gyrus. 
However, it should be remembered that most TLE models show a simultaneous degeneration of 
mossy cells and of GABAergic interneurons, as for example of hilar NPY- and SOM-positive 
neurons.  
The role of BDNF signaling in acquired epilepsy 
At the same time, intrahippocampal BDNF was shown to induce seizures and mild mossy fiber 
sprouting (Scharfman et al., 2002), while IHK-induced SE increases BDNF expression in the 
dentate gyrus (Suzuki et al., 1995b). Interestingly, the inhibition of TrkB (Liu et al., 2013), or 
more specifically TrkB-mediated PLCɣ1 signaling, by genetically uncoupling TrkB from adaptor 
proteins and enzymes (Gu et al., 2015) was shown to alleviate SE if applied in advance. Also, it 
massively reduces the number of SRS during chronic period if applied after SE. Together with 
recent findings from the same lab revealing that structural LTP induction involves NMDAR-
CaMKII-dependent BDNF release and an autocrine activation of TrkB (Harward et al., 2016; 
Hedrick et al., 2016), aberrant activity during early stages of epileptogenesis become more 
important, while BDNF-TrkB signaling might serve as a link to explain mechanistically the 
results seen after early COI (Figure 6, study III). Antonucci et al. (2008) demonstrated that 
General Discussion 
116 
intrahippocampal application of botulinum neurotoxin E (BoNT/E) after IHK injection reduced 
cell loss in CA1 and GC dispersion in the DG, while the latency to the first EEG seizure was 
prolonged and the frequency of spikes and sharp waves was reduced during the latent period. 
BoNT/E was injected to unleash its full potential several hours after IHK-induced SE until 
around 2 weeks later. It cleaves SNAP-25 within presynaptic terminals and therefore impairs 
vesicle fusion (Davletov et al., 2005). While BoNT/E treatment during the latent period had no 
effect on the frequency of SRS or the time spent in seizure during the early chronic period 
(Antonucci et al., 2008), a BoNT/E application during the chronic phase transiently reduced both 
SRS frequency and time spent in seizure (Antonucci et al., 2009). As BoNT/E during the latent 
period had no effect on SRS three weeks after IHK (Antonucci et al., 2008), it will have to be 
tested if our preliminary data in the third study (Figure 6) also holds true during the early chronic 
phase.  
The importance of the BDNF-TrkB signaling during epileptogenesis was further highlighted by 
the effect of BoNT/E treatment in reducing the SE-induced elevation of TrkB-IR in Cajal-
Retzius during the latent period, while simultaneously also reducing granule cell dispersion 
(Duveau et al., 2011). In this regard, innate and adaptive immune cells, as a source of BDNF 
(Kerschensteiner et al., 1999; Chan et al., 2015), might play a pivotal role. It would have to be 
determined if peripheral mononuclear phagocytes significantly contribute to BDNF in the DG, 
either by secretion or by stimulating BDNF expression in GC (Heinrich et al., 2011), and if a 
compensatory mechanism, substituting BDNF, can be hold responsible for the unexpected GC 
dispersion seen in CCR2-KO mice. Moreover, considering the importance of BDNF for LTP, 
BDNF from immune cells might contribute directly to early seizure-mediated plasticity. 
Parkhurst et al. (2013), for example, showed that a selective depletion of BDNF in microglia 
caused reduced levels of the NMDA receptor subunit NR2B and VGluT1, less improvement in 
rotarod performance after training, and impaired memory in the auditory fear-conditioning task, 
whereas it was not affecting performance in the novel object-recognition task nor synapse 
density in motor cortex or CA1. However, selective depletion of BDNF receptors in PV-positive 
interneurons lead to a desynchronization and reduced firing of PV-positive neurons and, in CA1, 
to decreased network activity in the gamma-frequency band (30-80 Hz) (Zheng et al., 2011). 
Interestingly, in our AD transgenic mouse model, the frequency of sIPSCs and the relative 
gamma power (90-100 Hz) in CA1 pyramidal cells were reduced after KA application, but not at 
baseline (Figure 3, study II). Balkowiec and Katz (2002) found that BDNF secretion in 
hippocampal neurons was significantly more effective upon 100 Hz tetanus and theta-burst 
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stimulation than upon lower-frequency stimulation. Although we found no difference in BDNF 
mRNA expression in naive ArcticAβ mice compared to wildtype littermates at 3 and 9 months of 
age (data not shown), it might be interesting to examine other members of the BDNF-TrkB 
signaling cascade. 
Transient expression of anticonvulsants 
Besides network alterations discussed in the former paragraph, which may or may not require 
time to establish an epileptic focus, several lines of evidence suggest that anticonvulsive agents 
transiently suppress epileptic discharges. In our second study, we report a transient bilateral 
increase in NPY in mossy fibers and GC within 24 hours after IHK-induced SE in wildtype 
mice, followed by a gradual decline over the next couple of days (Figure 7). Many studies found 
that NPY has anticonvulsive properties and alleviates seizures by either injecting it locally 
(Woldbye et al., 1996; Baraban et al., 1997; Woldbye et al., 1997; Vezzani et al., 1999a), or 
overexpressing NPY and its receptors, Y2R or Y5R (Richichi et al., 2004; Sorensen et al., 2009; 
Woldbye et al., 2010; Gotzsche et al., 2012). Interestingly, ArcticAβ mice showed a reduced 
seizure-induced activation of NPY signaling during the latent phase (Figure 7, study II), 
coinciding with the early onset of SRS. However, to test whether reduced levels of NPY are 
responsible for curtailment of the latent period, we would need to restore levels in ArcticAβ mice 
back to wildtypes, or vice versa. Another indirect approach to test the assumption would be to 
assess NPY signaling in other animal models with early onset of SRS. For example, in RAG1-
KO mice lacking T- and B-cells, which show SRS already 2-3 days after IHK injection (Zattoni 
et al., 2011), it would be interesting to test if we see similar changes in NPY-IR as detected in 
ArcticAβ mice. 
Animal models with an early onset of SRS or reduced dispersion 
In two animal models of TLE, the pilocarpine and the IHK model, the contribution of T cells was 
emphasized for the development of SRS. By blocking the seizure-induced elevation of vascular 
cell adhesion molecules and thereby T cell extravasation, acute seizures and the development of 
SRS in response to pilocarpine-induced SE were markedly prevented (Fabene et al., 2008). The 
same study further reported that neutrophil depletion had the same effect and blood-brain barrier 
leakage could be prevented, suggesting a direct contribution of plasma proteins and K+ ions to 
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SRS (Marchi et al., 2007; Marchi et al., 2010). More relevant for a direct comparison to 
epileptogenesis was a study made with RAG1-KO mice injected with IHK. As assessed in Nissl-
stained sections, neurodegeneration was exacerbated in CA1 and CA3 of mice lacking B and T 
cells, including a loss of dentate GC that start to become evident between 14 and 28 days 
(Deprez et al., 2011; Zattoni et al., 2011). The increased neurodegeneration was attributed to the 
occurrence of Gr-1-positive neutrophils in the ipsilateral hippocampus (except in the dentate 
gyrus), while GC survival and dispersion was supposed to be dependent on the presence of 
protective, infiltrating macrophages in the ipsilateral dentate gyrus (except in the hilus), an 
assumption that we could not confirm in mice lacking CCR2+ peripheral mononuclear 
phagocytes (Figure 6, study I). ArcticAβ mice did not show any difference in the overall 
neurodegeneration (e.g. CA1 or CA3), the GC survival or dispersion, and the number of 
infiltrating peripheral mononuclear phagocytes 21 days after injection (Figure 1, study II). 
Further, the number of infiltrating T cells was comparable between ArcticAβ mice and wildtype 
controls as revealed by a qualitative assessment of the number and distribution of CD3+ cells at 
1, 3, 6, 14 dpi (data not shown). The lack of any abnormalities in the IHK-associated immune 
response in ArcticAβ mice (mentioned above) and RAG1-KO mice (Deprez et al., 2011; Zattoni 
et al., 2011; Bernhard, 2016) within the first few days when SRS start to occur suggests that the 
immune response (at least the elements described here) is not directly responsible for or capable 
of generating SRS. However, it cannot be excluded that the immune system contributes to the 
development of seizures by either promoting a pro-epileptic environment (e.g. lowering the 
seizure threshold) or by influencing anticonvulsive signaling. 
In our second study, we cleared soluble Aβ species by injecting an Aβ-specific antibody or 
control immunoglobulin G (IgG) intracerebroventricularly in ArcticAβ mice (Figure 10). 
Interestingly, GC dispersion was not observed 18 days after injection in these two groups, albeit 
no GC loss was evident. Notably, the absence of T and B lymphocytes in RAG1-KO mice is 
associated with a lack of IgG production, revealed by the missing “background” in their IHC-
stained tissue sections (Zattoni et al., 2011). Further, RAG1-KO mice showed a loss of GC at 28 
dpi and peripheral mononuclear phagocytes were missing in mice with a severe degeneration at 
14 dpi. Therefore, IgG might affect either granule cell dispersion directly, for example through 
BDNF-TrkB signaling (Duveau et al., 2011), or both peripheral and resident microglia in the DG 
by suppressing any putative contribution to GC dispersion and repressing the phagocytic activity, 
respectively. It will be interesting to determine how intraventricular IgG affects the innate 
immune response, in particular the infiltration of peripheral mononuclear phagocytes. 
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Discrepancies in AD mouse models: disease-stage dependent? 
Aberrant network activity was reported in several animal models of AD. While 5-weeks-old 
Tg2576 mice (hAPPSwe) already showed a predisposition for interictal spikes during REM 
sleep, they only showed at an age of 7 months spontaneous seizures similar to 3- to 7-months-old 
J20 mice (hAPPSwe/Ind) or 3- to 4.5-months-old APdE9 mice (hAPPSwe/PS1dE9) (Palop et al., 
2007; Minkeviciene et al., 2008; Kam et al., 2016). Although we assessed hippocampal LFP in 
untreated 3-months-old ArcticAβ mice only in three 3 hour recording sessions (data not shown), 
we did not find any spontaneous seizures in our mice. However, in the studies mentioned above, 
SRS were detected at an age in which most of these mice already suffer from a more advanced 
Aβ pathology, reporting already deposition of amyloid plaques (Mucke et al., 2000; 
Kawarabayashi et al., 2001; Minkeviciene et al., 2008). There are findings in some of these AD 
mouse models showing an early hyperexcitability and increased susceptibility to pro-convulsives 
(Roberson et al., 2007; Kam et al., 2016). While many studies related early hyperreactivity and 
neuronal network dysfunction to the presence of soluble or intraneuronal Aβ species (Billings et 
al., 2005; Busche et al., 2012), others attributed its effect to the Aβ composition (increased 
Aβ42/Aβ40 ratio) or its fibrillary or oligomeric conformation (Mucke et al., 2000; Minkeviciene 
et al., 2008). In line with these reports, we were able to alleviate the pro-epileptogenic phenotype 
in ArcticAβ mice by clearing Aβ species with an anti-Aβ-antibody prior to IHK-induced SE 
(Figure 11, study II). Several studies in J20 mice, showing SRS already at an age between 3 and 
7 months, report an ectopic expression of NPY in mossy fibers, NPY axons in the molecular 
layer and a degeneration of CB-interneurons in the hippocampus (Palop et al., 2007; Roberson et 
al., 2007; Roberson et al., 2011). Similar observations were made by us in wildtype mice after 
SE-induced epileptogenesis (Figure 8, study II) and others (Vezzani et al., 1999a; Bouilleret et 
al., 2000b). Interestingly, the subset of APdE9 mice that did not show spontaneous seizures 
between 3 and 4.5 months did not exhibit any changes in NPY expression (Minkeviciene et al., 
2008). We also did not find any changes in NPY-IR of 3-months-old ArcticAβ mice. However, 
as reported by Palop et al. (2007), we found an increased YR2 expression and first signs of NPY-
IR in mossy fibers of our ArcticAβ mice (Figure 10, study II). Together with a body of literature 
highlighting anticonvulsive properties of NPY signaling (compare above), it suggests that these 
changes in NPY-IR reflect a compensatory mechanism to the earlier occurrence of SRS in 
APPJ20 mice. More recently, it was found that the same mice featured a reduced expression of 
the interneuron-specific and PV-cell-predominant voltage-gated sodium channel subunit Nav1.1 
(also called SCN1A) in both hippocampus and parietal cortex, which through specific restorage 
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of Nav1.1in GABAergic neurons (primarily in PV interneurons) increased inhibitory synaptic 
currents and gamma activity, reducing thereby epileptiform discharges in the parietal cortex of 
hAPPJ20 mice (Verret et al., 2012). However, we did not detect any difference in hippocampal 
SCN1A expression in neither 3- nor 9-months-old ArcticAβ mice, suggesting that the reduced 
synaptic strength (Figure 2, study II), frequency of inhibitory activity and the trend towards a 
reduced gamma power (Figure 3, study II) are most likely affected by another mechanism.  
Conclusion 
In the IHK model of TLE, we aimed to reveal critical factors for the development of epilepsy by 
assessing morphological and functional alterations during early epileptogenesis. Several lines of 
evidence suggest that neuroinflammation following SE affects the formation of an epileptic focus 
and thereby the generation of seizures, through cytokines release and phagocytic activity. 
However, attempts to affect the innate immune response by prenatal priming with polyI:C, a lack 
of NLRP3 inflammasomes or peripheral mononuclear CCR2+ phagocytes had no effect on the 
development of IHK pathology. Although we cannot definitely exclude (e.g. strain-dependent) 
compensatory mechanisms interfering genetically or during development, our findings suggest 
that the innate immune response contributes indirectly to epileptogenesis and is not crucial for 
the chronic occurrence of SRS in this model of TLE. In line with this assumption, increased 
excitability and early onset of SRS in an AD mouse model after IHK-induced SE do not correlate 
with differences in neuroinflammation, which rather indicates that cellular hyperexcitability and 
impaired anticonvulsive NPY signaling are potentially affected early in AD pathology by Aβ 
oligomers. Although it still remains unknown what molecular or cellular alterations are 
ultimately responsible for the generation of seizures and the presence of a latent period, our 
preliminary data indicates that COI upon early aberrant activity of principal cells, but not PV 
interneurons, affects seizure pathology in the long-term. Hence, we assume that plasticity during 
epileptogenesis is activity-driven. Although epileptic discharges have an effect on many 
processes (compare e.g. kindling), we hope to untangle at least secondary sequelae of SE from 
mechanisms crucial for SRS generation by taking advantage of this reciprocal dependency 
between aberrant network activity of focal origin and activity-dependent structural plasticity in 
the epileptic focus. However, in particular concerning the controversy raised around the latent 
period, future studies will not be able to avoid research into endogenous seizure alleviating 
mechanisms (e.g. NPY signaling), which might camouflage the latent period as an 
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indispensability of the network to reorganize. Expanded effort into a holistic understanding of 
the etiology and pathogenesis of TLE might not only uncover new potential drug targets, but will 
also help to define treatment-specific therapeutic windows for more accurate intervention, 
thereby minimizing interference with normal brain activity.  
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ABBREVIATIONS 
AAV  Adeno-associated virus 
A  amyloid- 
AD  Alzheimer's disease 
AICD  APP intracellular domain 
AIM2  absent in melanoma 2 
ALR  absent in melanoma 2 (AIM2)-like receptors 
apoE  apolipoprotein E 
APP  amyloid precursor protein 
AUC  area under the curve 
BACE1 beta-secretase 1 
BBB  blood brain barrier 
BDNF  brain derived neurotrophic factor 
BoNT/E botulinum neurotoxin E 
CA1  cornu ammonis area 1 
CA3  cornu ammonis area 3 
CB  calbindin 
CCL2  chemokine (C-C motif) ligand 2 
CCR2  chemokine (C-C motif) receptor type 2 
CD68  cluster of differentiation 68 
CNS  central nervous system 
CR  calretinin 
CSF  cerebrospinal fluid 
dpi  days post injection 
DAB  3,3-diaminobenzidine 
DAMPS damage-associated molecular pattern 
DG  dentate gyrus 
DREADD designer receptors exclusively activated by designer drug 
dsRNA double-stranded ribonucleic acid 
DT  diphtheria toxin 
EC  entorhinal cortex 
ENK  enkephalin 
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FAD  familial Alzheimer’s disease 
GABA  γ-aminobutyric acid 
GD  gestational day 
GFAP   glial fibrillary acidic protein 
GL  granule layer (of the dentate gyrus) 
hAPP  human amyloid precursor protein 
HMGB1 high mobility group box 1 
HS  hippocampal sclerosis 
Iba1  ionized calcium-binding adapter molecule 1 
ICAM-1 intercellular adhesion molecule 1 
i.c.v.  intracerebroventricular 
IgG  Immunoglobulin G 
IHC  immunohistochemistry 
IL  interleukin 
ILAE  International League Against Epilepsy 
IFN  interferon 
IHK  intrahippocampal kainic acid 
i.p.  intraperitoneal 
IR  immunoreactivity 
i.v.  intravenous 
KA  kainic acid 
LFP  local field potential 
LOAD  late-onset Alzheimer’s disease 
LPS  lipopolysaccharides 
LTD  long-term depression 
LTLE  lateral temporal lobe epilepsy 
LTP  long-term potentiation 
mEPSC miniature excitatory postsynaptic currents  
mIPSC  miniature inhibitory postsynaptic currents  
MIP  macrophage inflammatory protein 
ML  molecular layer (of the dentate gyrus) 
MTLE  medial temporal lobe epilepsy 
μOR  Mu opioid receptor 
NFT  neurofibrillary tangles 
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NLR  NOD-like receptors 
NLRP  nucleotide-binding domain, leucine-rich repeat containing proteins 
NPY  neuropeptide Y 
NSC  neural stem cell 
O-LM  oriens lacunosum-moleculare 
PBS  phosphate-buffered saline 
PolyI:C polyriboinosinic-polyribocytidilic acid 
PRR  pattern recognition receptor 
PS1  presenilin 1 
PSGL-1 P-selectin glycoprotein ligand-1 
PV  parvalbumin 
pTau  phosphorylated Tau  
PTZ  pentylenetetrazol 
RAG1  recombination activating gene 1 
REM  rapid eye movement 
ROI  region of interest 
SE  status epilepticus 
SEM  standard error of the mean 
sEPSC  spontaneous excitatory postsynaptic currents  
SGZ  subgranular zone 
sIPSC  spontaneous inhibitory postsynaptic currents  
SL  stratum lucidum 
SLM  stratum lacunosum moleculare 
SO  stratum oriens 
SOM  somatostatin 
SP  stratum pyramidale 
SR  stratum radiatum 
SRS  spontaneous recurrent seizures 
ssf  optical fractionator sampling fraction 
SSSE  self-sustained status epilepticus 
SVZ  subventricular zone 
SWR  sharp-wave ripples 
TeLC  tetanus toxin light chain 
TLE  temporal lobe epilepsy 
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TLR  Toll-like receptor 
TNF  tumor necrosis factor 
TrkB  tropomyosin receptor kinase B 
VCAM-1 vascular cell adhesion molecule 1 
vEEG  synchronous video and EEG recording 
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